<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">104375</article-id><article-id pub-id-type="doi">10.7554/eLife.104375</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.104375.3</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group></article-categories><title-group><article-title>Computer prediction and genetic analysis identifies retinoic acid modulation as a driver of conserved longevity pathways in genetically diverse <italic>Caenorhabditis</italic> nematodes</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Banse</surname><given-names>Stephen A</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5540-4526</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Sedore</surname><given-names>Christine A</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9512-2806</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Coleman-Hulbert</surname><given-names>Anna</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8090-551X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Johnson</surname><given-names>Erik</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Onken</surname><given-names>Brian</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Hall</surname><given-names>David</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Segerdell</surname><given-names>Erik</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Jackson</surname><given-names>E Grace</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Song</surname><given-names>Yuhua</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Osman</surname><given-names>Haley C</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Xue</surname><given-names>Jian</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Basttistoni</surname><given-names>Elena</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Guo</surname><given-names>Suhzen</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Foulger</surname><given-names>Anna</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Achanta</surname><given-names>Madhuri</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con15"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Sheikh</surname><given-names>Mustafa</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con16"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Fitzgibbon</surname><given-names>Theresa</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con17"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Willis</surname><given-names>John H</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4263-7347</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con18"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Woodruff</surname><given-names>Gavin C</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con19"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Driscoll</surname><given-names>Monica</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8751-7429</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con20"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Lithgow</surname><given-names>Gordon</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8953-3043</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con21"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Phillips</surname><given-names>Patrick C</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7271-342X</contrib-id><email>pphil@uoregon.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con22"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0293rh119</institution-id><institution>Institute of Ecology and Evolution, University of Oregon</institution></institution-wrap><addr-line><named-content content-type="city">Eugene</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05vt9qd57</institution-id><institution>Rutgers University, Department of Molecular Biology and Biochemistry</institution></institution-wrap><addr-line><named-content content-type="city">Piscataway</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/050sv4x28</institution-id><institution>The Buck Institute for Research on Aging</institution></institution-wrap><addr-line><named-content content-type="city">Novato</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Ghazi</surname><given-names>Arjumand</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01an3r305</institution-id><institution>University of Pittsburgh School of Medicine</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Kapahi</surname><given-names>Pankaj</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/050sv4x28</institution-id><institution>Buck Institute for Research on Aging</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>23</day><month>12</month><year>2025</year></pub-date><volume>13</volume><elocation-id>RP104375</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2024-10-17"><day>17</day><month>10</month><year>2024</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2024-10-26"><day>26</day><month>10</month><year>2024</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2024.10.23.619838"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-12-27"><day>27</day><month>12</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.104375.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2025-08-06"><day>06</day><month>08</month><year>2025</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.104375.2"/></event></pub-history><permissions><copyright-statement>© 2024, Banse et al</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Banse et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-104375-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-104375-figures-v1.pdf"/><abstract><p>Discovery of new compounds that ameliorate the negative health impacts of aging promises to be of tremendous benefit across a number of age-based comorbidities. One method to prioritize a testable subset of the nearly infinite universe of potential compounds is to use computational prediction of their likely anti-aging capacity. Here, we present a survey of longevity effects for 16 compounds suggested by a previously published computational prediction set, capitalizing upon the comprehensive, multi-species approach utilized by the <italic>Caenorhabditis</italic> Intervention Testing Program. While 11 compounds (aldosterone, arecoline, bortezomib, dasatinib, decitabine, dexamethasone, erlotinib, everolimus, gefitinib, temsirolimus, and thalidomide) either had no effect on median lifespan or were toxic, 5 compounds (all-trans retinoic acid, berberine, fisetin, propranolol, and ritonavir) extended lifespan in <italic>Caenorhabditis elegans</italic>. These computer predictions yield a remarkable positive hit rate of 30%. Deeper genetic characterization of the longevity effects of one of the most efficacious compounds, the endogenous signaling ligand all-trans retinoic acid (atRA, designated tretinoin in medical products), demonstrated a requirement for the regulatory kinases AKT-1 and AKT-2. While the canonical Akt-target FOXO/DAF-16 was largely dispensable, other conserved Akt-targets (Nrf2/SKN-1 and HSF1/HSF-1), as well as the conserved catalytic subunit of AMPK AAK-2, were all necessary for longevity extension by atRA. Our results highlight the potential of combining computational prediction of longevity interventions with the power of nematode functional genetics and underscore that the manipulation of a conserved metabolic regulatory circuit by co-opting endogenous signaling molecules is a powerful approach for discovering aging interventions.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd><italic>C. briggsae</italic></kwd><kwd><italic>C. tropicalis</italic></kwd><kwd><italic>Caenorhabditis</italic> Intervention Testing Program</kwd><kwd>CITP</kwd><kwd>lifespan</kwd><kwd>healthspan</kwd><kwd>compound screen</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>C. elegans</italic></kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01cwqze88</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>AG045844</award-id><principal-award-recipient><name><surname>Lithgow</surname><given-names>Gordon</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01cwqze88</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>AG045864</award-id><principal-award-recipient><name><surname>Driscoll</surname><given-names>Monica</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01cwqze88</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>AG045829</award-id><principal-award-recipient><name><surname>Phillips</surname><given-names>Patrick C</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01cwqze88</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>AG056052</award-id><principal-award-recipient><name><surname>Phillips</surname><given-names>Patrick C</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection, and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Computer screening identifies that the widely prescribed vitamin A derivative all-trans retinoic acid increases both longevity and late-life health in a powerful genetic model system.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Aging is a primary risk factor for a myriad of chronic illnesses, health declines, and mortality. A central premise of research in the current aging field is that aging per se can be treated directly, leading to ancillary benefits across a broad range of age-related comorbidities (the ‘geroscience hypothesis’; <xref ref-type="bibr" rid="bib10">Austad, 2016</xref>; <xref ref-type="bibr" rid="bib80">Kennedy et al., 2014</xref>). But how best to identify compounds holding the potential for broad-spectrum effects across an individual’s lifespan? While comprehensive screens using model organisms such as the nematode <italic>Caenorhabditis elegans</italic> provide a good approach (<xref ref-type="bibr" rid="bib124">Petrascheck et al., 2007</xref>), a complementary alternative is to use emerging databases of compound-specific physiological effects to predict which compounds are most likely to lead to positive effects on extending lifespan (<xref ref-type="bibr" rid="bib73">Janssens et al., 2019</xref>; <xref ref-type="bibr" rid="bib131">Ribeiro et al., 2023</xref>). An advantage of this approach is that the predictive models should become better and better as the training set of positive hits continues to expand over time (<xref ref-type="bibr" rid="bib162">Vanhaelen et al., 2020</xref>; <xref ref-type="bibr" rid="bib176">Zhavoronkov et al., 2019</xref>). Still, the efficacy of any predictive model is strongly dependent on the quality of the input data, and the well-documented heterogeneity of aging as a phenotype, as well as general challenges in reproducibility per se, create barriers to the successful application of predictive approaches to aging research. The <italic>Caenorhabditis</italic> Intervention Testing Program (CITP) tests compounds for lifespan and healthspan effects across a genetic diversity panel of <italic>Caenorhabditis</italic> nematode strains (<xref ref-type="bibr" rid="bib96">Lucanic et al., 2017</xref>). Beyond <italic>robustness</italic> of response across genetic backgrounds, the CITP has painstakingly focused on <italic>reproducibility</italic> across laboratories and trials via standardization of methods and a hierarchical statistical approach that accounts for experimental variation at a variety of levels of replication. These features make the CITP an ideal framework for testing computer predictions of longevity interventions and serve as the foundation for data collection for improved models in the future.</p><p>As a first step toward testing the efficacy of computational prediction of lifespan-extending compounds, we used a previously published set of compound predictions developed via an analysis of the overlap of drug-induced and aging-related gene expression and protein interactions (<xref ref-type="bibr" rid="bib51">Fuentealba et al., 2019</xref>) to develop a list of candidate compounds for further investigation using the CITP workflow. We prioritized compounds with the highest predictive scores and eliminated several compounds whose effects in <italic>C. elegans</italic> were already well characterized. Our analysis led to a set of 16 compounds (aldosterone, all-trans retinoic acid (atRA), arecoline, berberine, bortezomib, dasatinib, decitabine, dexamethasone, erlotinib, everolimus, fisetin, gefitinib, propranolol, ritonavir, temsirolimus, and thalidomide) selected for further testing. As outlined below, we found that of the five candidate compounds – atRA, berberine, fisetin, ritonavir, and propranolol – that extended median lifespan, propranolol and atRA conferred the largest positive effects. Potential confounding interactions of propranolol with the bacterial food of the nematodes led us to focus on atRA for more in-depth genetic and functional analysis.</p><p>atRA is an FDA-approved intervention used topically in dermatology and systemically as a chemotherapeutic adjuvant (<xref ref-type="bibr" rid="bib54">Giuli et al., 2020</xref>; <xref ref-type="bibr" rid="bib152">Szymański et al., 2020</xref>). Endogenously, atRA is the most bioactive retinoid derived from vitamin A, known to function as a highly conserved signaling ligand involved in transcriptional regulation (<xref ref-type="bibr" rid="bib3">Albalat, 2009</xref>; <xref ref-type="bibr" rid="bib4">Albalat and Cañestro, 2009</xref>; <xref ref-type="bibr" rid="bib49">Fonseca et al., 2020</xref>). In <italic>C. elegans</italic>, the presence of vitamin A metabolism pathway genes (<xref ref-type="bibr" rid="bib83">Kostrouch et al., 1995</xref>; <xref ref-type="bibr" rid="bib168">Yilmaz and Walhout, 2016</xref>), metabolism of exogenous vitamin A into retinal and atRA (<xref ref-type="bibr" rid="bib31">Chen et al., 2018</xref>), known affinity of <italic>C. elegans</italic> fatty acid- and retinol-binding proteins for retinoids (<xref ref-type="bibr" rid="bib53">Garofalo et al., 2003</xref>), and endogenous atRA detection in untreated animals (<xref ref-type="bibr" rid="bib31">Chen et al., 2018</xref>) combine to suggest the presence of an endogenous nematode atRA signaling pathway. While conservation of the ligand atRA is well supported, the canonical vertebrate downstream retinoid receptors (RXR and RAR) that effect transcriptional responses have not been identified in nematodes. In contrast with the elusive retinoic acid receptors, however, the mammalian kinases modulated by atRA have extensively studied <italic>C. elegans</italic> orthologs. In humans, atRA modulates transcription via PI3K/Akt (<xref ref-type="bibr" rid="bib17">Bastien et al., 2006</xref>; <xref ref-type="bibr" rid="bib19">Ben-Sasson et al., 2011</xref>; <xref ref-type="bibr" rid="bib48">Farias et al., 2005</xref>; <xref ref-type="bibr" rid="bib52">García-Regalado et al., 2013</xref>; <xref ref-type="bibr" rid="bib90">Lee et al., 2014</xref>; <xref ref-type="bibr" rid="bib101">Masiá et al., 2007</xref>; <xref ref-type="bibr" rid="bib127">Qiao et al., 2012</xref>) and p38 MAPK (<xref ref-type="bibr" rid="bib7">Alsayed et al., 2001</xref>; <xref ref-type="bibr" rid="bib42">De Genaro et al., 2013</xref>; <xref ref-type="bibr" rid="bib65">Hormi-Carver et al., 2007</xref>; <xref ref-type="bibr" rid="bib88">Lee et al., 2008</xref>; <xref ref-type="bibr" rid="bib134">Roe et al., 2020</xref>; <xref ref-type="bibr" rid="bib139">Shinozaki et al., 2007</xref>) kinase signaling. Functionally, kinase signaling is likely mediated by atRA regulation of the kinase phosphorylation state, as has been shown for Akt in mammalian (<xref ref-type="bibr" rid="bib17">Bastien et al., 2006</xref>; <xref ref-type="bibr" rid="bib52">García-Regalado et al., 2013</xref>; <xref ref-type="bibr" rid="bib127">Qiao et al., 2012</xref>) and avian (<xref ref-type="bibr" rid="bib171">Yu et al., 2012</xref>) cell culture.</p><p>Building upon our general screening approach, we present a more comprehensive genetic analysis of atRA impact on longevity that suggests functional conservation of atRA kinase regulation, as the effects of atRA on longevity require kinases encoded by both <italic>akt-1</italic> and <italic>akt-2</italic>. In <italic>C. elegans</italic> and mammals, Akt kinases regulate powerful aging pathways (e.g., insulin-like signaling (IIS), FOXO, and Nrf2). Our genetic analysis of atRA longevity in <italic>C. elegans</italic> suggests that the FOXO/DAF-16 transcription factor is not necessary, consistent with atRA acting downstream of, or in parallel to, FOXO. In contrast to FOXO/DAF-16, the Akt-phosphorylation targeted Nrf2 homolog SKN-1 and heat shock transcription factor 1 homolog HSF-1, along with the conserved catalytic subunit of the energy sensor AMPK AAK-2, are required for atRA-induced lifespan extension. The conservation of atRA as a signaling molecule, and the pathways through which atRA affects metabolism and lifespan, anchor the prediction that all-trans retinoic acid intervention (or atRA chemical variants) will translate into efficacious anti-aging in future mammalian and clinical studies.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Experimental testing of computational predictions identifies all-trans retinoic acid as a candidate pro-longevity intervention</title><p>To select compounds for CITP testing (<xref ref-type="fig" rid="fig1">Figure 1A</xref>), we began with the top 10% of candidates from a published list of computationally ranked compounds built using known drug-protein interactions (<xref ref-type="bibr" rid="bib51">Fuentealba et al., 2019</xref>). To avoid duplicative effort and to favor novel discovery, we used the DrugAge database (<xref ref-type="bibr" rid="bib16">Barardo et al., 2017b</xref>) to de-prioritize compounds that had already been published to extend <italic>C. elegans</italic> lifespan. We then selected 16 candidate interventions by cross-referencing the remaining compounds with the top 10% of two additional computational efforts that predicted aging effects based on comparative transcriptional responses (<xref ref-type="bibr" rid="bib73">Janssens et al., 2019</xref>) (all-trans retinoic acid, arecoline, propranolol, thalidomide) and machine-learning models based on gene ontologies and physical structures (<xref ref-type="bibr" rid="bib15">Barardo et al., 2017a</xref>) (aldosterone, berberine, bortezomib, dasatinib, decitabine, dexamethasone, erlotinib, gefitinib, ritonavir, temsirolimus), or listing in the DrugAge database with published lifespan extension in other systems everolimus (<xref ref-type="bibr" rid="bib142">Spindler et al., 2012</xref>) and fisetin (<xref ref-type="bibr" rid="bib170">Yousefzadeh et al., 2018</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Summary of lifespan effects for candidate compounds.</title><p>(<bold>A</bold>) Compounds were selected for testing by filtering the top 10% of predicted hits from <xref ref-type="bibr" rid="bib51">Fuentealba et al., 2019</xref> and cross-referencing for compounds that also appeared in the top 10% of <xref ref-type="bibr" rid="bib15">Barardo et al., 2017a</xref>, or <xref ref-type="bibr" rid="bib73">Janssens et al., 2019</xref>, or had been shown to work in other model organisms via the DrugAge database. Candidate compounds were then filtered using the DrugAge database and a literature search to deprioritize compounds previously characterized as extending lifespan in <italic>C. elegans</italic> to generate a list of 16 compounds for screening using lifespan analysis. (<bold>B</bold>) Percent difference in median lifespan of individual trial plates compared to the median survival from their pooled carrier control (DMSO and H<sub>2</sub>O) for animals treated with one of 16 candidate compounds selected for preliminary analysis. The dot represents the mean of all plate replicates across two trials, and the bars represent the standard error. Shown are the results from the longest-lived concentration treatment (4–5 concentrations were tested) for each candidate compound. The shown p-values and error bars are taken from the hierarchical CPH model (see Materials and methods).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-104375-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Longevity analysis screen in <italic>C</italic>. <italic>elegans</italic> N2 of 14 candidate compounds that were not selected for further study.</title><p>Four compounds (fisetin, berberine, aldosterone, and ritonavir) showed a positive but non-robust lifespan effect. Seven (decitabine, dasatinib, erlotinib, dexamethasone, temsirolimus, everolimus, and thalidomide) had no significant effect on survival, and three compounds (gefitinib, arecoline, and bortezomib) showed toxic effects. Each compound was assayed at 4–5 concentrations, with the upper limit defined by solubility of the compound or toxicity. The Kaplan–Meier curves presented consist of pooled replicates from two trials. Asterisks represent p-values from the CPH model such that ****p &lt; 0.0001, ***p &lt; 0.001, **p &lt; 0.01, and *p &lt; 0.05.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-104375-fig1-figsupp1-v1.tif"/></fig></fig-group><p>The selected compounds comprise a number of common aging-related classes, including bortezomib (a proteasome inhibitor; <xref ref-type="bibr" rid="bib30">Chen et al., 2011</xref>), fisetin (a sirtuin activator; <xref ref-type="bibr" rid="bib81">Kim et al., 2015</xref>), temsirolimus (a PI3K/mTOR inhibitor and derivative of rapamycin; <xref ref-type="bibr" rid="bib5">Ali et al., 2022</xref>), and dasatinib (a tyrosine kinase inhibitor; <xref ref-type="bibr" rid="bib153">Talpaz et al., 2006</xref>), among others (<xref ref-type="table" rid="table1">Table 1</xref>). We then screened the selected compounds at 4–5 concentrations using full lifespan analysis (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). Among the 16 candidate interventions, 3 were water-soluble and 13 were DMSO-soluble. While DMSO can impact lifespan (<xref ref-type="bibr" rid="bib165">Wang et al., 2010</xref>)<italic>,</italic> we did not observe a difference between the H<sub>2</sub>O and DMSO vehicle control treatments (median lifespan 17 days for both, p = n.s.), consistent with the published absence of DMSO effects at concentrations similar to those used in our studies (<xref ref-type="bibr" rid="bib6">AlOkda and Van Raamsdonk, 2022</xref>)<italic>.</italic> Among the 16 computationally prioritized candidate compounds, we found that aldosterone, dexamethasone, erlotinib, decitabine, dasatinib, everolimus, thalidomide, and temsirolimus did not significantly change median lifespan at any tested concentration (<xref ref-type="fig" rid="fig1">Figure 1B</xref>; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>)<italic>.</italic></p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>CITP tested compounds that meet computational prediction selection criteria of this study.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Candidate</th><th align="left" valign="bottom">Predictions</th><th align="left" valign="bottom">CITP publication</th><th align="left" valign="bottom">Beneficial effect on median survival in <italic>C. elegans</italic> in CITP?</th><th align="left" valign="bottom">Pathway/mode of action</th></tr></thead><tbody><tr><td align="left" valign="bottom"><bold>Bortezomib</bold></td><td align="left" valign="bottom">F + B</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">Proteasome inhibitor (<xref ref-type="bibr" rid="bib30">Chen et al., 2011</xref>)</td></tr><tr><td align="left" valign="bottom">Metformin</td><td align="left" valign="bottom">F + J</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib115">Onken et al., 2022</xref></td><td align="left" valign="bottom">41% increase at 70 mM</td><td align="left" valign="bottom">Anti-diabetes</td></tr><tr><td align="left" valign="bottom">17-Alpha estradiol</td><td align="left" valign="bottom">F + J</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib14">Banse et al., 2024b</xref></td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">Estrogen receptor agonist</td></tr><tr><td align="left" valign="bottom">Rapamycin</td><td align="left" valign="bottom">F + J</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib14">Banse et al., 2024b</xref></td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">mTOR inhibitor</td></tr><tr><td align="left" valign="bottom">Aspirin</td><td align="left" valign="bottom">F + J</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib96">Lucanic et al., 2017</xref></td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">NSAID</td></tr><tr><td align="left" valign="bottom">Imatinib</td><td align="left" valign="bottom">F + J + B</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib34">Coleman-Hulbert et al., 2019</xref></td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">Tyrosine kinase inhibitor</td></tr><tr><td align="left" valign="bottom"><bold>atRA</bold></td><td align="left" valign="bottom">F + J</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">29% extension at 150 µM</td><td align="left" valign="bottom">Collagen formation, activates xenobiotic metabolism</td></tr><tr><td align="left" valign="bottom"><bold>Dasatinib</bold></td><td align="left" valign="bottom">F + B</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">Tyrosine kinase inhibitor</td></tr><tr><td align="left" valign="bottom"><bold>Temsirolimus</bold></td><td align="left" valign="bottom">F + B</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">mTOR inhibitor</td></tr><tr><td align="left" valign="bottom"><bold>Gefitinib</bold></td><td align="left" valign="bottom">F + B</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">EGFR inhibitor (tyrosine kinase inhibitor)</td></tr><tr><td align="left" valign="bottom">Resveratrol</td><td align="left" valign="bottom">F + J</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib96">Lucanic et al., 2017</xref></td><td align="left" valign="bottom">12% extension at 100 µM</td><td align="left" valign="bottom">Sirtuin activator</td></tr><tr><td align="left" valign="bottom"><bold>Berberine</bold></td><td align="left" valign="bottom">F + B</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">16.3% extension at 100 µM</td><td align="left" valign="bottom">AMPK activator</td></tr><tr><td align="left" valign="bottom"><bold>Decitabine</bold></td><td align="left" valign="bottom">F + B</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">Nucleic acid synthesis inhibitor</td></tr><tr><td align="left" valign="bottom"><bold>Erlotinib</bold></td><td align="left" valign="bottom">F + B</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">EGFR inhibitor (tyrosine kinase inhibitor)</td></tr><tr><td align="left" valign="bottom">Valproic acid</td><td align="left" valign="bottom">F + J</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib96">Lucanic et al., 2017</xref></td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">Blocks sodium-gated ion channels, increases GABA</td></tr><tr><td align="left" valign="bottom"><bold>Aldosterone</bold></td><td align="left" valign="bottom">F + B</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Significant at 50 µM due to late life effects, no change in median lifespan</td><td align="left" valign="bottom">Steroid hormone</td></tr><tr><td align="left" valign="bottom"><bold>Dexamethasone</bold></td><td align="left" valign="bottom">F + B</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">Anti-inflammatory corticosteroid</td></tr><tr><td align="left" valign="bottom"><bold>Propranolol</bold></td><td align="left" valign="bottom">F + J</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">44% extension at 1 mM<xref ref-type="table-fn" rid="table1fn1">*</xref></td><td align="left" valign="bottom">Beta-blocker</td></tr><tr><td align="left" valign="bottom"><bold>Thalidomide</bold></td><td align="left" valign="bottom">F + J</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">TNF-a inhibition</td></tr><tr><td align="left" valign="bottom"><bold>Arecoline</bold></td><td align="left" valign="bottom">F + J</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">Muscarinic agonist (inhibits pharyngeal pumping)</td></tr><tr><td align="left" valign="bottom"><bold>Ritonavir</bold></td><td align="left" valign="bottom">F + B</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">4.1% extension at 20 µM</td><td align="left" valign="bottom">HIV protease inhibitor: inhibits enzymes that normally metabolize other protease inhibitors (primarily in intestines, liver, etc.)</td></tr><tr><td align="left" valign="bottom"><bold>Fisetin</bold></td><td align="left" valign="bottom">F + D</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">11.7% extension at 50 µM</td><td align="left" valign="bottom">Sirtuin activator</td></tr><tr><td align="left" valign="bottom"><bold>Everolimus</bold></td><td align="left" valign="bottom">F + D</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">mTOR inhibitor</td></tr></tbody></table><table-wrap-foot><fn id="table1fn1"><label>*</label><p>May be an indirect effect. NP = no positive effect detected. F – in the top 10% of <xref ref-type="bibr" rid="bib51">Fuentealba et al., 2019</xref>, B – in the top 10% of <xref ref-type="bibr" rid="bib15">Barardo et al., 2017a</xref>, J – in the top 10% of <xref ref-type="bibr" rid="bib73">Janssens et al., 2019</xref>, and D – a positive listing in DrugAge <xref ref-type="bibr" rid="bib16">Barardo et al., 2017b</xref>. Compounds denoted in <bold>bold</bold> were tested by the CITP for this study, while other listed compounds were tested previously by the CITP.</p></fn></table-wrap-foot></table-wrap><p>Among the eight remaining candidates, we found that three compounds shortened median lifespan (arecoline, gefitinib, and bortezomib). Tests of muscarinic/nicotinic agonist arecoline at five concentrations ranging from 50 µM to 8 mM revealed toxic effects at the highest concentration (–29.4% median lifespan, p &lt; 0.0001). The epidermal growth factor inhibitor gefitinib also had small, but significant, negative effects at 10, 25, 50, and 80 µM (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). In contrast, the 26S proteasome inhibitor bortezomib conferred strong toxicity effects that increased with concentration through the entire concentration range we tested (5, 10, 20, and 30 µM, –10.5% to –47.3% median lifespan; p = 0.0002 at 5 µM and p &lt; 0.0001 at all other concentrations; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). Thus, some compounds computationally predicted to enhance longevity can be found to be toxic when empirically investigated, underscoring that validation is a key element of any prediction pipeline.</p><p>We found that the remaining five compounds conferred statistically significant positive effects on median lifespan for at least one tested concentration (<xref ref-type="fig" rid="fig1">Figure 1B</xref>; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>), representing a hit success rate of 31.25% (5/16) for our test set (<xref ref-type="table" rid="table1">Table 1</xref>). Seven additional compounds met our selection criteria, but because they had been previously tested by the CITP, we did not include these compounds in tests presented here (see <xref ref-type="table" rid="table1">Table 1</xref>). With those previously tested compounds included, we see a similar overall hit success rate of ~30% (7/23) (<xref ref-type="table" rid="table1">Table 1</xref>). The bioactivity of these compounds was as follows: ritonavir had effects at 20 and 35 µM (6.3%, p = 0.0016 and p = 0.0282, respectively). The sirtuin activation/mTOR inhibitor fisetin had positive effects at 10, 50, and 100 µM (p = 0.0081, p = 0.0025, and p = 0.0032, respectively), with an effect size up to 11.8%, and no effect detected at 20 µM. The AMPK activator berberine conferred significant effects only at 100 µM, with an 11.8% increase in median lifespan (p &lt; 0.0001). In support of the potential translatability of the computationally predicted candidate compounds tested here, fisetin (<xref ref-type="bibr" rid="bib170">Yousefzadeh et al., 2018</xref>) and berberine (<xref ref-type="bibr" rid="bib39">Dang et al., 2020</xref>) have also been found to increase median lifespan in mice.</p><p>The two remaining candidate interventions induced large increases in longevity, with propranolol extending median lifespan 44.4% at 1 mM (p &lt; 0.0001) and atRA extending median lifespan 23.5% at 150 µM (p &lt; 0.0001) (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). Propranolol and atRA are particularly interesting interventions because they are both FDA-approved drugs, potentially providing an easier path toward clinical use as aging interventions. For example, propranolol is a well-tolerated drug with a long history of use (<xref ref-type="bibr" rid="bib143">Srinivasan, 2019</xref>, p. 50; <xref ref-type="bibr" rid="bib172">Zacharias et al., 1972</xref>) treating high blood pressure (<xref ref-type="bibr" rid="bib125">Prichard and Gillam, 1964</xref>), angina (<xref ref-type="bibr" rid="bib60">Hamer et al., 1964</xref>), and atrial fibrillation (<xref ref-type="bibr" rid="bib135">Rowlands et al., 1965</xref>). While we observed a large (44.4%, p &lt; 0.0001) median lifespan extension at 1 mM propranolol, we also saw extension at 0.5 mM (16.7%, p &lt; 0.0001) (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). In contrast to the positive effects that we observed at 0.5 and 1 mM, we found that increasing the treatment concentration to 5 mM propranolol resulted in toxicity and a reduction in lifespan (–61.1%, p &lt; 0.0001) (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). These observations led us to extend our tests into the related species <italic>C. briggsae</italic> (AF16) and <italic>C. tropicalis</italic> (JU1630). In these two species, we observed similar toxicity at 5 mM (p &lt; 0.0001), but no beneficial effects at lower concentrations (<xref ref-type="fig" rid="fig2">Figure 2E, F</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Dose-dependent lifespan effects of all-trans retinoic acid and propranolol across diverse <italic>Caenorhabditis</italic> species.</title><p>(<bold>A–C</bold>) Manual lifespan analysis of five concentrations of atRA (black – DMSO control, increasing levels of teal 1–150 µM) and (<bold>D–F</bold>) propranolol (black – H<sub>2</sub>O control, increasing levels of pink – 50–5000 µM) on three <italic>Caenorhabditis</italic> species. The upper limit tested was determined by compound solubility (atRA), or toxicity (propranolol). The Kaplan–Meier curves presented consist of pooled replicates from two trials. Asterisks represent p-values from the CPH model such that ****p &lt; 0.0001, ***p &lt; 0.001, **p &lt; 0.01, and *p &lt; 0.05.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-104375-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Median lifespan dose response of all-trans retinoic acid and propranolol in <italic>C.</italic> <italic>elegans</italic> N2.</title><p>Percent difference in median lifespan of an individual trial plate (1–150 µM atRA, 50–5000 µM propranolol) compared to its specific control (DMSO control for atRA or H<sub>2</sub>O for propranolol) for <italic>C. elegans</italic> N2 (data also presented as survival curves in <xref ref-type="fig" rid="fig2">Figure 2A, D</xref>). Each point represents a single plate replicate with approximately 50 worms. The error bars represent the mean ± the standard error of the mean. Error bars and p-values are from the hierarchical CPH model, with ****p &lt; 0.0001, ***p &lt; 0.001, **p &lt; 0.01, and *p &lt; 0.05.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-104375-fig2-figsupp1-v1.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Metoprolol does not extend lifespan in <italic>C.</italic> <italic>elegans</italic>, nor does propranolol on PFA-treated OP50-1, consistent with its bacteriostatic activity.</title><p>(<bold>A</bold>) Manual lifespan analysis of five concentrations of metoprolol (black – H<sub>2</sub>O control, increasing levels of blue – 50–1500 µM) on <italic>C. elegans</italic> N2. (<bold>B</bold>) Manual lifespan analysis of <italic>C. elegans</italic> N2 on propranolol (black – H<sub>2</sub>O control, increasing levels of pink – 500 and 1000 µM) using paraformaldehyde treated OP50-1 <italic>E. coli.</italic> Kaplan–Meier curves consist of pooled replicates from two trials. Asterisks represent p-values from the CPH model such that ****p &lt; 0.0001, ***p &lt; 0.001, **p &lt; 0.01, and *p &lt; 0.05. (<bold>C</bold>) Colony forming units of <italic>E. coli</italic> cultures (100 µl at a 1 × 10<sup>–6</sup> dilution) on LB plates treated with H<sub>2</sub>O, 500, 1000, and 5000 µM propranolol.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-104375-fig2-figsupp2-v1.tif"/></fig></fig-group><p>In human applications, propranolol functions as a general antagonist of β1 and β2 beta-adrenergic receptors. We therefore sought to determine if a β1-specific antagonist like metoprolol could recapitulate the longevity effects in <italic>C. elegans</italic>. We assayed longevity effects for metoprolol across a concentration range of 5 µM to 1.5 mM and observed no positive effects (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A</xref>). Although there could be multiple reasons that metoprolol was not effective, we followed up by asking whether the effects of propranolol require β2 antagonism or are unrelated to β-adrenergic antagonism. A β-adrenergic-independent mechanism was suggested by the change we noted in the appearance of the bacterial lawns on propranolol-treated plates. When we tested bacterial growth, we found that propranolol reduced bacterial growth at the same concentrations at which we observed lifespan effects (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2C</xref>). The propranolol impact on bacterial food source growth suggests a potential indirect food-dependent mechanism for propranolol on <italic>C. elegans</italic> lifespan. We therefore repeated the lifespan studies at 0.5 and 1 mM in the presence of paraformaldehyde-treated bacteria that are metabolically inert (<xref ref-type="bibr" rid="bib21">Beydoun et al., 2021</xref>). Under conditions in which propranolol effects on bacterial growth were eliminated, we observed shorter lifespans in populations treated by propranolol (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2B</xref>). These observations suggest that propranolol either does not exert direct beneficial effects on lifespan in <italic>C. elegans</italic> or has confounding direct and indirect effects that depend on bacterial food state. The potential food-dependent effects of propranolol require further study beyond the scope of our current screening protocols. Therefore, we elected to focus on the large lifespan extension generated by atRA treatment for the remainder of this study.</p></sec><sec id="s2-2"><title>Longevity extension via atRA treatment is dependent upon genetic background</title><p>The scientific literature is rife with examples of intervention effects on longevity that vary in response to experimental differences. Indeed, previous experiments treating <italic>C. elegans</italic> with atRA have resulted in contradictory effects (<xref ref-type="bibr" rid="bib73">Janssens et al., 2019</xref>; <xref ref-type="bibr" rid="bib144">Statzer et al., 2021</xref>) for reasons that are not entirely clear. To determine the most efficacious concentration of atRA treatment, we tested a dosage range from 1 to 150 µM. For <italic>C. elegans</italic> N2, we observed increasing positive effects at all tested concentrations above 1 µM (which had no detectable effect; <xref ref-type="fig" rid="fig2">Figure 2</xref>) and a very slight but significant increase in median lifespan for <italic>C. tropicalis</italic> JU1630 at 150 µM atRA (7.7%, p = 0.0215). However, we observed no effects in <italic>C. briggsae</italic> across the tested concentration range (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Given these observations, we elected to use 150 µM atRA for the remainder of the experiments in this study. In contrast with propranolol, we observed no obvious effects of atRA on bacterial growth using replica plating<italic>.</italic></p><p>Expanding this analysis across a more extensive genetic diversity set following the full CITP replication protocol, we tested the effects of atRA on three strains of <italic>C. elegans</italic> (N2, JU775, MY16), <italic>C. briggsae</italic> (AF16, ED3092, HK104), and <italic>C. tropicalis</italic> (JU1630, JU1373, QG834) (<xref ref-type="fig" rid="fig3">Figure 3</xref>) with replication at three distinct geographic sites (University of Oregon, Rutgers University, and the Buck Institute). Total genetic variation across <italic>C. elegans</italic> strains is comparable to that observed among humans, while the differences among species are comparable to the genetic distance between humans and mice (<xref ref-type="bibr" rid="bib156">Teterina et al., 2022</xref>). We found that the substantial atRA-associated effects on longevity are robust to genetic variation across all three <italic>C. elegans</italic> strains, yielding lifespan extensions of 18.8–44.4% (<xref ref-type="fig" rid="fig3">Figure 3</xref>; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>). While the lifespan extension initially observed in <italic>C. tropicalis</italic> JU1630 failed to replicate, <italic>C. tropicalis</italic> QG834 displayed a small but significant increase in lifespan (<xref ref-type="fig" rid="fig3">Figure 3</xref>; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>). Clearly, given the small effect size, we are at the edge of statistical power to detect a positive effect within this species. Again, atRA did not register any significant positive effects in the <italic>C. briggsae</italic> strains (<xref ref-type="fig" rid="fig3">Figure 3</xref>; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>). Partitioning total variation across this large set of experimental replicates, we found only a small amount of variability attributable to site (3.9%) or differences among experimenters (7.1%), with the majority of variance being attributable to individual variation (53.2%; <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a</xref>), consistent with previous CITP studies (<xref ref-type="bibr" rid="bib13">Banse et al., 2024a</xref>; <xref ref-type="bibr" rid="bib96">Lucanic et al., 2017</xref>). Thus, atRA treatment is reproducible within and between laboratories, but subject to high levels of individual variation, as are all longevity studies.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>The vitamin A derivative atRA extends life in a species-specific manner.</title><p>The effect of adult exposure to 150 µM atRA on median survival in manual lifespan assays. Three strains were tested from each of three species: <italic>C. elegans</italic> strains N2, JU775, and MY16, <italic>C. briggsae</italic> AF16, ED3092, and HK104, and <italic>C. tropicalis</italic> strains JU1630, JU1373, and QG834. Each point represents the percent change in median survival for an individual trial plate relative to the vehicle control median. The bars represent the mean ± the standard error of the mean. Replicates were completed at the three CITP testing sites (circles – Oregon, squares – Buck Institute, and diamonds – Rutgers). Error bars and asterisks represent p-values from the hierarchical CPH model such that ****p &lt; 0.0001, ***p &lt; 0.001, **p &lt; 0.01, and *p &lt; 0.05.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-104375-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Lifespan curves for the data presented in <xref ref-type="fig" rid="fig3">Figure 3</xref> – manual survival of nine <italic>Caenorhabditis</italic> strains with 150 µM atRA treatment.</title><p>Lifespan analysis for DMSO control (black) and 150 µM (dark teal) atRA treatment starting at day 1 of adulthood. Three <italic>C. elegans</italic> (N2, JU775, MY16), three <italic>C. briggsae</italic> (AF16, ED3092, HK104), and <italic>C. tropicalis</italic> (JU1630, JU1373, QG834) strains were tested. Kaplan–Meier curves represent pooled replicates from multiple trials at each of the three CITP testing sites (Oregon, Buck Institute, Rutgers). Asterisks represent p-values from the CPH model such that ****p &lt; 0.0001, ***p &lt; 0.001, **p &lt; 0.01, and *p &lt; 0.05.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-104375-fig3-figsupp1-v1.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>Survival of nine CITP strains with atRA treatment on the ALM.</title><p>Longevity analysis for control (black) and 150 µM (dark green) atRA. Three <italic>C. elegans</italic> (N2, JU775, MY16), three <italic>C. briggsae</italic> (AF16, ED3092, HK104), and <italic>C. tropicalis</italic> (JU1630, JU1373, QG834) strains were tested. The longevity analysis was performed using the Lifespan Machine technology (<xref ref-type="bibr" rid="bib146">Stroustrup et al., 2013</xref>) in a single lab. Kaplan–Meier curves represent pooled replicates from at least three trials. Asterisks represent p-values from the CPH model such that ****p &lt; 0.0001, ***p &lt; 0.001, **p &lt; 0.01, and *p &lt; 0.05.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-104375-fig3-figsupp2-v1.tif"/></fig><fig id="fig3s3" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 3.</label><caption><title>Swimming ability of the nine CITP strains with atRA treatment.</title><p>The <italic>C. elegans</italic> Swim Test (CeleST) was used to assess swimming ability in all nine strains as a locomotory measure of healthspan. Eight measures of swimming ability were combined to create a single composite measure, the adjusted swimming score. Each dot represents the mean adjusted swimming score for a single trial at one of the three CITP testing sites (circle – Oregon, square – The Buck Institute, diamond – Rutgers). Bars indicate the mean ± the standard error of the mean. Error bars and p<italic>-</italic>values are from the linear mixed model, with ****p &lt; 0.0001, ***p &lt; 0.001, **p &lt; 0.01, and *p &lt; 0.05.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-104375-fig3-figsupp3-v1.tif"/></fig></fig-group><p>To increase the temporal resolution of our survivorship curves, we repeated our longevity analyses using the Automated Lifespan Machine (ALM) technology (<xref ref-type="bibr" rid="bib146">Stroustrup et al., 2013</xref>) across the same nine genetically diverse strains. We again observed a positive effect for the three <italic>C. elegans</italic> strains, demonstrating the robustness of atRA longevity effects across genetic backgrounds in these strains (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>). Interestingly, we do not see any positive effects of atRA on the ALM for <italic>C. briggsae</italic> or <italic>C. tropicalis</italic>, but instead see slightly toxic effects for <italic>C. briggsae</italic> strains AF16 and HK104 and <italic>C. tropicalis</italic> strain JU1630. It is not clear what might drive this difference, although the ALM introduces some different environmental stresses and conditions as compared to manual assay conditions (e.g., repeated light exposure and distinct compound introduction; see <xref ref-type="bibr" rid="bib12">Banse et al., 2019</xref> for discussion).</p></sec><sec id="s2-3"><title>atRA tends to enhance locomotory healthspan in <italic>C. elegans</italic>, but not in <italic>C. briggsae</italic> or <italic>C. tropicalis</italic></title><p>A goal of longevity interventions is to enhance physiological health, which, like in humans, can be measured as improvement in older age locomotory capacity. We therefore determined the effect of atRA exposure on aging adult swim performance using a video analysis of swimming behavior (<xref ref-type="bibr" rid="bib70">Ibáñez-Ventoso et al., 2016</xref>; <xref ref-type="bibr" rid="bib130">Restif et al., 2014</xref>). In previous work, we reported that anti-aging interventions can have disparate effects on longevity and adult swimming ability and that treated strains can show positive effects in motility enhancement (<xref ref-type="bibr" rid="bib14">Banse et al., 2024b</xref>) even in the absence of longevity enhancement. Using strain-specific models for swimming behavior to generate a composite swimming score based on eight underlying measures (<xref ref-type="bibr" rid="bib14">Banse et al., 2024b</xref>), we observed significant improvement for two of the <italic>C. elegans</italic> strains at day 12 of adulthood (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3</xref>). Similar to atRA effects on longevity, we find that atRA was generally ineffectual at promoting swimming health in <italic>C. briggsae</italic> and <italic>C. tropicalis</italic>, with improvements only seen in day 16 of AF16 (41.6%, p = 0.00191), while decreased swimming scores were observed in all three <italic>C. tropicalis</italic> strains at one or more test days. Overall, then, atRA has largely positive effects on <italic>C. elegans</italic> longevity and health while it has the potential to be detrimental to <italic>C. briggsae</italic> and <italic>C. tropicalis</italic> depending on the assay type and particular genetic background.</p></sec><sec id="s2-4"><title>atRA lifespan extension requires atRA-modulated kinases AKT-1, AKT-2, and AMPK</title><p>Given the plasticity of genetically determined longevity within <italic>C. elegans</italic>, we next sought to identify the pathways required for atRA lifespan extension. Because no retinoic acid binding transcription factors have been identified in <italic>C. elegans</italic>, we looked to the known effects of atRA in modulating human kinase activity (<xref ref-type="bibr" rid="bib3">Albalat, 2009</xref>; <xref ref-type="bibr" rid="bib4">Albalat and Cañestro, 2009</xref>; <xref ref-type="bibr" rid="bib49">Fonseca et al., 2020</xref>) to identify candidate pathways. The vertebrate atRA-responsive kinases do have extensively studied orthologs in <italic>C. elegans</italic>. Akt homologs emerged as particularly relevant due to their involvement in longevity-related IIS signaling, and the fact that in mammals, phosphorylation of Akt in response to atRA occurs at a site that appears to be conserved in the <italic>C. elegans</italic> Akt homologs (<xref ref-type="bibr" rid="bib52">García-Regalado et al., 2013</xref>). We therefore asked whether either <italic>akt-1</italic> or <italic>akt-2</italic> was required for atRA lifespan effects by measuring the lifespans of <italic>akt-1(ok525)</italic> and <italic>akt-2(ok393)</italic> loss of function mutants (<xref ref-type="fig" rid="fig4">Figure 4A, B</xref>). Consistent with previously published studies (<xref ref-type="bibr" rid="bib110">Newell Stamper et al., 2018</xref>; <xref ref-type="bibr" rid="bib141">Soukas et al., 2009</xref>), in control-treated animals, we observed longer median lifespans for the mutants (median 26 and 23 days vs. 17 in WT). When we performed longevity analysis of <italic>akt-1(ok525)</italic> in the presence of atRA (<xref ref-type="fig" rid="fig4">Figure 4A</xref>), we observed a significant decrease in longevity (–7.7% median lifespan, p <italic>=</italic> 0.00000142), demonstrating a requirement for AKT-1 in atRA-induced longevity extension. Repeating the analysis in <italic>akt-2(ok393)</italic> mutants (<xref ref-type="fig" rid="fig4">Figure 4B</xref>) demonstrated a complete dependence on AKT-2, with atRA having no significant effect in the <italic>akt-2</italic> mutant background (p = 0.7170). We conclude that atRA longevity effects require <italic>akt-1</italic> and <italic>akt-2</italic>, consistent with a known atRA signaling mechanism in mammals.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Genetic analysis of atRA effects on lifespan.</title><p>Lifespan analysis under 150 µM atRA (green) or vehicle control (black). For wildtype, the canonical CITP N2 strain was used. This response was compared to loss of function/downregulation of the Akt/protein kinase B (PKB) homologs (<bold>A</bold>) <italic>akt-1</italic> and (<bold>B</bold>) <italic>akt-2</italic>, (<bold>C</bold>) the AMP-activated protein kinase <italic>aak-2</italic>, (<bold>D</bold>) the heat shock transcription factor homolog <italic>hsf-1</italic>, (<bold>E</bold>) the Nrf transcription factor homolog <italic>skn-1</italic>, (<bold>F</bold>) the FOXO transcription factor homolog <italic>daf-16</italic>, (<bold>G</bold>) the p38 MAP kinase homolog <italic>pmk-1</italic>, (<bold>H</bold>) the toll-like receptor <italic>tol-1</italic>, and (<bold>I</bold>) the acetylcholine receptor <italic>eat-2</italic>. For <italic>skn-1</italic>, RNAi knockdown was used because of the lethality of the mutant (see <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref> for control RNAi experiment). For all other genes, loss of function mutants were used. Kaplan–Meier curves include pooled replicates from two trials, except for the RNAi experiment, which consisted of three trials. Asterisks represent p-values from the CPH model such that ****p &lt; 0.0001, ***p &lt; 0.001, **p &lt; 0.01, and *p &lt; 0.05.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-104375-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>SKN-1 regulation and <italic>skn-1</italic> RNAi lifespan.</title><p>(<bold>A</bold>) Post-transcriptional regulation of SKN-1 via phosphorylation is mediated by the <italic>pmk-1</italic>/p38 MAPK, PI3K/Akt, and GSK kinase pathways. Each pathway regulates phosphorylation of pathway-specific serines of SKN-1, enabling additive regulation. (<bold>B</bold>) Kaplan–Meier lifespan curves of worms grown on <italic>E. coli</italic> HT115 expressing either an empty vector control (solid) or <italic>skn-1</italic> RNAi (dashed) and treated with either 150 µM atRA (dark green) or the vehicle control (black). Each curve represents pooled replicates from three independent trials. Asterisks represent p-values from the CPH model such that ****p &lt; 0.0001, ***p &lt; 0.001, **p &lt; 0.01, and *p &lt; 0.05.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-104375-fig4-figsupp1-v1.tif"/></fig></fig-group><p>Similarly, in human cell culture (<xref ref-type="bibr" rid="bib72">Ishijima et al., 2015</xref>) and mouse models (<xref ref-type="bibr" rid="bib174">Zhang et al., 2019</xref>), retinoic acid activates AMPK. AMPK is a conserved sensor of intracellular energy state that regulates glucose and lipid metabolism. Previous work has shown that AMPK is involved in the transition to gluconeogenesis in the long-lived dauer stage (<xref ref-type="bibr" rid="bib122">Penkov et al., 2020</xref>) and may also play a role in gluconeogenesis in adults (<xref ref-type="bibr" rid="bib111">Nguyen et al., 2020</xref>). In <italic>C. elegans</italic>, AMPK is required for many longevity interventions (<xref ref-type="bibr" rid="bib74">Jayarathne et al., 2020</xref>; <xref ref-type="bibr" rid="bib114">Onken and Driscoll, 2010</xref>; <xref ref-type="bibr" rid="bib121">Peng et al., 2019</xref>), while overexpression of the AMPK catalytic subunit <italic>aak-2</italic> (<xref ref-type="bibr" rid="bib9">Apfeld et al., 2004</xref>)<italic>,</italic> or expression of a constitutively activated AAK-2 (<xref ref-type="bibr" rid="bib57">Greer et al., 2007</xref>; <xref ref-type="bibr" rid="bib98">Mair et al., 2011</xref>), can directly increase lifespan. Additionally, AMPK both regulates and is regulated by Akt, making AMPK an interesting candidate for involvement in atRA longevity effects. We therefore tested aak-2(ok524) mutants for atRA lifespan extension. We observed that the atRA lifespan extension was fully dependent on aak-2 (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). Overall, our data suggest that atRA longevity may be mediated through a conserved signaling process.</p></sec><sec id="s2-5"><title>Robust atRA lifespan extension requires the HSF-1 and SKN-1 transcription factors</title><p>Another set of atRA transducing factors signaling are <italic>hsf-1</italic>, the human heat shock factor 1 transcription factor homolog, and <italic>skn-1</italic>, the nematode homolog of the mammalian Akt-target Nrf2. Previous work has demonstrated that HSF-1 is required for several lifespan-extending genetic and pharmacological interventions in <italic>C. elegans</italic> (<xref ref-type="bibr" rid="bib87">Lazaro-Pena et al., 2022</xref>; <xref ref-type="bibr" rid="bib145">Steinkraus et al., 2008</xref>; <xref ref-type="bibr" rid="bib159">Todorova et al., 2023</xref>) and that skn-1 can directly promote lifespan (<xref ref-type="bibr" rid="bib154">Tang and Choe, 2015</xref>; <xref ref-type="bibr" rid="bib161">Tullet et al., 2017</xref>), as well as being implicated in multiple longevity interventions (<xref ref-type="bibr" rid="bib43">Duangjan et al., 2019</xref>; <xref ref-type="bibr" rid="bib138">Seo et al., 2015</xref><xref ref-type="bibr" rid="bib138">Seo et al., 2015</xref>) including vitamin D (<xref ref-type="bibr" rid="bib100">Mark et al., 2016</xref>) and thioflavin T (<xref ref-type="bibr" rid="bib2">Alavez et al., 2011</xref>; <xref ref-type="bibr" rid="bib96">Lucanic et al., 2017</xref>). In mammalian studies, Akt directly regulates HSF1 through phosphorylation (<xref ref-type="bibr" rid="bib28">Carpenter et al., 2015</xref>; <xref ref-type="bibr" rid="bib38">Da Costa et al., 2020</xref>; <xref ref-type="bibr" rid="bib95">Lu et al., 2022</xref><xref ref-type="bibr" rid="bib95">Lu et al., 2022</xref>; <xref ref-type="bibr" rid="bib155">Tang et al., 2020</xref>), and hsf-1 has been implicated as a downstream effector of PI3K/Akt signaling that functions in conjunction with DAF-16 to regulate lifespan in <italic>C. elegans</italic> (<xref ref-type="bibr" rid="bib32">Chiang et al., 2012</xref>; <xref ref-type="bibr" rid="bib68">Hsu et al., 2003</xref>). We tested for atRA lifespan extension in a hsf-1(sy441) mutant encoding a premature stop codon that removes the conserved transactivation domain (<xref ref-type="bibr" rid="bib59">Hajdu-Cronin et al., 2004</xref>)<italic>.</italic> In this <italic>hsf-1</italic> background, atRA treatment had a greatly reduced impact on lifespan, showing only a small increase in median lifespan and no extension in maximum lifespan (<xref ref-type="fig" rid="fig4">Figure 4D</xref>)<italic>.</italic></p><p>Because <italic>skn-1</italic> is an essential gene required developmentally to specify mesodermal fates (<xref ref-type="bibr" rid="bib24">Bowerman et al., 1992</xref>; <xref ref-type="bibr" rid="bib97">Maduro et al., 2001</xref>), we tested for longevity effects of atRA in animals fed HT115 <italic>E. coli</italic> carrying an RNAi vector targeting <italic>skn-1</italic> (<xref ref-type="bibr" rid="bib79">Kamath and Ahringer, 2003</xref>) starting from the L3/L4 developmental stage (skn-1 is an essential gene for early development, and thus assaying a knockout mutation or beginning with earlier interventions is not possible). It should be noted that we observed that the HT115 strain of <italic>E. coli</italic> itself extends lifespan relative to strain OP50, consistent with previous findings (<xref ref-type="bibr" rid="bib148">Stuhr and Curran, 2020</xref>; <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>). When we compared skn-1 RNAi-treated animals exposed to atRA versus vehicle control, in contrast to the lifespan extension for animals under control RNAi conditions, we observed a 23.8% decrease in median lifespan (p &lt; 0.001) (<xref ref-type="fig" rid="fig4">Figure 4E</xref> and <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>), suggesting that atRA is toxic in the absence of skn-1 function. Our data are consistent with hsf-1 and skn-1 being necessary for the lifespan-extending transcriptional response to atRA and/or for addressing potential toxic side effects of atRA<italic>.</italic></p></sec><sec id="s2-6"><title>The FoxO/DAF-16 transcription factor is not essential for atRA lifespan extension</title><p>Given the dependence on <italic>akt-1/2</italic>, we sought to determine if atRA lifespan extension requires the canonical <italic>C. elegans</italic> AKT-target <italic>daf-16</italic>/FOXO, a known regulator of aging (<xref ref-type="bibr" rid="bib108">Murphy and Hu, 2013</xref>) for which activation is a common feature of chemical interventions that extend <italic>C. elegans</italic> lifespan (<xref ref-type="bibr" rid="bib82">Kim et al., 2019</xref>; <xref ref-type="bibr" rid="bib166">Wang et al., 2015</xref>; <xref ref-type="bibr" rid="bib175">Zhao et al., 2017</xref>) (although <italic>daf-16</italic> independent lifespan extension is also possible; <xref ref-type="bibr" rid="bib114">Onken and Driscoll, 2010</xref>). We therefore measured longevity in <italic>daf-16(mu86)</italic> null mutants treated with atRA. We found that <italic>daf-16(mu86)</italic> animals still exhibited a lifespan extension (12%, p &lt; 0.0001) compared to vehicle control animals (<xref ref-type="fig" rid="fig4">Figure 4F</xref>). The fact that the atRA longevity effect size is larger in wildtype animals (24% vs. 12%) reveals that although <italic>daf-16</italic> contributes in part to the atRA effect, DAF-16 is not absolutely required, and therefore additional or alternative outputs must be operative. Inputs to longevity pathways are well documented to be complex and inter-related (<xref ref-type="bibr" rid="bib109">Narasimhan et al., 2009</xref>; <xref ref-type="bibr" rid="bib113">Nikoletopoulou et al., 2014</xref>; <xref ref-type="bibr" rid="bib119">Parkhitko et al., 2020</xref>). For example, <italic>akt-1</italic> and <italic>akt-2</italic> are primary upstream modulators of <italic>daf-16</italic> in the IIS pathway regulation of the long-lived alternative dauer larval state (<xref ref-type="bibr" rid="bib117">Paradis and Ruvkun, 1998</xref>), but have little effect on IIS modulation of adult longevity, when <italic>sgk-1</italic> becomes the primary regulator of DAF-16 (<xref ref-type="bibr" rid="bib62">Hertweck et al., 2004</xref>). We conclude that atRA acts in part via DAF-16 but infer that atRA either acts independently of the IIS pathway, or primarily through the PI3K/Akt portion of the IIS pathway, which would be consistent with Akt-dependent atRA signaling in mammals (<xref ref-type="bibr" rid="bib17">Bastien et al., 2006</xref>; <xref ref-type="bibr" rid="bib52">García-Regalado et al., 2013</xref>; <xref ref-type="bibr" rid="bib127">Qiao et al., 2012</xref>)<italic>.</italic></p></sec><sec id="s2-7"><title>atRA lifespan extension in <italic>tol-1</italic> and <italic>pmk-1</italic> mutants</title><p>While our observation that atRA requires AKT-1/2 and SKN-1 is consistent with a simple signaling cascade in which atRA modulates Akt regulation of SKN-1, more complicated responses are possible. Previous research has established that there is crosstalk between Akt and p38 MAPK signaling in humans (<xref ref-type="bibr" rid="bib55">Gonzalez et al., 2004</xref>) and in <italic>C. elegans</italic> (<xref ref-type="bibr" rid="bib160">Tullet et al., 2008</xref>)<italic>.</italic> Genetic and biochemical analysis of SKN-1 has shown that in addition to Akt regulation, SKN-1 is also post-translationally regulated by the <italic>pmk-1</italic>/p38 MAPK pathway (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>). Importantly, work in mammals has implicated p38/MAPK signaling in atRA responses (<xref ref-type="bibr" rid="bib7">Alsayed et al., 2001</xref>; <xref ref-type="bibr" rid="bib42">De Genaro et al., 2013</xref>; <xref ref-type="bibr" rid="bib65">Hormi-Carver et al., 2007</xref>; <xref ref-type="bibr" rid="bib88">Lee et al., 2008</xref>; <xref ref-type="bibr" rid="bib134">Roe et al., 2020</xref>; <xref ref-type="bibr" rid="bib139">Shinozaki et al., 2007</xref>), suggesting that atRA may affect two different signaling cascades that can regulate SKN-1<italic>.</italic></p><p>In light of these considerations, we addressed p38 MAPK signaling as a potential effector pathway for atRA. <italic>C. elegans</italic> has three known p38 mitogen-activated protein kinase homologs, <italic>pmk-1</italic>, <italic>pmk-2</italic>, and <italic>pmk-3</italic>. SKN-1 is regulated by the MAPK cascade that culminates with p38/PMK-1 phosphorylation of SKN-1 at serines 164 and 430 (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>). The phosphorylation of S164 and A430 sites results in increased nuclear SKN-1 levels, resulting in transcription of innate immunity and oxidative stress genes (<xref ref-type="bibr" rid="bib71">Inoue et al., 2005</xref>). When we tested <italic>pmk-1(km25)</italic> mutants for atRA longevity effects, we found that <italic>pmk-1(km25)</italic> mutants exhibit an atRA-induced extension in median lifespan (26.3%, <italic>P</italic>&lt;0.0001), but did not exert an effect on maximum lifespan, suggesting enhanced importance of <italic>pmk-1</italic> later in life (<xref ref-type="fig" rid="fig4">Figure 4G</xref>). Although our data identify AKT-1 and AKT-2 as more impactful than p38/PMK-1 in atRA-mediated longevity, additive and more complex atRA regulation of SKN-1 by PI3K/Akt and p38 MAPK pathways may be possible. For example, Akt regulates SKN-1 through phosphorylation of serine 12 (<xref ref-type="bibr" rid="bib23">Blackwell et al., 2015</xref>), while <italic>pmk-1</italic> regulates SKN-1 through serines 164 and 430 (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>).</p><p>To probe the candidate signaling pathways further, we considered potential pathway receptors. <italic>C. elegans PMK-1</italic> functions downstream of <italic>TIR-1</italic> (<xref ref-type="bibr" rid="bib93">Liberati et al., 2004</xref>; <xref ref-type="bibr" rid="bib123">Peterson et al., 2022</xref>)<italic>,</italic> one of two Toll/interleukin-1 receptor homology (TIR) domain-containing genes (<xref ref-type="bibr" rid="bib120">Paysan-Lafosse et al., 2023</xref>). The second TIR-domain containing protein is the membrane-associated TOL-1, which signals through a p38 MAPK cascade including <italic>mom-3</italic> and <italic>pmk-3</italic>, and ultimately IKB-1. We measured the lifespan of <italic>tol-1(nr2033)</italic> mutants treated with atRA to find that <italic>tol-1(nr2033)</italic> animals exhibit an enhanced response to atRA, with an 82.4% increase in median lifespan in the mutant background relative to the 23.5% increase observed in the N2 wildtype background (<xref ref-type="fig" rid="fig4">Figure 4H</xref>)<italic>.</italic></p></sec><sec id="s2-8"><title>atRA can extend lifespan in a genetic caloric restriction model</title><p>One widely conserved mechanism for lifespan extension is caloric restriction. In <italic>C. elegans</italic> longevity research, one frequently used caloric restriction model is genetic mutation of <italic>eat-2</italic>. EAT-2 is a nicotinic acetylcholine receptor expressed in the pharyngeal muscle that facilitates normal, fast feeding behavior (<xref ref-type="bibr" rid="bib11">Avery, 1993</xref>; <xref ref-type="bibr" rid="bib102">McKay et al., 2004</xref>; <xref ref-type="bibr" rid="bib128">Raizen et al., 1995</xref>). In an <italic>eat-2</italic> mutant background, feeding behavior is slowed, inducing a caloric restriction state that extends life (<xref ref-type="bibr" rid="bib86">Lakowski and Hekimi, 1998</xref>), either via dietary restriction itself or via a combination of dietary restriction and an innate immunity response to altered bacterial processing (<xref ref-type="bibr" rid="bib84">Kumar et al., 2019</xref>). Previous work has shown that some compound interventions are incapable of further prolonging <italic>eat-2</italic> lifespan (e.g., metformin; <xref ref-type="bibr" rid="bib114">Onken and Driscoll, 2010</xref>), while other interventions appear independent/additive (e.g., Sonneradon A; <xref ref-type="bibr" rid="bib76">Jiang et al., 2022</xref>) with <italic>eat-2</italic> effects. We were particularly interested in the possibility that atRA might act as an <italic>eat-2</italic>-like dietary restriction mimetic because previous characterization demonstrated that <italic>eat-2</italic> longevity was independent of <italic>daf-16</italic> (<xref ref-type="bibr" rid="bib86">Lakowski and Hekimi, 1998</xref>)<italic>,</italic> but dependent on <italic>skn-1</italic> (<xref ref-type="bibr" rid="bib118">Park et al., 2010</xref>)<italic>,</italic> mimicking our observations for atRA. We therefore treated <italic>eat-2(ad1113)</italic> mutants with vehicle and atRA. Consistent with atRA acting through a mechanism distinct from <italic>eat-2</italic>, we observed a significant atRA-induced extension in lifespan in the <italic>eat-2(ad1113)</italic> animals (36.8% increase in median survival, p &lt; 2e−16) (<xref ref-type="fig" rid="fig4">Figure 4I</xref>). In <italic>C. elegans</italic> studies, caloric restriction can be induced through several different experimental regimes, each of which requires a different set of genetic pathways to exert longevity effects (<xref ref-type="bibr" rid="bib58">Greer and Brunet, 2009</xref>). We therefore conclude that atRA longevity effects are either unrelated to and/or are mechanistically distinct from <italic>eat-2</italic> effects on longevity<italic>.</italic></p></sec><sec id="s2-9"><title>atRA treatment alters gene expression in stress-response pathways</title><p>Given the dependency of lifespan extension under atRA treatment, we used RNA-seq to assess transcriptional changes under atRA treatment in wildtype N2 animals. We performed RNA-seq on day 4 adult animals treated with atRA compared to carrier control. We were able to detect the expression of 12,746 <italic>C. elegans</italic> genes in our dataset (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). Among the detected genes, 17% (2169) were differentially expressed with atRA treatment (FDR &lt;0.05). We defined the subset of differentially expressed genes with an absolute log<sub>2</sub> fold change (LFC) greater than one as <underline>w</underline>ildtype <underline>a</underline>tRA <underline>r</underline>esponse <underline>g</underline>enes (WaRGs). The WaRGs represent ~5.1% of all detected genes (653 total) and were more heavily weighted toward downregulated genes, with 487 (3.8% of total) downregulated versus 166 (1.3% of total) upregulated. Analysis of the expression pattern of the WaRGs shows a skewed distribution among the upregulated genes, with 86% (138/160; <italic>q</italic> = 5.9e−38) of the genes with characterized expression being produced in the intestine. The downregulated genes are enriched for genes expressed in the excretory duct (32/470; <italic>q</italic> = 4.1e−9), excretory socket cell (29/470; <italic>q</italic> = 5.1e−08), and the epithelial system (281/470; <italic>q</italic> = 2.7e−8). Potentially relevant to metabolic regulation of aging, the intestine and the hypodermal cells are the primary energy storage tissues in <italic>C. elegans</italic> (<xref ref-type="bibr" rid="bib99">Mak, 2012</xref>; <xref ref-type="bibr" rid="bib107">Mullaney and Ashrafi, 2009</xref>)<italic>.</italic></p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Altered transcriptome under atRA treatment.</title><p>(<bold>A</bold>) Volcano plot for gene expression from RNA-seq experiments performed on day 4 of adulthood exposed to 150 µM atRA or vehicle control. (<bold>B</bold>) Enrichment analysis using WormCat (<xref ref-type="bibr" rid="bib63">Higgins et al., 2022</xref>; <xref ref-type="bibr" rid="bib64">Holdorf et al., 2020</xref>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-104375-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Collagens are downregulated in response to atRA exposure.</title><p>Using a previously published in silico analysis of the <italic>C. elegans</italic> matrisome (i.e., all proteins that make up the extracellular matrix; <xref ref-type="bibr" rid="bib157">Teuscher et al., 2019</xref>), we extracted all collagen and collagen-related genes with expression data from our RNA-seq dataset. For easier presentation, we used the in silico analysis grouping of core matrisome genes (e.g., collagens, proteoglycans, glycoproteins) and matrisome associate genes (ECM-affiliated proteins like C-type lectins, galectins, annexins, and ECM regulators like MMPs, ADAMs, and crosslinking enzymes, and secreted factors like BMPs, FGFs, and chemokines [see <xref ref-type="bibr" rid="bib157">Teuscher et al., 2019</xref> and supplemental data, <xref ref-type="bibr" rid="bib26">Caenorhabditis Intervention Testing Program, 2025</xref> for a full list]). The genes were further divided into genes for which mammal to <italic>C. elegans</italic> orthology could be established, and those that were nematode specific.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-104375-fig5-figsupp1-v1.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>Effects of atRA on transcription of sphingolipid metabolism genes.</title><p>(<bold>A</bold>) The <italic>C. elegans</italic> sphingolipid metabolism network with genes significantly (FDR &lt;0.05) downregulated (red) or upregulated (blue), noted by color. (<bold>B</bold>) The log fold change for the genes and a (<bold>C</bold>) volcano plot showing the genes with their respective FDRs. All data available in supplemental information (<xref ref-type="bibr" rid="bib26">Caenorhabditis Intervention Testing Program, 2025</xref>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-104375-fig5-figsupp2-v1.tif"/></fig></fig-group><p>A WormCat 2.0 (<xref ref-type="bibr" rid="bib63">Higgins et al., 2022</xref>; <xref ref-type="bibr" rid="bib64">Holdorf et al., 2020</xref>) enrichment analysis of the WaRGs (<xref ref-type="fig" rid="fig5">Figure 5B</xref>) showed overlapping and differing enrichments between up- and downregulated genes. For example, we noted stress-related gene enrichments in both classes of WaRGs, consistent with known PI3K/Akt and p38 MAPK functions in <italic>C. elegans</italic> and with the strong correlation between stress response and longevity (<xref ref-type="bibr" rid="bib178">Zhou et al., 2011</xref>). Among the non-overlapping enrichments, we found that the upregulated set was enriched for metabolism and transmembrane transport genes (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). We found that collagen and neuropeptide-related genes (<xref ref-type="fig" rid="fig5">Figure 5B</xref>) were disproportionally represented among the non-overlapping but downregulated set. We were particularly surprised by the former because atRA was identified as a longevity modulator through induction of a collagen (<italic>col-144::gfp</italic>) reporter (<xref ref-type="bibr" rid="bib144">Statzer et al., 2021</xref>) and some observations correlate longevity with collagen expression (<xref ref-type="bibr" rid="bib47">Ewald et al., 2015</xref>; <xref ref-type="bibr" rid="bib56">Goyala and Ewald, 2023</xref>). Separation of the collagen and collagen-related genes by type <xref ref-type="bibr" rid="bib157">Teuscher et al., 2019</xref> demonstrated a general trend of atRA either not changing or downregulating collagen genes (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>). For example, the cuticular collagens, of which <italic>col-144</italic> is a predicted member, and other core genes associated with the extracellular matrix (matrisome genes) were either unchanged in expression or downregulated (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>). In contrast with the core-matrisome genes, the matrisome-associated category did include a number of upregulated genes in the ECM-regulator and ECM-affiliated subclasses.</p><p>We also analyzed the WaRGs from a metabolic perspective using the WormFlux Pathway enrichment tool (<xref ref-type="bibr" rid="bib164">Walker et al., 2021</xref>). Among the 166 upregulated WaRGs, we documented an enrichment of sphingolipid metabolism (8/45 genes, p<sub>enrichment</sub> = 2.3e−07) (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>) and iron metabolism (2/15 genes, p<sub>enrichment</sub> = 0.025) pathway genes, while the 487 downregulated WaRGs were enriched for fatty acid biosynthesis (6/24 genes, p<sub>enrichment</sub> = 0.00051), fatty acid degradation (2/8, p = 0.048), folate biosynthesis (2/8 genes, p<sub>enrichment</sub> = 0.048), and UGT enzyme (8/67, p<sub>enrichment</sub> = 0.0094) pathway genes. Interestingly, WormFlux analysis also suggests that genes related to the electron transport chain may be under-represented (0/88 genes, p<sub>depletion</sub> = 0.013) among the downregulated WaRGs.</p><p>Because of the potential overlap of enriched gene categories with the functions of the IIS-PI3K/Akt and Nrf2-p38 MAPK pathways in <italic>C. elegans</italic>, we wanted to determine if the genes with the largest fold change in expression were among the known IIS and Nrf2 regulons. Focusing on genes with a significant absolute LFC &gt;3, we observed that among the 24 most upregulated genes, 83% (20) have previously been observed to be regulated by the IIS pathway and 71% (17) have been observed to be regulated by the Nrf2 pathway (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1b</xref>). Interestingly, the four genes without a known connection to the IIS pathway appear non-random. For example, the most upregulated gene (<italic>E02C12.10</italic>, LFC = 9.9) is a member of a family of 31 paralogs in <italic>C. elegans</italic> predicted to have kinase-like activity (<xref ref-type="bibr" rid="bib41">Davis et al., 2022</xref>; <xref ref-type="bibr" rid="bib163">Vilella et al., 2009</xref>). Interestingly, the E02C12.10 gene, which clearly merits further investigation, was also identified as a significant contributor to survival of AMPK-deficient dauer larvae using a genome-wide RNAi screen (<xref ref-type="bibr" rid="bib167">Xie and Roy, 2012</xref>). Two additional members of the ‘most upregulated’ gene set (E02C12.12 and E02C12.6) were also members of this gene family, in addition to 10 additional genes in the upregulated WaRGS, representing 32% of all family members and ~48% (10/21) of the family members detected in our dataset, a significant enrichment over the observed rate (1.3%, p &lt; 0.0001). In contrast with the upregulated WaRGs, none of the family members were classified as downregulated WaRGs. The function of these genes is unknown, but the family is defined by a putative protein kinase domain and a nuclear hormone receptor-like structure (<xref ref-type="bibr" rid="bib41">Davis et al., 2022</xref>) that suggests a potential for transduction of an atRA regulatory response. There were fewer downregulated genes with an LFC &lt;−3, with only 12 genes reaching the threshold. Among those 12 genes, 100% have previously been shown to be regulated by both the IIS and Nrf2 pathways (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1c</xref>).</p><p>Overall, consistent with our genetic results, there is a clear footprint of atRA activity across a broad set of stress-response and longevity-related pathways, with some indication of novel activity as well.</p></sec><sec id="s2-10"><title>The HSF-1 transcription factor is an important effector of the overall atRA transcriptional response</title><p>To further dissect the transcriptional response to atRA in detail, we repeated our transcriptional analysis in several mutant backgrounds. Using <italic>hsf-1(sy441)</italic> mutants, we were able to identify mRNA from 13,737 genes (compared to 12,746 in N2). A comparison of transcriptional responses to atRA for all genes shows that there is a strong correlation between the N2 and <italic>hsf-1(sy441)</italic> expression changes (<italic>R</italic><sup>2</sup> = 0.306, p &lt; 0.0001) (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). Using the same cutoffs that we used for our wildtype dataset to define WaRGs, we determined that the atRA regulon for <italic>hsf-1(sy441)</italic> animals (298/13737) is ~42% the size of wildtype (653/12,746), with half of the response unique to <italic>hsf-1(sy441)</italic> (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). Comparing the 653 WaRGs from the general analysis with the subset identified in <italic>hsf-1</italic> mutants, ~96% (629/653) were detected in both datasets. Among the 470 downregulated WaRGs, only 14% (64/470) still meet the WaRG thresholds in the <italic>hsf-1</italic> background. Among the 158 upregulated WaRGs that were detectible in our <italic>hsf-1(sy441)</italic> dataset, half (79/158) of the genes still met the threshold for classification as a WaRG. The loss of differential expression could result from fewer genes changing expression or by a decrease in magnitude of the response that drops genes below our current threshold for defining WaRG genes. This potential for ‘lost’ regulation would be particularly skewed for genes whose expression change was near the absolute LFC = 1 threshold, where a negligible change could alter the categorization of the response. We therefore categorized the WaRG response as being maintained (0.5–2x WT response), weakened (&lt;0.5X WT), lost (FDR &gt;0.05), or flipped in the <italic>hsf-1</italic> background (<xref ref-type="fig" rid="fig6">Figure 6C</xref>). We found that a greater portion of the downregulated WaRG response was dependent on <italic>hsf-1</italic>, with only 29% of the downregulated response being maintained, compared to 61% of the upregulated response (<xref ref-type="fig" rid="fig6">Figure 6D</xref>). We then sought to determine if the lost and maintained WaRGs represented unique functions by performing an enrichment analysis using the WormCat analysis tool (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>). We found that the maintained response was enriched for sphingolipid (6/44, p <italic>=</italic> 6.1e−06), sterol (6/59, p = 6.9e−04), and short chain dehydrogenase (6/42, p = 0.00011) metabolism genes. Additionally, the maintained response was also enriched for C-type lectin (10/256, p = 0.00029), CYP detoxification (10/82, p = 1.7e−07), and CUB pathogen (4/25, p = 0.004) stress-response genes. The same analysis of the lost WaRG response genes suggests an <italic>hsf-1</italic> dependence for atRA regulation of solute carrier (12/197, p = 0.000103), neuropeptide (10/139, p = 0.000196), and stress-response genes. Thus, <italic>hsf-1</italic> plays an important, but hardly absolute, role in mediating the atRA longevity response.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Analysis of the role of <italic>hsf-1</italic> and <italic>aak-2</italic> in atRA transcriptional response.</title><p>(<bold>A</bold>) Comparison of DE genes with FDR &lt;0.5 and |LFC| &gt;1 in the <italic>hsf-1</italic> background to the changes observed in the wildtype background. The gray dashed line shows the expected relationship if the mutation had no effect on atRA response, while the orange dashed line shows the fit to the observed data. (<bold>B</bold>) Comparison of the genome-wide atRA-induced change in expression for all genes detected in both the N2 and <italic>hsf-1(sy441)</italic>. (<bold>C</bold>) Plot of the FDR for the WaRGs detected in the <italic>hsf-1(sy441)</italic> background by the difference in expression changes between WT and mutant background normalized to the change observed in WT animals. (<bold>D</bold>) Classification of WaRGs as maintaining, weakening, losing, or flipping their response in <italic>hsf-1(sy441)</italic> animals. (<bold>E</bold>) Comparison of the genome-wide atRA-induced change in expression for all genes detected in both the N2 and <italic>aak-2(ok524)</italic> datasets. The gray dashed line shows the expected relationship if the mutation had no effect on atRA response, while the blue dashed line shows the fit to the observed data. (<bold>F</bold>) Comparison of DE genes with FDR &lt;0.5 and |LFC| &gt;1 in the <italic>aak-2(ok524)</italic> background to the changes observed in the wildtype background. (<bold>G</bold>) Plot of the FDR for the WaRGs detected in the <italic>aak-2(ok524)</italic> background by the difference in expression change between WT and mutant background normalized to the change observed in WT animals. (<bold>H</bold>) Classification of WaRGs has maintaining, weakening, losing, or flipping their response in <italic>aak-2(ok524)</italic> animals.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-104375-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>The WormCat enrichment analysis for the WaRGs whose response was maintained, weakened, or lost in <italic>hsf-1(sy441)</italic> or <italic>aak-2(ok524)</italic> animals<italic>.</italic></title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-104375-fig6-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-11"><title>Loss of AMPK results in both lost and gained transcriptional responses to atRA</title><p>To determine the role of AMPK in regulating the transcriptional response to atRA, we repeated our RNA-seq analysis in <italic>aak-2(ok524)</italic> mutants. A comparison of the transcriptional response to atRA for all genes shows that there is a strong correlation between the N2 and <italic>aak-2(ok524)</italic> data sets for expression changes (<italic>R</italic><sup>2</sup> = 0.589, p &lt; 0.0001) (<xref ref-type="fig" rid="fig6">Figure 6E</xref>). Using the same cutoffs that we used for our wildtype dataset to define WaRGs, we determined that the atRA regulon for <italic>aak-2(ok524)</italic> mutants (802/12,611) is actually larger than wildtype (653/12,746), with more than half (456/802) of the response unique to <italic>aak-2(524)</italic> (<xref ref-type="fig" rid="fig6">Figure 6F</xref>). We next sought to determine what portion of the wildtype atRA transcriptional response was lost in <italic>aak-2</italic> mutants. We therefore analyzed the 96% of the WaRGs (627/653) that were detected in our <italic>aak-2</italic> dataset and found that 76% (122/160) of the upregulated and 79% (367/467) of the downregulated WaRGs were similarly regulated in <italic>aak-2</italic> animals (<xref ref-type="fig" rid="fig6">Figure 6G, H</xref>). A WormCat 2.0 analysis (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>) of the maintained atRA response demonstrated enrichment for secreted extracellular proteins (7/54, p = 0.004), collagen (12/184, p <italic>=</italic> 0<italic>.</italic>006), and solute carrier (18/197, p = 8.67e−7) genes. The maintained response was also enriched for sphingolipid (6/44, p <italic>=</italic> 1.5e−06) metabolism genes, suggesting that this metabolism category of changed expression observed in wildtype animals is upstream of <italic>aak-2</italic>. Additionally, there is an enrichment for caenacin (4/11, p = 0.007), and CUB pathogen (5/25, p = 0.009) stress-response genes. There was also an enrichment for ABC transmembrane transport (9/50, p = 82.9e−5) and cathepsin (5/22, p = 0.005) genes. We conclude that while <italic>aak-2</italic> is absolutely required for the longevity effects of atRA, <italic>aak-2</italic> is required for only a small proportion (~1/4) of the transcriptional response.</p></sec><sec id="s2-12"><title>AAK-2 functions downstream of HSF-1 in the transcriptional response to atRA</title><p>Given that HSF-1 and AAK-2 are both required for atRA lifespan extension, we sought to determine if HSF-1 and AAK-2 act in series or in parallel. Because a typical genetic analysis of longevity would not enable such a determination, we turned to the atRA transcriptional response (653 WaRGs) identified in wildtype animals. Compared to our datasets from <italic>aak-2(ok524)</italic> and <italic>hsf-1(sy441)</italic>, 610/653 WaRGs were detectible in both mutants. We therefore analyzed those 610 genes for patterns of transcriptional response. We observed that <italic>aak-2(ok524)</italic> mutants retained a larger portion of the response, with 84.4% (515/610) of the WaRGs still being differentially expressed (FDR &lt;0.05) in the <italic>aak-2(ok524)</italic> mutants, while only 52.6% (315/610) were in <italic>hsf-1(sy441)</italic> animals.</p><p>We next sought to categorize the atRA response overlap between mutants. We first used our normalized LFCΔ-based classification of WaRGs (maintained, enhanced, lost, weakened, or flipped) to determine the relationship between regulation in <italic>hsf-1</italic> and <italic>aak-2</italic> backgrounds. We find that nearly 87% (85/98) of the lost response in <italic>aak-2</italic> was also lost in <italic>hsf-1</italic> animals, while nearly 90% of the response retained in <italic>hsf-1(sy441)</italic> animals was retained in <italic>aak-2(ok524)</italic> animals (208/232; <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1d</xref>). These results are inconsistent with two parallel responses where we would expect (mostly) non-overlapping classes of regulated (lost) genes. In fact, we see a significant enrichment of overlap beyond the expected overlap for random regulation between <italic>hsf-1</italic> and <italic>aak-2</italic>. This suggests that HSF-1 and AAK-2 regulators act in series, with <italic>hsf-1</italic> upstream of <italic>aak-2</italic>, in the atRA pathway.</p><p>We then reanalyzed the WaRGs after subsetting based on response in the mutant backgrounds. We found no enrichments at the levels used in our previous analyses for the response lost in both genetic backgrounds. In contrast, we observed enrichments for iron, amino acid, and sphingolipid metabolism among those genes whose response was maintained in both <italic>hsf-1</italic> and <italic>aak-2</italic> backgrounds. We interpret these changes to be either independent of the atRA longevity pathway, or upstream of <italic>hsf-1</italic> in the atRA longevity response. A similar analysis of the 212 WaRGs that were lost in <italic>hsf-1(sy441)</italic>, but retained in <italic>aak-2</italic>, showed an enrichment for fatty acid biosynthesis and UGT pathway genes. Interestingly, HSF1 has been implicated in regulating fatty acid biosynthesis in mammals (<xref ref-type="bibr" rid="bib77">Jin et al., 2011</xref>), suggesting a potentially conserved <italic>hsf-1</italic> function that lies upstream of <italic>aak-2</italic> in the atRA longevity response.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>The translation of the biology of aging to improvements in human health will require an extensive and varied set of interventions as candidates for clinical trials. Among these interventions, small drug-like chemical compounds, or actual approved drugs, are likely to feature in translation. There is now a 25-year-old history of experiments showing small molecule extension in lifespan in simple laboratory animals and a 15-year history of extending lifespan in laboratory mice. Identifying novel compounds that hold the potential to extend life, especially if they do so by increasing the overall period of healthy living (healthspan) and not just lifespan per se (<xref ref-type="bibr" rid="bib35">Crimmins, 2015</xref>; <xref ref-type="bibr" rid="bib45">EbioMedicine, 2015</xref>) is of import. While there have been some celebrated successes in this area, the chemical space explored to date for longevity interventions is small. Hence, the field is shifting toward a systematic appraisal of a more comprehensive set of target compounds. One potential method of accomplishing this goal is to use a broad collection of information on biological activity and structural characteristics of individual compounds to create a ‘training set’ that allows computational prediction of compound effects, thereby providing a means of prioritizing validation efforts in the face of many hundreds of thousands of potential options. Here we present a ‘proof of concept’ of this approach using a comprehensive, multi-species approach in <italic>Caenorhabditis</italic> nematodes via the CITP that draws upon a previously published set of compounds predicted to have positive effects on lifespan-related pathways (<xref ref-type="bibr" rid="bib51">Fuentealba et al., 2019</xref>). Overall, focusing primarily on top-ranked and novel compounds, we find the mining of these predictions can be highly effective, with more than 31% of tested compounds leading to an increase in lifespan. When this list is augmented by additional predicted compounds previously tested by the CITP (and therefore not retested here), the prediction success rate stays very similar at 30% (<xref ref-type="table" rid="table1">Table 1</xref>). In comparison, several large-scale compound screens in <italic>C. elegans</italic> yielded much lower initial hit rates (&lt;2%) and required multiple rounds of experimental validation to narrow down compounds to move forward into full lifespan assays (<xref ref-type="bibr" rid="bib124">Petrascheck et al., 2007</xref>; <xref ref-type="bibr" rid="bib96">Lucanic et al., 2017</xref>). The retest hit rate in both of these studies was less than 0.2%.</p><p>While most compounds tested here had relatively moderate effects (&lt;15% increase in median lifespan), two interventions conferred large effects, including propranolol with a greater than 44% increase in median lifespan and all-trans retinoic acid (atRA), with a greater than 23% increase in median lifespan in <italic>C. elegans</italic>. The effects of both compounds were variable and were much reduced in related species <italic>C. briggsae</italic> and <italic>C. tropicalis</italic>, which has been a common feature of CITP tests for reasons that remain currently unknown (<xref ref-type="bibr" rid="bib14">Banse et al., 2024b</xref>; <xref ref-type="bibr" rid="bib12">Banse et al., 2019</xref>; <xref ref-type="bibr" rid="bib96">Lucanic et al., 2017</xref>; <xref ref-type="bibr" rid="bib115">Onken et al., 2022</xref>). Fortunately, <italic>C. elegans</italic> itself has been a reliable testing platform, including robust responses across a wide set of genetic backgrounds (<xref ref-type="bibr" rid="bib12">Banse et al., 2019</xref>). Tests of the effect of propranolol directly on bacterial growth suggest that the increase in lifespan with that treatment might be caused by a dietary-restriction-like response in the nematodes, since growth of the bacteria that serve as their food source is inhibited under propranolol exposure. This effect deserves further investigation but was outside of the scope of the current project.</p><p>Of the sixteen compounds initially targeted, atRA emerged as the most interesting candidate, with positive effects on both lifespan and locomotory healthspan across diverse natural isolates of <italic>C. elegans</italic>. The positive effects of atRA have also been indicated by other studies, which generated a positive hit using a distinct approach involving the maintenance of collagen expression in adult <italic>C. elegans</italic> (<xref ref-type="bibr" rid="bib144">Statzer et al., 2021</xref>). As such, atRA presented itself as an ideal candidate for using the power of nematode genetics to move from computational prediction to functional analysis. The fact that atRA is already an FDA-approved intervention for other indications makes it a particularly inviting compound. This observation is strengthened by the recent observation that the atRA precursor vitamin A can also enhance longevity in <italic>C. elegans</italic> and does so in a <italic>skn-1</italic>-dependent manner (<xref ref-type="bibr" rid="bib140">Sirakawin et al., 2024</xref>).</p><sec id="s3-1"><title>Putative atRA targets</title><p>Analysis of mutants in a number of key regulatory and stress-response systems treated with atRA suggests that atRA functions through the AKT-1 and AKT-2 kinases to affect conserved AMPK, Nrf2, and HSF1 pathways. Using a comprehensive RNA-seq approach with and without atRA treatment in both wildtype and mutant backgrounds suggests extensive remodeling of sphingolipid and fatty acid metabolic networks, both of which are known to modulate lifespan. While these data support a model for atRA affecting longevity through Akt and its downstream longevity transcription factors <italic>hsf-1</italic> and <italic>skn-1</italic>, the mechanism of initiation upstream of Akt remains unknown. One explanatory model of upstream initiation is suggested by our observation that atRA transcriptionally alters sphingolipid metabolism in <italic>C. elegans</italic>, which has also been seen in mammals (<xref ref-type="bibr" rid="bib27">Camdzic et al., 2023</xref>; <xref ref-type="bibr" rid="bib33">Clarke et al., 2011</xref>; <xref ref-type="bibr" rid="bib78">Kalén et al., 1992</xref>; <xref ref-type="bibr" rid="bib150">Sun and Wang, 2021</xref>). Sphingolipids are known to regulate developmental rate and lifespan in <italic>C. elegans</italic> (<xref ref-type="bibr" rid="bib37">Cutler et al., 2014</xref>)<italic>,</italic> and potentially in mammals as well (<xref ref-type="bibr" rid="bib36">Cutler and Mattson, 2001</xref>). For example, remodeling the sphingolipid metabolism network through RNAi-induced reductions in <italic>ttm-5</italic> (dihydroceramide desaturase homologue), <italic>W02F12.2</italic> (neutral/acidic ceramidase homologue), <italic>cgt-2</italic> (glucosylceramide synthase homologue) or <italic>K06A9.1</italic> (neutral sphingomyelinase homolog), all result in lifespan extension. Additionally, genetic disruption of the ceramide synthases alters lifespan, with loss of <italic>hyl-2</italic> shortening and simultaneous loss of <italic>hyl-1</italic> and <italic>lagr-1</italic> extending <italic>C. elegans</italic> lifespan through a <italic>skn-1</italic>-dependent process (<xref ref-type="bibr" rid="bib105">Mosbech et al., 2013</xref>). Additionally, the control of the relative ceramide and sphingomyelin levels by sphingomyelin synthases mediates crosstalk between DAF-16 and CREBH (<xref ref-type="bibr" rid="bib61">He et al., 2021</xref>), which would have a significant impact on glucose and lipid metabolism, and therefore longevity. As such, the atRA-altered sphingolipid network observed in our RNA-seq data (<xref ref-type="fig" rid="fig5">Figure 5B</xref>; <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>) could have significant impacts on longevity.</p><p>The importance of sphingolipid regulation of metabolism, and ultimately lifespan, is not a unique feature of nematodes. The network has been proposed to function in mammals as a metabolic rheostat that uses the ratios of ceramide, ceramide-1P, sphingosine, and sphingosine-1P to determine metabolic regulatory response (<xref ref-type="bibr" rid="bib149">Summers et al., 2019</xref>). This may be a mechanistic contributor to atRA longevity effects as there is known cross-talk between longevity pathways and ceramide/sphingolipids (<xref ref-type="bibr" rid="bib75">Jęśko et al., 2019</xref>). Interestingly, ceramide and sphingolipid metabolism may provide a conserved functional connection to the observed relationship between atRA and protein kinase B/Akt function. In cell culture, treatment with atRA increases ceramide levels (<xref ref-type="bibr" rid="bib78">Kalén et al., 1992</xref>), and cell-permeable ceramide inhibits Akt kinase activity (<xref ref-type="bibr" rid="bib177">Zhou et al., 1998</xref>). Additionally, exogenous ceramide induces dephosphorylation and inhibition of Akt (<xref ref-type="bibr" rid="bib179">Zinda et al., 2001</xref>). This functionality is known to be biologically relevant, as ceramide is a known negative regulator of insulin activity via regulation of Akt (<xref ref-type="bibr" rid="bib67">Hsieh et al., 2014</xref>).</p><p>Considering these findings, a simple model consistent with our observations is that the application of atRA changes sphingolipid metabolism, which in turn induces a change in the functional state of <italic>akt-1</italic> and <italic>akt-2</italic>. Our observations that HSF-1, AAK-2, and SKN-1 are necessary for atRA longevity extension are easily understood within this model, as all three have been identified as potential direct targets of Akt regulation. How (and if) atRA directly regulates sphingolipid metabolism remains an open question. In cell culture, atRA induces growth arrest in many cell types, and that arrest is mediated through nSMase2 induction, which increases ceramide levels (<xref ref-type="bibr" rid="bib33">Clarke et al., 2011</xref>). Additionally, the involvement of sphingosine kinases in atRA signaling has been demonstrated in K562 chronic myeloid leukemia cells (<xref ref-type="bibr" rid="bib150">Sun and Wang, 2021</xref>), but the identity of the transcriptional effector remains unclear.</p></sec><sec id="s3-2"><title>Conservation of aging effects of atRA</title><p>The retinoids – atRA in particular – are broadly conserved regulators of transcription (<xref ref-type="bibr" rid="bib8">Amann et al., 2011</xref>). In vertebrates, atRA functions in a broad range of biological activities, from development (<xref ref-type="bibr" rid="bib44">Duester, 2008</xref>; <xref ref-type="bibr" rid="bib112">Niederreither and Dollé, 2008</xref>), immune function (<xref ref-type="bibr" rid="bib69">Huang et al., 2018</xref>), and memory and learning, to energy metabolism (<xref ref-type="bibr" rid="bib173">Zhang et al., 2015</xref>). In mammals, some research suggests a potential role for atRA signaling in modulating aging. Among clinical aging studies of both natural and synthetic retinoids, the bulk of the research has been for aging and/or UV photoaging of skin. Among those studies, atRA is the most widely investigated retinoid and potentially the most potent (<xref ref-type="bibr" rid="bib106">Mukherjee et al., 2006</xref>). Beyond skin phenotypes, studies in mouse models have also shown that age-dependent decreases in atRA signaling result in poor performance on spatial learning and memory tasks, and dietary supplementation with atRA can ameliorate the age-related decreases in hippocampal long-term-memory potentiation and other brain functions (<xref ref-type="bibr" rid="bib46">Etchamendy et al., 2001</xref>). The potential use of atRA as an intervention in age-related diseases of neurophysiology has not been ignored and is receiving significant attention as a therapeutic for Alzheimer’s disease and related dementias (<xref ref-type="bibr" rid="bib40">Das et al., 2019</xref>; <xref ref-type="bibr" rid="bib89">Lee et al., 2009</xref>; <xref ref-type="bibr" rid="bib151">Szutowicz et al., 2015</xref>).</p><p>While atRA may function as an anti-aging agent due to the phenotypic outcomes of application, the molecular mechanisms responsible for these activities are not fully understood. One possibility is that atRA functions as a high-affinity ligand for PPARβ/δ peroxisome proliferation-activated receptor, which is a master regulator of lipid metabolism and glucose homeostasis. Activation of PPARβ/δ increases lipid catabolism in adipose tissue and skeletal muscle to prevent obesity (<xref ref-type="bibr" rid="bib85">Kuri-Harcuch, 1982</xref>; <xref ref-type="bibr" rid="bib116">Pairault et al., 1988</xref>; <xref ref-type="bibr" rid="bib136">Sato et al., 1980</xref>; <xref ref-type="bibr" rid="bib137">Schwarz et al., 1997</xref>). Additionally, in an obese mouse model, treatment with atRA-induced PPARβ/δ and RAR regulated genes, correlating with weight loss and improved insulin responsiveness (<xref ref-type="bibr" rid="bib20">Berry and Noy, 2009</xref>). Alternatively, atRA could be affecting longevity through effects on Akt proteins, as we observed and has been shown for other atRA phenotypes in mammals. Indeed, multiple pathways are likely to be engaged.</p></sec><sec id="s3-3"><title>Conclusions</title><p>We tested the hypothesis that using intersecting computational predictions can identify aging interventions at a high frequency in <italic>Caenorhabditis</italic> species. We found that using cross-validated computational predictions resulted in a high discovery rate (30%), which is compatible with screening across a dosage range using full lifespan analysis. The future success of computational prediction approaches should increase as AI methodologies are brought to bear on an ever-increasing body of research. In the example described above, computational predictions led to the identification of an endogenous signaling ligand that regulates metabolism and can be co-opted to extend life. Our study demonstrates the potential of metabolic manipulation for aging interventions and the benefits of computational predictions in prioritizing a compound screening.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top">Reagent type (species) or resource</th><th align="left" valign="top">Designation</th><th align="left" valign="top">Source or reference</th><th align="left" valign="top">Identifiers</th><th align="left" valign="top">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom">See strain list in Methods</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Available at <italic>Caenorhabditis</italic> Genetics Center</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. briggsae</italic>)</td><td align="left" valign="bottom">See strain list in Methods</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Available at <italic>Caenorhabditis</italic> Genetics Center</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. tropicalis</italic>)</td><td align="left" valign="bottom">See strain list in Methods</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Available at <italic>Caenorhabditis</italic> Genetics Center</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Lifespan (R script) – ATRA</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.6084/m9.figshare.26308177">10.6084/m9.figshare.26308177</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Lifespan (R script) – compound screen</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.6084/m9.figshare.26308153">10.6084/m9.figshare.26308153</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Lifespan (R script) – propranolol PFA-killed OP50-1</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.6084/m9.figshare.26308159">10.6084/m9.figshare.26308159</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Lifespan (R script) – pathway mutants</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.6084/m9.figshare.26308165">10.6084/m9.figshare.26308165</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Lifespan (R script) – ATRA automated lifespan</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.6084/m9.figshare.26308186">10.6084/m9.figshare.26308186</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">CeleST (R script)</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.6084/m9.figshare.26308198">10.6084/m9.figshare.26308198</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Lifespan (R script) – <italic>C. briggsae</italic> and <italic>C. tropicalis</italic></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.6084/m9.figshare.26308171">10.6084/m9.figshare.26308171</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">RNA-seq (R script)</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.6084/m9.figshare.26314531">10.6084/m9.figshare.26314531</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Transcriptomic alignments and feature counts</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.6084/m9.figshare.26314591">10.6084/m9.figshare.26314591</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound/drug</td><td align="left" valign="bottom">Bortezomib</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound/drug</td><td align="left" valign="bottom">Tretinoin</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound/drug</td><td align="left" valign="bottom">Fisetin</td><td align="left" valign="bottom">Tocris Bioscience</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound/drug</td><td align="left" valign="bottom">Temsirolimus</td><td align="left" valign="bottom">Cayman Chemical</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound/drug</td><td align="left" valign="bottom">Everolimus</td><td align="left" valign="bottom">Cayman Chemical</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound/drug</td><td align="left" valign="bottom">Dasatinib</td><td align="left" valign="bottom">Cayman Chemical</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound/drug</td><td align="left" valign="bottom">Decitabine</td><td align="left" valign="bottom">Selleck Chemicals</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound/drug</td><td align="left" valign="bottom">Gefitinib</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound/drug</td><td align="left" valign="bottom">Metoprolol</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound/drug</td><td align="left" valign="bottom">Berberine</td><td align="left" valign="bottom">Cayman Chemical</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound/drug</td><td align="left" valign="bottom">Erlotinib</td><td align="left" valign="bottom">Cayman Chemical</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound/drug</td><td align="left" valign="bottom">Dexamethasone</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound/drug</td><td align="left" valign="bottom">Aldosterone</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound/drug</td><td align="left" valign="bottom">Propranolol</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound/drug</td><td align="left" valign="bottom">Metoprolol</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr></tbody></table></table-wrap><p>A detailed set of standard operating procedures is available online (<xref ref-type="bibr" rid="bib26">Caenorhabditis Intervention Testing Program, 2025</xref>). The experimental details in brief are as follows:</p><sec id="s4-1"><title>Caenorhabditis strains and maintenance</title><p>All Caenorhabditis strains were obtained from the <italic>Caenorhabditis</italic> Genetics Center: N2-PD1073 <xref ref-type="bibr" rid="bib156">Teterina et al., 2022</xref>; <xref ref-type="bibr" rid="bib169">Yoshimura et al., 2019</xref>; CF1038 daf-16(mu86) (<xref ref-type="bibr" rid="bib94">Lin et al., 1997</xref>); DA1113 eat-2(ad1113) <xref ref-type="bibr" rid="bib128">Raizen et al., 1995</xref>; IG10 tol-1(nr2033) <xref ref-type="bibr" rid="bib126">Pujol et al., 2001</xref>; RB754 aak-2(ok524) <xref ref-type="bibr" rid="bib29"><italic>C. elegans</italic> Deletion Mutant Consortium, 2012</xref>; PS3551 <italic>hsf-1(sy441)</italic> <xref ref-type="bibr" rid="bib59">Hajdu-Cronin et al., 2004</xref>; <italic>KU25 pmk-1(km25)</italic> <xref ref-type="bibr" rid="bib104">Mizuno et al., 2004</xref>; RB759 akt-1(ok525); and VC204 akt-2(ok393). Wild isolates in this study include <italic>C. elegans</italic> JU775 and MY16, <italic>C. briggsae</italic> AF16, ED3092, and HK104, and <italic>C. tropicalis</italic> JU1630, JU1373, and QG834. All strains were maintained on nematode growth medium plates seeded with <italic>Escherichia coli</italic> OP50-1 at 20°C. For experimental synchronization, cohorts were generated by timed egg lays (<xref ref-type="bibr" rid="bib96">Lucanic et al., 2017</xref>)<italic>.</italic></p></sec><sec id="s4-2"><title>Compound treatment</title><p>Compound treatment was conducted as previously published (<xref ref-type="bibr" rid="bib12">Banse et al., 2019</xref>; <xref ref-type="bibr" rid="bib96">Lucanic et al., 2017</xref>). Compounds were obtained as a solid and dissolved in DMSO (dimethyl sulfoxide) or H<sub>2</sub>O to obtain a stock solution. The following compounds were used: temsirolimus (Cayman 11590), ritonavir (Sigma-Aldrich SML0491), thalidomide (Calbiochem 585970), arecoline (Cayman 13662), everolimus (Cayman 11597), temsirolimus (Cayman 11590), erlotinib (Cayman 10483), berberine (Cayman 10006427), dasatinib (Cayman 11498), propranolol (Sigma-Aldrich P0884), aldosterone (Sigma-Aldrich A9477), dexamethasone (Sigma-Aldrich D1756), gefitinib (Sigma-Aldrich SML1657), tretinoin (all-trans retinoic acid) (Sigma-Aldrich PHR1187), bortezomib (Sigma-Aldrich 5043140001), decitabine (Selleck Chemical S1200), fisetin (Tocris 5016), and metoprolol (Sigma-Aldrich M5391). DMSO stock solutions were mixed with water to form a working solution before being added to plates. In-plate concentrations were calculated by presuming the final volume to be equal to that of the volume of agar. For 50, 100, and 150 µM atRA plates, stock solutions formed precipitates at working solution concentrations, requiring working solutions to be prepared individually for each plate.</p></sec><sec id="s4-3"><title>Lifespan assays</title><p>Lifespan assays were performed as previously published (<xref ref-type="bibr" rid="bib12">Banse et al., 2019</xref>; <xref ref-type="bibr" rid="bib96">Lucanic et al., 2017</xref>). Briefly, worms were age-synchronized via timed egg lays and transferred to control or compound treated plates on days 1, 2, and 5 of adulthood (or day 4 for <italic>C. tropicalis</italic> strains), and once weekly thereafter until dead. All lifespans were conducted using 51 µM FUdR (5-fluoro-2′-deoxyuridine) to prevent progeny production (<xref ref-type="bibr" rid="bib66">Hosono, 1978</xref>; <xref ref-type="bibr" rid="bib96">Lucanic et al., 2017</xref>; <xref ref-type="bibr" rid="bib103">Mitchell et al., 1979</xref>). For automated lifespan assays, worms were transferred to the Automated Lifespan Machines (Epson Perfection V800s) (<xref ref-type="bibr" rid="bib1">Abbott et al., 2020</xref>) on day 5 (<italic>C. elegans</italic> and <italic>C. briggsae</italic>) or day 4 (<italic>C. tropicalis</italic>) of adulthood, at which point survival data was collected and analyzed using the Lifespan Machine software (<ext-link ext-link-type="uri" xlink:href="https://github.com/nstroustrup/lifespan">https://github.com/nstroustrup/lifespan</ext-link>; <xref ref-type="bibr" rid="bib147">Stroustrup, 2022</xref>; <xref ref-type="bibr" rid="bib146">Stroustrup et al., 2013</xref>). For lifespans using RNAi feeding, RNAi plates (25 mg/l carbenicillin and 1 mM IPTG) were seeded using an RNase II deficient <italic>E. coli</italic> strain (HT115) harboring either the <italic>skn-1</italic> (T19E7.2) targeting or control L4440 plasmid from the Ahringer RNAi library (<xref ref-type="bibr" rid="bib79">Kamath and Ahringer, 2003</xref>). Worms were transferred to RNAi plates at the L3/L4 stage before being transferred to compound-treated RNAi plates containing 51 µM FUdR on day 1 of adulthood. An additional transfer on day 3 of adulthood was also added for lifespans using RNAi. All lifespan assays were conducted at 20°C and 80% relative humidity with 50 animals per Petri plate. Analysis of propranolol effects in the presence of paraformaldehyde-treated bacteria was performed as published (<xref ref-type="bibr" rid="bib22">Beydoun et al., 2023</xref>).</p></sec><sec id="s4-4"><title>CeleST health assays</title><p><italic>CeleST</italic> health assays were performed as previously published (<xref ref-type="bibr" rid="bib14">Banse et al., 2024b</xref>). In brief, animals were exposed to compound intervention during adulthood as described above until CeleST measurements were collected at two time points (adult days 6 and 12 for <italic>C. elegans</italic> and <italic>C. tropicalis</italic>, and days 8 and 16 for <italic>C. briggsae</italic>). For two biological replicates at each of the three CITP sites, 40 animals were tested per condition (age and compound or control) per strain. For full experimental protocols, see our online protocol (<xref ref-type="bibr" rid="bib25">Caenorhabditis Intervention Testing Program, 2022</xref>). Eight different parameters (wave initiation rate, body wave number, asymmetry, stretch, curling, travel speed, brush stroke, and activity index; <xref ref-type="bibr" rid="bib70">Ibáñez-Ventoso et al., 2016</xref>; <xref ref-type="bibr" rid="bib130">Restif et al., 2014</xref>) were measured using the CeleST software and used to create a composite swimming score (<xref ref-type="bibr" rid="bib14">Banse et al., 2024b</xref>).</p></sec><sec id="s4-5"><title>Statistical analysis</title><p>Statistical analyses for lifespan experiments were performed as previously described (<xref ref-type="bibr" rid="bib96">Lucanic et al., 2017</xref>). In summary, we used a mixed-model approach where compound treatment was considered a fixed effect, and other potential variables were treated as random effects. Survival was analyzed both with generalized linear models using the lme4 (version 1.1.32) package (<xref ref-type="bibr" rid="bib18">Bates et al., 2015</xref>), and a mixed-model Cox-Proportional Hazards (CPH) model using the coxme package (version 2.2-18.1) (<xref ref-type="bibr" rid="bib158">Therneau, 2020</xref>) in the R statistical language (<xref ref-type="bibr" rid="bib129">R Development Core Team, 2021</xref>). The effect of compound treatment was tested using CPH analysis within each strain to allow for each compound treatment replicate to be compared to its specific control in the randomized blocks design. Compound effects were analyzed as a planned comparison between the responses of individuals on the treatment in question and those on the appropriate treatment control. Hits were classified based on a significant <italic>p-</italic>value from the CPH model coupled with an increase in median lifespan. It should be noted that one compound, aldosterone at 50 µM, showed a significant decrease in the hazard estimate without an increase in median lifespan, and thus was not considered a hit.</p><p>Swimming behavior was analyzed using the composite score (described above) as the variable of interest in mixed effects general linear models built for each strain in R using the lme4 package (version 1.1.32) (<xref ref-type="bibr" rid="bib18">Bates et al., 2015</xref>) as previously described (<xref ref-type="bibr" rid="bib14">Banse et al., 2024b</xref>). Determination of significant age by compound interactions was made using the R car package (version 3.1-2) (<xref ref-type="bibr" rid="bib50">Fox and Weisberg, 2019</xref>).</p></sec><sec id="s4-6"><title>Transcriptomic analysis</title><p>For RNA-sequencing, worms were synchronized and compound treated as described above. Four biological replicates of both atRA-treated (150 µM) and vehicle control worms were aged to day 4 of adulthood and collected in tandem (approximately 50 worms total per replicate). We selected this timepoint because it corresponded to the timepoint at which the Ewald study detected increased <italic>col-144p::GFP</italic> that predicted longevity (<xref ref-type="bibr" rid="bib144">Statzer et al., 2021</xref>). Worms were picked into 0.2 ml tubes each containing 50 µl of lysis buffer (45 µl elution buffer plus 5 µl proteinase K) and flash frozen with liquid nitrogen, then stored at –80°C until library prep. Libraries were prepared using the KAPA mRNA HyperPrep kit (KK8580 from Kapa Biosystems) as per the manufacturer’s protocol except that the total volume was adjusted to ¼ per reaction. Final libraries were normalized by concentration and sequenced on an Illumina Novaseq 6000 with the SP 100 cycle (GC3F, University of Oregon).</p><p>Paired-end FASTQ files for all atRA-treated and DMSO control samples were aligned to the <italic>C. elegans</italic> WBcel235 (build 104) reference genome using the Subread package (version 2.0.2) (<xref ref-type="bibr" rid="bib91">Liao et al., 2013</xref>). Uniquely mapped reads were assigned to <italic>C. elegans</italic> genes with Subread’s featureCounts program (<xref ref-type="bibr" rid="bib92">Liao et al., 2014</xref>) using reversely stranded read counting. Subsequent filtering, normalization, and differential expression analysis were performed on each strain-specific dataset with the edgeR package (version 3.28.1) (<xref ref-type="bibr" rid="bib132">Robinson et al., 2010</xref>), using R (version 3.6.2) (<xref ref-type="bibr" rid="bib129">R Development Core Team, 2021</xref>). Lowly expressed genes were removed from each dataset; only genes that had at least 10 reads in at least four samples and a minimum total count of 15 reads across samples were retained. To remove composition biases between libraries, the library sizes were normalized using a trimmed mean of <italic>M</italic>-values (<xref ref-type="bibr" rid="bib133">Robinson and Oshlack, 2010</xref>) between each pair of samples. A pairwise expression analysis was performed on the transcriptomes of the treatment and control samples from each strain. Quasi-likelihood <italic>F</italic>-tests for treatment vs. control sample effect were carried out on fitted gene-wise negative binomial generalized log-linear models. p-values were corrected for false discovery using the Benjamini–Hochberg method.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Formal analysis, Investigation, Visualization, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Data curation, Formal analysis, Investigation, Visualization, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Conceptualization, Investigation, Writing - original draft, Project administration</p></fn><fn fn-type="con" id="con4"><p>Investigation, Writing - original draft</p></fn><fn fn-type="con" id="con5"><p>Supervision, Investigation</p></fn><fn fn-type="con" id="con6"><p>Investigation</p></fn><fn fn-type="con" id="con7"><p>Data curation, Formal analysis, Visualization</p></fn><fn fn-type="con" id="con8"><p>Data curation, Formal analysis</p></fn><fn fn-type="con" id="con9"><p>Investigation</p></fn><fn fn-type="con" id="con10"><p>Investigation</p></fn><fn fn-type="con" id="con11"><p>Investigation</p></fn><fn fn-type="con" id="con12"><p>Investigation</p></fn><fn fn-type="con" id="con13"><p>Conceptualization, Project administration</p></fn><fn fn-type="con" id="con14"><p>Investigation</p></fn><fn fn-type="con" id="con15"><p>Investigation</p></fn><fn fn-type="con" id="con16"><p>Investigation</p></fn><fn fn-type="con" id="con17"><p>Investigation</p></fn><fn fn-type="con" id="con18"><p>Conceptualization</p></fn><fn fn-type="con" id="con19"><p>Conceptualization, Formal analysis</p></fn><fn fn-type="con" id="con20"><p>Supervision, Funding acquisition, Writing - review and editing</p></fn><fn fn-type="con" id="con21"><p>Supervision, Funding acquisition, Writing - review and editing</p></fn><fn fn-type="con" id="con22"><p>Conceptualization, Supervision, Funding acquisition, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Supplementary tables providing additional quantitative detail for the results.</title><p>Tables containing (a) sources of experimental variation across trials, genes significantly (b) up- and (c) downregulated by atRA treatment, and (d) WaRG comparisons across <italic>hsf-1</italic> and <italic>aak-2</italic> gene expression analyses.</p></caption><media xlink:href="elife-104375-supp1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-104375-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All data is available at <ext-link ext-link-type="uri" xlink:href="https://citpaging.org/portal">https://citpaging.org/portal</ext-link> and at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.6084/m9.figshare.c.7350250">https://doi.org/10.6084/m9.figshare.c.7350250</ext-link> (Caenorhabditis Intervention Testing Program, 2025). Additionally, transcriptomic data have been deposited in NCBI's Gene are accessible through the NCBI GEO database via accession number GSE272535 (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE272535">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE272535</ext-link>).</p><p>The following datasets were generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Banse</surname><given-names>SA</given-names></name><name><surname>Sedore</surname><given-names>CA</given-names></name><name><surname>Coleman-Hulbert</surname><given-names>AL</given-names></name><name><surname>Johnson</surname><given-names>E</given-names></name><name><surname>Onken</surname><given-names>B</given-names></name><name><surname>Hall</surname><given-names>D</given-names></name><name><surname>Segerdell</surname><given-names>E</given-names></name><name><surname>Jones</surname><given-names>EG</given-names></name><name><surname>Song</surname><given-names>Y</given-names></name><name><surname>Osman</surname><given-names>H</given-names></name><name><surname>Xue</surname><given-names>J</given-names></name><name><surname>Battistoni</surname><given-names>E</given-names></name><name><surname>Guo</surname><given-names>S</given-names></name><name><surname>Foulger</surname><given-names>AC</given-names></name><name><surname>Achanta</surname><given-names>M</given-names></name><name><surname>Sheikh</surname><given-names>M</given-names></name><name><surname>Fitzgibbon</surname><given-names>T</given-names></name><name><surname>Willis</surname><given-names>JH</given-names></name><name><surname>Woodruff</surname><given-names>GC</given-names></name><name><surname>Driscoll</surname><given-names>M</given-names></name><name><surname>Lithgow</surname><given-names>G</given-names></name><name><surname>Phillips</surname><given-names>PC</given-names></name></person-group><year iso-8601-date="2024">2024</year><data-title>Computer prediction and genetic analysis identifies retinoic acid modulation as a driver of conserved longevity pathways in genetically-diverse Caenorhabditis nematodes</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE272535">GSE272535</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset2"><person-group person-group-type="author"><collab>Caenorhabditis Intervention Testing Program</collab></person-group><year iso-8601-date="2025">2025</year><data-title>Caenorhabditis Intervention Testing Program: Data, analysis, and SOPs for the all-trans retinoic acid manuscript</data-title><source>figshare</source><pub-id pub-id-type="doi">10.6084/m9.figshare.c.7350250</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We acknowledge and thank Max Guo (NIA), Viviana Perez (previously at NIA), Tiziana Cogliati (NIA), and the members of the Phillips, Driscoll, and Lithgow labs for helpful discussions and the Barber lab (University of Oregon) for kindly providing equipment access and technical expertise. Some strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). Some deletion mutants used in this work were generated by the International <italic>C. elegans</italic> Gene Knockout Consortium (<italic>C. elegans</italic> Gene Knockout Facility at the Oklahoma Medical Research Foundation, which is funded by the National Institutes of Health; and the <italic>C. elegans</italic> Reverse Genetics Core Facility at the University of British Columbia, which is funded by the Canadian Institute for Health Research, Genome Canada, Genome BC, the Michael Smith Foundation, and the National Institutes of Health). This work was directly supported by funding from National Institutes of Health grants (U01 AG045844, U01 AG045864, U01 AG045829, and U24 AG056052).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abbott</surname><given-names>M</given-names></name><name><surname>Banse</surname><given-names>SA</given-names></name><name><surname>Melentijevic</surname><given-names>I</given-names></name><name><surname>Jarrett</surname><given-names>CM</given-names></name><name><surname>St. Ange</surname><given-names>J</given-names></name><name><surname>Sedore</surname><given-names>CA</given-names></name><name><surname>Falkowski</surname><given-names>R</given-names></name><name><surname>Blue</surname><given-names>BW</given-names></name><name><surname>Coleman-Hulbert</surname><given-names>AL</given-names></name><name><surname>Johnson</surname><given-names>E</given-names></name><name><surname>Guo</surname><given-names>M</given-names></name><name><surname>Lithgow</surname><given-names>GJ</given-names></name><name><surname>Phillips</surname><given-names>PC</given-names></name><name><surname>Driscoll</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A simplified design for the <italic>C. elegans</italic> lifespan machine</article-title><source>Journal of Biological Methods</source><volume>7</volume><elocation-id>e332</elocation-id><pub-id pub-id-type="doi">10.14440/jbm.2020.332</pub-id><pub-id pub-id-type="pmid">33204740</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alavez</surname><given-names>S</given-names></name><name><surname>Vantipalli</surname><given-names>MC</given-names></name><name><surname>Zucker</surname><given-names>DJS</given-names></name><name><surname>Klang</surname><given-names>IM</given-names></name><name><surname>Lithgow</surname><given-names>GJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Amyloid-binding compounds maintain protein homeostasis during ageing and extend lifespan</article-title><source>Nature</source><volume>472</volume><fpage>226</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.1038/nature09873</pub-id><pub-id pub-id-type="pmid">21451522</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albalat</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The retinoic acid machinery in invertebrates: ancestral elements and vertebrate innovations</article-title><source>Molecular and Cellular Endocrinology</source><volume>313</volume><fpage>23</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1016/j.mce.2009.08.029</pub-id><pub-id pub-id-type="pmid">19737598</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albalat</surname><given-names>R</given-names></name><name><surname>Cañestro</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Identification of Aldh1a, Cyp26 and RAR orthologs in protostomes pushes back the retinoic acid genetic machinery in evolutionary time to the bilaterian ancestor</article-title><source>Chemico-Biological Interactions</source><volume>178</volume><fpage>188</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1016/j.cbi.2008.09.017</pub-id><pub-id pub-id-type="pmid">18926806</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ali</surname><given-names>ES</given-names></name><name><surname>Mitra</surname><given-names>K</given-names></name><name><surname>Akter</surname><given-names>S</given-names></name><name><surname>Ramproshad</surname><given-names>S</given-names></name><name><surname>Mondal</surname><given-names>B</given-names></name><name><surname>Khan</surname><given-names>IN</given-names></name><name><surname>Islam</surname><given-names>MT</given-names></name><name><surname>Sharifi-Rad</surname><given-names>J</given-names></name><name><surname>Calina</surname><given-names>D</given-names></name><name><surname>Cho</surname><given-names>WC</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Recent advances and limitations of mTOR inhibitors in the treatment of cancer</article-title><source>Cancer Cell International</source><volume>22</volume><elocation-id>284</elocation-id><pub-id pub-id-type="doi">10.1186/s12935-022-02706-8</pub-id><pub-id pub-id-type="pmid">36109789</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>AlOkda</surname><given-names>A</given-names></name><name><surname>Van Raamsdonk</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Effect of DMSO on lifespan and physiology in <italic>C. elegans</italic>: Implications for use of DMSO as a solvent for compound delivery</article-title><source>microPublication Biology</source><volume>2022</volume><elocation-id>000634</elocation-id><pub-id pub-id-type="doi">10.17912/micropub.biology.000634</pub-id><pub-id pub-id-type="pmid">36158529</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alsayed</surname><given-names>Y</given-names></name><name><surname>Uddin</surname><given-names>S</given-names></name><name><surname>Mahmud</surname><given-names>N</given-names></name><name><surname>Lekmine</surname><given-names>F</given-names></name><name><surname>Kalvakolanu</surname><given-names>DV</given-names></name><name><surname>Minucci</surname><given-names>S</given-names></name><name><surname>Bokoch</surname><given-names>G</given-names></name><name><surname>Platanias</surname><given-names>LC</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Activation of Rac1 and the p38 mitogen-activated protein kinase pathway in response to all-trans-retinoic acid</article-title><source>The Journal of Biological Chemistry</source><volume>276</volume><fpage>4012</fpage><lpage>4019</lpage><pub-id pub-id-type="doi">10.1074/jbc.M007431200</pub-id><pub-id pub-id-type="pmid">11060298</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amann</surname><given-names>PM</given-names></name><name><surname>Eichmüller</surname><given-names>SB</given-names></name><name><surname>Schmidt</surname><given-names>J</given-names></name><name><surname>Bazhin</surname><given-names>AV</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Regulation of gene expression by retinoids</article-title><source>Current Medicinal Chemistry</source><volume>18</volume><fpage>1405</fpage><lpage>1412</lpage><pub-id pub-id-type="doi">10.2174/092986711795029618</pub-id><pub-id pub-id-type="pmid">21366525</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Apfeld</surname><given-names>J</given-names></name><name><surname>O’Connor</surname><given-names>G</given-names></name><name><surname>McDonagh</surname><given-names>T</given-names></name><name><surname>DiStefano</surname><given-names>PS</given-names></name><name><surname>Curtis</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>The AMP-activated protein kinase AAK-2 links energy levels and insulin-like signals to lifespan in <italic>C. elegans</italic></article-title><source>Genes &amp; Development</source><volume>18</volume><fpage>3004</fpage><lpage>3009</lpage><pub-id pub-id-type="doi">10.1101/gad.1255404</pub-id><pub-id pub-id-type="pmid">15574588</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Austad</surname><given-names>SN</given-names></name></person-group><year iso-8601-date="2016">2016</year><chapter-title>The geroscience hypothesis: is it possible to change the rate of aging</chapter-title><person-group person-group-type="editor"><name><surname>Sierra</surname><given-names>F</given-names></name><name><surname>Kohanski</surname><given-names>R</given-names></name></person-group><source>Advances in Geroscience</source><publisher-name>Springer International Publishing</publisher-name><fpage>1</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1007/978-3-319-23246-1_1</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avery</surname><given-names>L</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>The genetics of feeding in <italic>Caenorhabditis elegans</italic></article-title><source>Genetics</source><volume>133</volume><fpage>897</fpage><lpage>917</lpage><pub-id pub-id-type="doi">10.1093/genetics/133.4.897</pub-id><pub-id pub-id-type="pmid">8462849</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banse</surname><given-names>SA</given-names></name><name><surname>Lucanic</surname><given-names>M</given-names></name><name><surname>Sedore</surname><given-names>CA</given-names></name><name><surname>Coleman-Hulbert</surname><given-names>AL</given-names></name><name><surname>Plummer</surname><given-names>WT</given-names></name><name><surname>Chen</surname><given-names>E</given-names></name><name><surname>Kish</surname><given-names>JL</given-names></name><name><surname>Hall</surname><given-names>D</given-names></name><name><surname>Onken</surname><given-names>B</given-names></name><name><surname>Presley</surname><given-names>MP</given-names></name><name><surname>Jones</surname><given-names>EG</given-names></name><name><surname>Blue</surname><given-names>BW</given-names></name><name><surname>Garrett</surname><given-names>T</given-names></name><name><surname>Abbott</surname><given-names>M</given-names></name><name><surname>Xue</surname><given-names>J</given-names></name><name><surname>Guo</surname><given-names>S</given-names></name><name><surname>Johnson</surname><given-names>E</given-names></name><name><surname>Foulger</surname><given-names>AC</given-names></name><name><surname>Chamoli</surname><given-names>M</given-names></name><name><surname>Falkowski</surname><given-names>R</given-names></name><name><surname>Melentijevic</surname><given-names>I</given-names></name><name><surname>Harinath</surname><given-names>G</given-names></name><name><surname>Huynh</surname><given-names>P</given-names></name><name><surname>Patel</surname><given-names>S</given-names></name><name><surname>Edgar</surname><given-names>D</given-names></name><name><surname>Jarrett</surname><given-names>CM</given-names></name><name><surname>Guo</surname><given-names>M</given-names></name><name><surname>Kapahi</surname><given-names>P</given-names></name><name><surname>Lithgow</surname><given-names>GJ</given-names></name><name><surname>Driscoll</surname><given-names>M</given-names></name><name><surname>Phillips</surname><given-names>PC</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Automated lifespan determination across Caenorhabditis strains and species reveals assay-specific effects of chemical interventions</article-title><source>GeroScience</source><volume>41</volume><fpage>945</fpage><lpage>960</lpage><pub-id pub-id-type="doi">10.1007/s11357-019-00108-9</pub-id><pub-id pub-id-type="pmid">31820364</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banse</surname><given-names>SA</given-names></name><name><surname>Jackson</surname><given-names>EG</given-names></name><name><surname>Sedore</surname><given-names>CA</given-names></name><name><surname>Onken</surname><given-names>B</given-names></name><name><surname>Hall</surname><given-names>D</given-names></name><name><surname>Coleman-Hulbert</surname><given-names>A</given-names></name><name><surname>Huynh</surname><given-names>P</given-names></name><name><surname>Garrett</surname><given-names>T</given-names></name><name><surname>Johnson</surname><given-names>E</given-names></name><name><surname>Harinath</surname><given-names>G</given-names></name><name><surname>Inman</surname><given-names>D</given-names></name><name><surname>Guo</surname><given-names>S</given-names></name><name><surname>Morshead</surname><given-names>M</given-names></name><name><surname>Xue</surname><given-names>J</given-names></name><name><surname>Falkowski</surname><given-names>R</given-names></name><name><surname>Chen</surname><given-names>E</given-names></name><name><surname>Herrera</surname><given-names>C</given-names></name><name><surname>Kirsch</surname><given-names>AJ</given-names></name><name><surname>Perez</surname><given-names>VI</given-names></name><name><surname>Guo</surname><given-names>M</given-names></name><name><surname>Lithgow</surname><given-names>GJ</given-names></name><name><surname>Driscoll</surname><given-names>M</given-names></name><name><surname>Phillips</surname><given-names>PC</given-names></name></person-group><year iso-8601-date="2024">2024a</year><article-title>The coupling between healthspan and lifespan in <italic>Caenorhabditis</italic> depends on complex interactions between compound intervention and genetic background</article-title><source>Aging</source><volume>16</volume><fpage>5829</fpage><lpage>5855</lpage><pub-id pub-id-type="doi">10.18632/aging.205743</pub-id><pub-id pub-id-type="pmid">38613792</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banse</surname><given-names>SA</given-names></name><name><surname>Sedore</surname><given-names>CA</given-names></name><name><surname>Johnson</surname><given-names>E</given-names></name><name><surname>Coleman-Hulbert</surname><given-names>AL</given-names></name><name><surname>Onken</surname><given-names>B</given-names></name><name><surname>Hall</surname><given-names>D</given-names></name><name><surname>Jackson</surname><given-names>EG</given-names></name><name><surname>Huynh</surname><given-names>P</given-names></name><name><surname>Foulger</surname><given-names>AC</given-names></name><name><surname>Guo</surname><given-names>S</given-names></name><name><surname>Garrett</surname><given-names>T</given-names></name><name><surname>Xue</surname><given-names>J</given-names></name><name><surname>Inman</surname><given-names>D</given-names></name><name><surname>Morshead</surname><given-names>ML</given-names></name><name><surname>Plummer</surname><given-names>WT</given-names></name><name><surname>Chen</surname><given-names>E</given-names></name><name><surname>Bhaumik</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>MK</given-names></name><name><surname>Harinath</surname><given-names>G</given-names></name><name><surname>Chamoli</surname><given-names>M</given-names></name><name><surname>Quinn</surname><given-names>RP</given-names></name><name><surname>Falkowski</surname><given-names>R</given-names></name><name><surname>Edgar</surname><given-names>D</given-names></name><name><surname>Schmidt</surname><given-names>MO</given-names></name><name><surname>Lucanic</surname><given-names>M</given-names></name><name><surname>Guo</surname><given-names>M</given-names></name><name><surname>Driscoll</surname><given-names>M</given-names></name><name><surname>Lithgow</surname><given-names>GJ</given-names></name><name><surname>Phillips</surname><given-names>PC</given-names></name></person-group><year iso-8601-date="2024">2024b</year><article-title>Antioxidants green tea extract and nordihydroguaiaretic acid confer species and strain-specific lifespan and health effects in Caenorhabditis nematodes</article-title><source>GeroScience</source><volume>46</volume><fpage>2239</fpage><lpage>2251</lpage><pub-id pub-id-type="doi">10.1007/s11357-023-00978-0</pub-id><pub-id pub-id-type="pmid">37923874</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barardo</surname><given-names>DG</given-names></name><name><surname>Newby</surname><given-names>D</given-names></name><name><surname>Thornton</surname><given-names>D</given-names></name><name><surname>Ghafourian</surname><given-names>T</given-names></name><name><surname>de Magalhães</surname><given-names>JP</given-names></name><name><surname>Freitas</surname><given-names>AA</given-names></name></person-group><year iso-8601-date="2017">2017a</year><article-title>Machine learning for predicting lifespan-extending chemical compounds</article-title><source>Aging</source><volume>9</volume><fpage>1721</fpage><lpage>1737</lpage><pub-id pub-id-type="doi">10.18632/aging.101264</pub-id><pub-id pub-id-type="pmid">28783712</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barardo</surname><given-names>D</given-names></name><name><surname>Thornton</surname><given-names>D</given-names></name><name><surname>Thoppil</surname><given-names>H</given-names></name><name><surname>Walsh</surname><given-names>M</given-names></name><name><surname>Sharifi</surname><given-names>S</given-names></name><name><surname>Ferreira</surname><given-names>S</given-names></name><name><surname>Anžič</surname><given-names>A</given-names></name><name><surname>Fernandes</surname><given-names>M</given-names></name><name><surname>Monteiro</surname><given-names>P</given-names></name><name><surname>Grum</surname><given-names>T</given-names></name><name><surname>Cordeiro</surname><given-names>R</given-names></name><name><surname>De-Souza</surname><given-names>EA</given-names></name><name><surname>Budovsky</surname><given-names>A</given-names></name><name><surname>Araujo</surname><given-names>N</given-names></name><name><surname>Gruber</surname><given-names>J</given-names></name><name><surname>Petrascheck</surname><given-names>M</given-names></name><name><surname>Fraifeld</surname><given-names>VE</given-names></name><name><surname>Zhavoronkov</surname><given-names>A</given-names></name><name><surname>Moskalev</surname><given-names>A</given-names></name><name><surname>de Magalhães</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2017">2017b</year><article-title>The DrugAge database of aging-related drugs</article-title><source>Aging Cell</source><volume>16</volume><fpage>594</fpage><lpage>597</lpage><pub-id pub-id-type="doi">10.1111/acel.12585</pub-id><pub-id pub-id-type="pmid">28299908</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bastien</surname><given-names>J</given-names></name><name><surname>Plassat</surname><given-names>JL</given-names></name><name><surname>Payrastre</surname><given-names>B</given-names></name><name><surname>Rochette-Egly</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The phosphoinositide 3-kinase/Akt pathway is essential for the retinoic acid-induced differentiation of F9 cells</article-title><source>Oncogene</source><volume>25</volume><fpage>2040</fpage><lpage>2047</lpage><pub-id pub-id-type="doi">10.1038/sj.onc.1209241</pub-id><pub-id pub-id-type="pmid">16288212</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bates</surname><given-names>D</given-names></name><name><surname>Mächler</surname><given-names>M</given-names></name><name><surname>Bolker</surname><given-names>B</given-names></name><name><surname>Walker</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Fitting linear mixed-effects models using lme4</article-title><source>Journal of Statistical Software</source><volume>1406</volume><elocation-id>i01</elocation-id><pub-id pub-id-type="doi">10.18637/jss.v067.i01</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ben-Sasson</surname><given-names>H</given-names></name><name><surname>Ben-Meir</surname><given-names>A</given-names></name><name><surname>Shushan</surname><given-names>A</given-names></name><name><surname>Karra</surname><given-names>L</given-names></name><name><surname>Rojansky</surname><given-names>N</given-names></name><name><surname>Klein</surname><given-names>BY</given-names></name><name><surname>Levitzki</surname><given-names>R</given-names></name><name><surname>Ben-Bassat</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>All-trans-retinoic acid mediates changes in PI3K and retinoic acid signaling proteins of leiomyomas</article-title><source>Fertility and Sterility</source><volume>95</volume><fpage>2080</fpage><lpage>2086</lpage><pub-id pub-id-type="doi">10.1016/j.fertnstert.2011.01.155</pub-id><pub-id pub-id-type="pmid">21354561</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname><given-names>DC</given-names></name><name><surname>Noy</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>All-trans-retinoic acid represses obesity and insulin resistance by activating both peroxisome proliferation-activated receptor beta/delta and retinoic acid receptor</article-title><source>Molecular and Cellular Biology</source><volume>29</volume><fpage>3286</fpage><lpage>3296</lpage><pub-id pub-id-type="doi">10.1128/MCB.01742-08</pub-id><pub-id pub-id-type="pmid">19364826</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beydoun</surname><given-names>S</given-names></name><name><surname>Choi</surname><given-names>HS</given-names></name><name><surname>Dela-Cruz</surname><given-names>G</given-names></name><name><surname>Kruempel</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>S</given-names></name><name><surname>Bazopoulou</surname><given-names>D</given-names></name><name><surname>Miller</surname><given-names>HA</given-names></name><name><surname>Schaller</surname><given-names>ML</given-names></name><name><surname>Evans</surname><given-names>CR</given-names></name><name><surname>Leiser</surname><given-names>SF</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>An alternative food source for metabolism and longevity studies in <italic>Caenorhabditis elegans</italic></article-title><source>Communications Biology</source><volume>4</volume><elocation-id>258</elocation-id><pub-id pub-id-type="doi">10.1038/s42003-021-01764-4</pub-id><pub-id pub-id-type="pmid">33637830</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beydoun</surname><given-names>S</given-names></name><name><surname>Kitto</surname><given-names>ES</given-names></name><name><surname>Wang</surname><given-names>E</given-names></name><name><surname>Huang</surname><given-names>S</given-names></name><name><surname>Leiser</surname><given-names>SF</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Methodology to metabolically inactivate bacteria for <italic>Caenorhabditis elegans</italic> research</article-title><source>Journal of Visualized Experiments</source><volume>01</volume><elocation-id>65775</elocation-id><pub-id pub-id-type="doi">10.3791/65775</pub-id><pub-id pub-id-type="pmid">37578251</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blackwell</surname><given-names>TK</given-names></name><name><surname>Steinbaugh</surname><given-names>MJ</given-names></name><name><surname>Hourihan</surname><given-names>JM</given-names></name><name><surname>Ewald</surname><given-names>CY</given-names></name><name><surname>Isik</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>SKN-1/Nrf, stress responses, and aging in <italic>Caenorhabditis elegans</italic></article-title><source>Free Radical Biology and Medicine</source><volume>88</volume><fpage>290</fpage><lpage>301</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2015.06.008</pub-id><pub-id pub-id-type="pmid">26232625</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowerman</surname><given-names>B</given-names></name><name><surname>Eaton</surname><given-names>BA</given-names></name><name><surname>Priess</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>skn-1, a maternally expressed gene required to specify the fate of ventral blastomeres in the early <italic>C. elegans</italic> embryo</article-title><source>Cell</source><volume>68</volume><fpage>1061</fpage><lpage>1075</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(92)90078-q</pub-id><pub-id pub-id-type="pmid">1547503</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="web"><person-group person-group-type="author"><collab>Caenorhabditis Intervention Testing Program</collab></person-group><year iso-8601-date="2022">2022</year><article-title>Caenorhabditis intervention testing program: Healthspan protocols</article-title><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.6084/m9.figshare.c.5089073">https://doi.org/10.6084/m9.figshare.c.5089073</ext-link><date-in-citation iso-8601-date="2022-09-15">September 15, 2022</date-in-citation></element-citation></ref><ref id="bib26"><element-citation publication-type="web"><person-group person-group-type="author"><collab>Caenorhabditis Intervention Testing Program</collab></person-group><year iso-8601-date="2025">2025</year><article-title>Caenorhabditis Intervention Testing Program: Data, analysis, and SOPs for the all-trans retinoic acid manuscript</article-title><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.6084/m9.figshare.c.7350250">https://doi.org/10.6084/m9.figshare.c.7350250</ext-link><date-in-citation iso-8601-date="2025-08-01">August 1, 2025</date-in-citation></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Camdzic</surname><given-names>M</given-names></name><name><surname>Aga</surname><given-names>DS</given-names></name><name><surname>Atilla-Gokcumen</surname><given-names>GE</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Cellular lipidome changes during Retinoic Acid (RA)-Induced differentiation in SH-SY5Y cells: A comprehensive <italic>in vitro</italic> model for assessing neurotoxicity of contaminants</article-title><source>Environment &amp; Health</source><volume>1</volume><fpage>110</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1021/envhealth.3c00022</pub-id><pub-id pub-id-type="pmid">37614295</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carpenter</surname><given-names>RL</given-names></name><name><surname>Paw</surname><given-names>I</given-names></name><name><surname>Dewhirst</surname><given-names>MW</given-names></name><name><surname>Lo</surname><given-names>HW</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Akt phosphorylates and activates HSF-1 independent of heat shock, leading to Slug overexpression and epithelial-mesenchymal transition (EMT) of HER2-overexpressing breast cancer cells</article-title><source>Oncogene</source><volume>34</volume><fpage>546</fpage><lpage>557</lpage><pub-id pub-id-type="doi">10.1038/onc.2013.582</pub-id><pub-id pub-id-type="pmid">24469056</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><collab><italic>C. elegans</italic> Deletion Mutant Consortium</collab></person-group><year iso-8601-date="2012">2012</year><article-title>large-scale screening for targeted knockouts in the <italic>Caenorhabditis elegans</italic> genome</article-title><source>G3: Genes, Genomes, Genetics</source><volume>2</volume><fpage>1415</fpage><lpage>1425</lpage><pub-id pub-id-type="doi">10.1534/g3.112.003830</pub-id><pub-id pub-id-type="pmid">23173093</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>D</given-names></name><name><surname>Frezza</surname><given-names>M</given-names></name><name><surname>Schmitt</surname><given-names>S</given-names></name><name><surname>Kanwar</surname><given-names>J</given-names></name><name><surname>Dou</surname><given-names>QP</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives</article-title><source>Current Cancer Drug Targets</source><volume>11</volume><fpage>239</fpage><lpage>253</lpage><pub-id pub-id-type="doi">10.2174/156800911794519752</pub-id><pub-id pub-id-type="pmid">21247388</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>AJ</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Jannasch</surname><given-names>A</given-names></name><name><surname>Mutlu</surname><given-names>AS</given-names></name><name><surname>Wang</surname><given-names>MC</given-names></name><name><surname>Cheng</surname><given-names>JX</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Fingerprint stimulated raman scattering imaging reveals retinoid coupling lipid metabolism and survival</article-title><source>Chemphyschem: A European Journal of Chemical Physics and Physical Chemistry</source><volume>19</volume><fpage>2500</fpage><lpage>2506</lpage><pub-id pub-id-type="doi">10.1002/cphc.201800545</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiang</surname><given-names>WC</given-names></name><name><surname>Ching</surname><given-names>TT</given-names></name><name><surname>Lee</surname><given-names>HC</given-names></name><name><surname>Mousigian</surname><given-names>C</given-names></name><name><surname>Hsu</surname><given-names>AL</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>HSF-1 regulators DDL-1/2 link insulin-like signaling to heat-shock responses and modulation of longevity</article-title><source>Cell</source><volume>148</volume><fpage>322</fpage><lpage>334</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2011.12.019</pub-id><pub-id pub-id-type="pmid">22265419</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clarke</surname><given-names>CJ</given-names></name><name><surname>Mediwala</surname><given-names>K</given-names></name><name><surname>Jenkins</surname><given-names>RW</given-names></name><name><surname>Sutton</surname><given-names>CA</given-names></name><name><surname>Tholanikunnel</surname><given-names>BG</given-names></name><name><surname>Hannun</surname><given-names>YA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Neutral sphingomyelinase-2 mediates growth arrest by retinoic acid through modulation of ribosomal S6 kinase</article-title><source>The Journal of Biological Chemistry</source><volume>286</volume><fpage>21565</fpage><lpage>21576</lpage><pub-id pub-id-type="doi">10.1074/jbc.M110.193375</pub-id><pub-id pub-id-type="pmid">21536668</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coleman-Hulbert</surname><given-names>AL</given-names></name><name><surname>Johnson</surname><given-names>E</given-names></name><name><surname>Sedore</surname><given-names>CA</given-names></name><name><surname>Banse</surname><given-names>SA</given-names></name><name><surname>Guo</surname><given-names>M</given-names></name><name><surname>Driscoll</surname><given-names>M</given-names></name><name><surname>Lithgow</surname><given-names>GJ</given-names></name><name><surname>Phillips</surname><given-names>PC</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title><italic>Caenorhabditis</italic> intervention testing program: the tyrosine kinase inhibitor imatinib mesylate does not extend lifespan in nematodes</article-title><source>microPublication Biology</source><volume>2019</volume><elocation-id>000131</elocation-id><pub-id pub-id-type="doi">10.17912/micropub.biology.000131</pub-id><pub-id pub-id-type="pmid">32010883</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crimmins</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Lifespan and healthspan: Past, present, and promise</article-title><source>The Gerontologist</source><volume>55</volume><fpage>901</fpage><lpage>911</lpage><pub-id pub-id-type="doi">10.1093/geront/gnv130</pub-id><pub-id pub-id-type="pmid">26561272</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cutler</surname><given-names>RG</given-names></name><name><surname>Mattson</surname><given-names>MP</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Sphingomyelin and ceramide as regulators of development and lifespan</article-title><source>Mechanisms of Ageing and Development</source><volume>122</volume><fpage>895</fpage><lpage>908</lpage><pub-id pub-id-type="doi">10.1016/s0047-6374(01)00246-9</pub-id><pub-id pub-id-type="pmid">11348657</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cutler</surname><given-names>RG</given-names></name><name><surname>Thompson</surname><given-names>KW</given-names></name><name><surname>Camandola</surname><given-names>S</given-names></name><name><surname>Mack</surname><given-names>KT</given-names></name><name><surname>Mattson</surname><given-names>MP</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Sphingolipid metabolism regulates development and lifespan in <italic>Caenorhabditis elegans</italic></article-title><source>Mechanisms of Ageing and Development</source><volume>143–144</volume><fpage>9</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1016/j.mad.2014.11.002</pub-id><pub-id pub-id-type="pmid">25437839</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Da Costa</surname><given-names>R</given-names></name><name><surname>De Almeida</surname><given-names>S</given-names></name><name><surname>Chevarin</surname><given-names>M</given-names></name><name><surname>Hadj-Rabia</surname><given-names>S</given-names></name><name><surname>Leclerc-Mercier</surname><given-names>S</given-names></name><name><surname>Thauvin-Robinet</surname><given-names>C</given-names></name><name><surname>Garrido</surname><given-names>C</given-names></name><name><surname>Faivre</surname><given-names>L</given-names></name><name><surname>Vabres</surname><given-names>P</given-names></name><name><surname>Duplomb</surname><given-names>L</given-names></name><name><surname>Jego</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Neutralization of HSF1 in cells from PIK3CA-related overgrowth spectrum patients blocks abnormal proliferation</article-title><source>Biochemical and Biophysical Research Communications</source><volume>530</volume><fpage>520</fpage><lpage>526</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2020.04.146</pub-id><pub-id pub-id-type="pmid">32620236</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dang</surname><given-names>Y</given-names></name><name><surname>An</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>B</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Gao</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>B</given-names></name><name><surname>Xie</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Berberine ameliorates cellular senescence and extends the lifespan of mice via regulating p16 and cyclin protein expression</article-title><source>Aging Cell</source><volume>19</volume><elocation-id>e13060</elocation-id><pub-id pub-id-type="doi">10.1111/acel.13060</pub-id><pub-id pub-id-type="pmid">31773901</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Das</surname><given-names>BC</given-names></name><name><surname>Dasgupta</surname><given-names>S</given-names></name><name><surname>Ray</surname><given-names>SK</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Potential therapeutic roles of retinoids for prevention of neuroinflammation and neurodegeneration in Alzheimer’s disease</article-title><source>Neural Regeneration Research</source><volume>14</volume><fpage>1880</fpage><lpage>1892</lpage><pub-id pub-id-type="doi">10.4103/1673-5374.259604</pub-id><pub-id pub-id-type="pmid">31290437</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>P</given-names></name><name><surname>Zarowiecki</surname><given-names>M</given-names></name><name><surname>Arnaboldi</surname><given-names>V</given-names></name><name><surname>Becerra</surname><given-names>A</given-names></name><name><surname>Cain</surname><given-names>S</given-names></name><name><surname>Chan</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>WJ</given-names></name><name><surname>Cho</surname><given-names>J</given-names></name><name><surname>da Veiga Beltrame</surname><given-names>E</given-names></name><name><surname>Diamantakis</surname><given-names>S</given-names></name><name><surname>Gao</surname><given-names>S</given-names></name><name><surname>Grigoriadis</surname><given-names>D</given-names></name><name><surname>Grove</surname><given-names>CA</given-names></name><name><surname>Harris</surname><given-names>TW</given-names></name><name><surname>Kishore</surname><given-names>R</given-names></name><name><surname>Le</surname><given-names>T</given-names></name><name><surname>Lee</surname><given-names>RYN</given-names></name><name><surname>Luypaert</surname><given-names>M</given-names></name><name><surname>Müller</surname><given-names>H-M</given-names></name><name><surname>Nakamura</surname><given-names>C</given-names></name><name><surname>Nuin</surname><given-names>P</given-names></name><name><surname>Paulini</surname><given-names>M</given-names></name><name><surname>Quinton-Tulloch</surname><given-names>M</given-names></name><name><surname>Raciti</surname><given-names>D</given-names></name><name><surname>Rodgers</surname><given-names>FH</given-names></name><name><surname>Russell</surname><given-names>M</given-names></name><name><surname>Schindelman</surname><given-names>G</given-names></name><name><surname>Singh</surname><given-names>A</given-names></name><name><surname>Stickland</surname><given-names>T</given-names></name><name><surname>Van Auken</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Williams</surname><given-names>G</given-names></name><name><surname>Wright</surname><given-names>AJ</given-names></name><name><surname>Yook</surname><given-names>K</given-names></name><name><surname>Berriman</surname><given-names>M</given-names></name><name><surname>Howe</surname><given-names>KL</given-names></name><name><surname>Schedl</surname><given-names>T</given-names></name><name><surname>Stein</surname><given-names>L</given-names></name><name><surname>Sternberg</surname><given-names>PW</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>WormBase in 2022-data, processes, and tools for analyzing <italic>Caenorhabditis elegans</italic></article-title><source>Genetics</source><volume>220</volume><elocation-id>iyac003</elocation-id><pub-id pub-id-type="doi">10.1093/genetics/iyac003</pub-id><pub-id pub-id-type="pmid">35134929</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Genaro</surname><given-names>P</given-names></name><name><surname>Simón</surname><given-names>MV</given-names></name><name><surname>Rotstein</surname><given-names>NP</given-names></name><name><surname>Politi</surname><given-names>LE</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Retinoic acid promotes apoptosis and differentiation in photoreceptors by activating the P38 MAP kinase pathway</article-title><source>Investigative Ophthalmology &amp; Visual Science</source><volume>54</volume><fpage>3143</fpage><lpage>3156</lpage><pub-id pub-id-type="doi">10.1167/iovs.12-11049</pub-id><pub-id pub-id-type="pmid">23580485</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duangjan</surname><given-names>C</given-names></name><name><surname>Rangsinth</surname><given-names>P</given-names></name><name><surname>Gu</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Wink</surname><given-names>M</given-names></name><name><surname>Tencomnao</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Glochidion zeylanicum leaf extracts exhibit lifespan extending and oxidative stress resistance properties in <italic>Caenorhabditis elegans</italic> via DAF-16/FoxO and SKN-1/Nrf-2 signaling pathways</article-title><source>Phytomedicine</source><volume>64</volume><elocation-id>153061</elocation-id><pub-id pub-id-type="doi">10.1016/j.phymed.2019.153061</pub-id><pub-id pub-id-type="pmid">31401497</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duester</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Retinoic acid synthesis and signaling during early organogenesis</article-title><source>Cell</source><volume>134</volume><fpage>921</fpage><lpage>931</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2008.09.002</pub-id><pub-id pub-id-type="pmid">18805086</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>EbioMedicine</collab></person-group><year iso-8601-date="2015">2015</year><article-title>Increasing healthspan: Prosper and live long</article-title><source>EBioMedicine</source><volume>2</volume><elocation-id>1559</elocation-id><pub-id pub-id-type="doi">10.1016/j.ebiom.2015.11.015</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Etchamendy</surname><given-names>N</given-names></name><name><surname>Enderlin</surname><given-names>V</given-names></name><name><surname>Marighetto</surname><given-names>A</given-names></name><name><surname>Vouimba</surname><given-names>RM</given-names></name><name><surname>Pallet</surname><given-names>V</given-names></name><name><surname>Jaffard</surname><given-names>R</given-names></name><name><surname>Higueret</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Alleviation of a selective age-related relational memory deficit in mice by pharmacologically induced normalization of brain retinoid signaling</article-title><source>The Journal of Neuroscience</source><volume>21</volume><fpage>6423</fpage><lpage>6429</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.21-16-06423.2001</pub-id><pub-id pub-id-type="pmid">11487666</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ewald</surname><given-names>CY</given-names></name><name><surname>Landis</surname><given-names>JN</given-names></name><name><surname>Porter Abate</surname><given-names>J</given-names></name><name><surname>Murphy</surname><given-names>CT</given-names></name><name><surname>Blackwell</surname><given-names>TK</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Dauer-independent insulin/IGF-1-signalling implicates collagen remodelling in longevity</article-title><source>Nature</source><volume>519</volume><fpage>97</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1038/nature14021</pub-id><pub-id pub-id-type="pmid">25517099</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farias</surname><given-names>EF</given-names></name><name><surname>Marzan</surname><given-names>C</given-names></name><name><surname>Mira-y-Lopez</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Cellular retinol-binding protein-I inhibits PI3K/Akt signaling through a retinoic acid receptor-dependent mechanism that regulates p85-p110 heterodimerization</article-title><source>Oncogene</source><volume>24</volume><fpage>1598</fpage><lpage>1606</lpage><pub-id pub-id-type="doi">10.1038/sj.onc.1208347</pub-id><pub-id pub-id-type="pmid">15608670</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fonseca</surname><given-names>E</given-names></name><name><surname>Ruivo</surname><given-names>R</given-names></name><name><surname>Borges</surname><given-names>D</given-names></name><name><surname>Franco</surname><given-names>JN</given-names></name><name><surname>Santos</surname><given-names>MM</given-names></name><name><surname>C Castro</surname><given-names>LF</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Of retinoids and organotins: The evolution of the retinoid X receptor in metazoa</article-title><source>Biomolecules</source><volume>10</volume><elocation-id>594</elocation-id><pub-id pub-id-type="doi">10.3390/biom10040594</pub-id><pub-id pub-id-type="pmid">32290525</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Fox</surname><given-names>J</given-names></name><name><surname>Weisberg</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><source>An R Companion to Applied Regression</source><publisher-name>Sage</publisher-name></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuentealba</surname><given-names>M</given-names></name><name><surname>Dönertaş</surname><given-names>HM</given-names></name><name><surname>Williams</surname><given-names>R</given-names></name><name><surname>Labbadia</surname><given-names>J</given-names></name><name><surname>Thornton</surname><given-names>JM</given-names></name><name><surname>Partridge</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Using the drug-protein interactome to identify anti-ageing compounds for humans</article-title><source>PLOS Computational Biology</source><volume>15</volume><elocation-id>e1006639</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1006639</pub-id><pub-id pub-id-type="pmid">30625143</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>García-Regalado</surname><given-names>A</given-names></name><name><surname>Vargas</surname><given-names>M</given-names></name><name><surname>García-Carrancá</surname><given-names>A</given-names></name><name><surname>Aréchaga-Ocampo</surname><given-names>E</given-names></name><name><surname>González-De la Rosa</surname><given-names>CH</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Activation of Akt pathway by transcription-independent mechanisms of retinoic acid promotes survival and invasion in lung cancer cells</article-title><source>Molecular Cancer</source><volume>12</volume><elocation-id>44</elocation-id><pub-id pub-id-type="doi">10.1186/1476-4598-12-44</pub-id><pub-id pub-id-type="pmid">23693014</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garofalo</surname><given-names>A</given-names></name><name><surname>Rowlinson</surname><given-names>MC</given-names></name><name><surname>Amambua</surname><given-names>NA</given-names></name><name><surname>Hughes</surname><given-names>JM</given-names></name><name><surname>Kelly</surname><given-names>SM</given-names></name><name><surname>Price</surname><given-names>NC</given-names></name><name><surname>Cooper</surname><given-names>A</given-names></name><name><surname>Watson</surname><given-names>DG</given-names></name><name><surname>Kennedy</surname><given-names>MW</given-names></name><name><surname>Bradley</surname><given-names>JE</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>The FAR protein family of the nematode <italic>Caenorhabditis elegans</italic>: Differential lipid binding properties, structural characteristics, and developmental regulation</article-title><source>The Journal of Biological Chemistry</source><volume>278</volume><fpage>8065</fpage><lpage>8074</lpage><pub-id pub-id-type="doi">10.1074/jbc.M206278200</pub-id><pub-id pub-id-type="pmid">12502713</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giuli</surname><given-names>MV</given-names></name><name><surname>Hanieh</surname><given-names>PN</given-names></name><name><surname>Giuliani</surname><given-names>E</given-names></name><name><surname>Rinaldi</surname><given-names>F</given-names></name><name><surname>Marianecci</surname><given-names>C</given-names></name><name><surname>Screpanti</surname><given-names>I</given-names></name><name><surname>Checquolo</surname><given-names>S</given-names></name><name><surname>Carafa</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Current trends in ATRA delivery for cancer therapy</article-title><source>Pharmaceutics</source><volume>12</volume><elocation-id>707</elocation-id><pub-id pub-id-type="doi">10.3390/pharmaceutics12080707</pub-id><pub-id pub-id-type="pmid">32731612</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez</surname><given-names>I</given-names></name><name><surname>Tripathi</surname><given-names>G</given-names></name><name><surname>Carter</surname><given-names>EJ</given-names></name><name><surname>Cobb</surname><given-names>LJ</given-names></name><name><surname>Salih</surname><given-names>DAM</given-names></name><name><surname>Lovett</surname><given-names>FA</given-names></name><name><surname>Holding</surname><given-names>C</given-names></name><name><surname>Pell</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Akt2, a novel functional link between p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways in myogenesis</article-title><source>Molecular and Cellular Biology</source><volume>24</volume><fpage>3607</fpage><lpage>3622</lpage><pub-id pub-id-type="doi">10.1128/MCB.24.9.3607-3622.2004</pub-id><pub-id pub-id-type="pmid">15082758</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goyala</surname><given-names>A</given-names></name><name><surname>Ewald</surname><given-names>CY</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>CRISPR-activated expression of collagen <italic>col-120</italic> increases lifespan and heat tolerance</article-title><source>microPublication Biology</source><volume>2023</volume><elocation-id>000730</elocation-id><pub-id pub-id-type="doi">10.17912/micropub.biology.000730</pub-id><pub-id pub-id-type="pmid">37122503</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greer</surname><given-names>EL</given-names></name><name><surname>Dowlatshahi</surname><given-names>D</given-names></name><name><surname>Banko</surname><given-names>MR</given-names></name><name><surname>Villen</surname><given-names>J</given-names></name><name><surname>Hoang</surname><given-names>K</given-names></name><name><surname>Blanchard</surname><given-names>D</given-names></name><name><surname>Gygi</surname><given-names>SP</given-names></name><name><surname>Brunet</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>An AMPK-FOXO pathway mediates longevity induced by a novel method of dietary restriction in <italic>C. elegans</italic></article-title><source>Current Biology</source><volume>17</volume><fpage>1646</fpage><lpage>1656</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2007.08.047</pub-id><pub-id pub-id-type="pmid">17900900</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greer</surname><given-names>EL</given-names></name><name><surname>Brunet</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Different dietary restriction regimens extend lifespan by both independent and overlapping genetic pathways in <italic>C. elegans</italic></article-title><source>Aging Cell</source><volume>8</volume><fpage>113</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.1111/j.1474-9726.2009.00459.x</pub-id><pub-id pub-id-type="pmid">19239417</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hajdu-Cronin</surname><given-names>YM</given-names></name><name><surname>Chen</surname><given-names>WJ</given-names></name><name><surname>Sternberg</surname><given-names>PW</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>The L-type cyclin CYL-1 and the heat-shock-factor HSF-1 are required for heat-shock-induced protein expression in <italic>Caenorhabditis elegans</italic></article-title><source>Genetics</source><volume>168</volume><fpage>1937</fpage><lpage>1949</lpage><pub-id pub-id-type="doi">10.1534/genetics.104.028423</pub-id><pub-id pub-id-type="pmid">15611166</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamer</surname><given-names>J</given-names></name><name><surname>Grandjean</surname><given-names>T</given-names></name><name><surname>Melendez</surname><given-names>L</given-names></name><name><surname>Sowton</surname><given-names>GE</given-names></name></person-group><year iso-8601-date="1964">1964</year><article-title>Effect of propranolol (inderal) in angina pectoris: Preliminary report</article-title><source>British Medical Journal</source><volume>2</volume><fpage>720</fpage><lpage>723</lpage><pub-id pub-id-type="doi">10.1136/bmj.2.5411.720</pub-id><pub-id pub-id-type="pmid">14172034</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>B</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Pang</surname><given-names>S</given-names></name><name><surname>Tang</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Phosphatidylcholine mediates the crosstalk between LET-607 and DAF-16 stress response pathways</article-title><source>PLOS Genetics</source><volume>17</volume><elocation-id>e1009573</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1009573</pub-id><pub-id pub-id-type="pmid">34014977</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hertweck</surname><given-names>M</given-names></name><name><surname>Göbel</surname><given-names>C</given-names></name><name><surname>Baumeister</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title><italic>C. elegans</italic> SGK-1 is the critical component in the Akt/PKB kinase complex to control stress response and life span</article-title><source>Developmental Cell</source><volume>6</volume><fpage>577</fpage><lpage>588</lpage><pub-id pub-id-type="doi">10.1016/s1534-5807(04)00095-4</pub-id><pub-id pub-id-type="pmid">15068796</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Higgins</surname><given-names>DP</given-names></name><name><surname>Weisman</surname><given-names>CM</given-names></name><name><surname>Lui</surname><given-names>DS</given-names></name><name><surname>D’Agostino</surname><given-names>FA</given-names></name><name><surname>Walker</surname><given-names>AK</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Defining characteristics and conservation of poorly annotated genes in <italic>Caenorhabditis elegans</italic> using WormCat 2.0</article-title><source>Genetics</source><volume>221</volume><elocation-id>iyac085</elocation-id><pub-id pub-id-type="doi">10.1093/genetics/iyac085</pub-id><pub-id pub-id-type="pmid">35587742</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holdorf</surname><given-names>AD</given-names></name><name><surname>Higgins</surname><given-names>DP</given-names></name><name><surname>Hart</surname><given-names>AC</given-names></name><name><surname>Boag</surname><given-names>PR</given-names></name><name><surname>Pazour</surname><given-names>GJ</given-names></name><name><surname>Walhout</surname><given-names>AJM</given-names></name><name><surname>Walker</surname><given-names>AK</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>WormCat: An online tool for annotation and visualization of <italic>Caenorhabditis elegans</italic> genome-scale data</article-title><source>Genetics</source><volume>214</volume><fpage>279</fpage><lpage>294</lpage><pub-id pub-id-type="doi">10.1534/genetics.119.302919</pub-id><pub-id pub-id-type="pmid">31810987</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hormi-Carver</surname><given-names>K</given-names></name><name><surname>Feagins</surname><given-names>LA</given-names></name><name><surname>Spechler</surname><given-names>SJ</given-names></name><name><surname>Souza</surname><given-names>RF</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>All trans-retinoic acid induces apoptosis via p38 and caspase pathways in metaplastic Barrett’s cells</article-title><source>American Journal of Physiology. Gastrointestinal and Liver Physiology</source><volume>292</volume><fpage>G18</fpage><lpage>G27</lpage><pub-id pub-id-type="doi">10.1152/ajpgi.00237.2006</pub-id><pub-id pub-id-type="pmid">16935849</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hosono</surname><given-names>R</given-names></name></person-group><year iso-8601-date="1978">1978</year><article-title>Sterilization and growth inhibition of <italic>Caenorhabditis elegans</italic> by 5-fluorodeoxyuridine</article-title><source>Experimental Gerontology</source><volume>13</volume><fpage>369</fpage><lpage>374</lpage><pub-id pub-id-type="doi">10.1016/0531-5565(78)90047-5</pub-id><pub-id pub-id-type="pmid">153845</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsieh</surname><given-names>CT</given-names></name><name><surname>Chuang</surname><given-names>JH</given-names></name><name><surname>Yang</surname><given-names>WC</given-names></name><name><surname>Yin</surname><given-names>Y</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Ceramide inhibits insulin-stimulated Akt phosphorylation through activation of Rheb/mTORC1/S6K signaling in skeletal muscle</article-title><source>Cellular Signalling</source><volume>26</volume><fpage>1400</fpage><lpage>1408</lpage><pub-id pub-id-type="doi">10.1016/j.cellsig.2014.03.004</pub-id><pub-id pub-id-type="pmid">24650522</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname><given-names>AL</given-names></name><name><surname>Murphy</surname><given-names>CT</given-names></name><name><surname>Kenyon</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Regulation of aging and age-related disease by DAF-16 and heat-shock factor</article-title><source>Science</source><volume>300</volume><fpage>1142</fpage><lpage>1145</lpage><pub-id pub-id-type="doi">10.1126/science.1083701</pub-id><pub-id pub-id-type="pmid">12750521</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Qi</surname><given-names>G</given-names></name><name><surname>Brand</surname><given-names>D</given-names></name><name><surname>Zheng</surname><given-names>SG</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Role of vitamin A in the immune system</article-title><source>Journal of Clinical Medicine</source><volume>7</volume><elocation-id>258</elocation-id><pub-id pub-id-type="doi">10.3390/jcm7090258</pub-id><pub-id pub-id-type="pmid">30200565</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ibáñez-Ventoso</surname><given-names>C</given-names></name><name><surname>Herrera</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>E</given-names></name><name><surname>Motto</surname><given-names>D</given-names></name><name><surname>Driscoll</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Automated analysis of <italic>C. elegans</italic> swim behavior using celeST software</article-title><source>Journal of Visualized Experiments</source><volume>2016</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.3791/54359</pub-id><pub-id pub-id-type="pmid">28060275</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inoue</surname><given-names>H</given-names></name><name><surname>Hisamoto</surname><given-names>N</given-names></name><name><surname>An</surname><given-names>JH</given-names></name><name><surname>Oliveira</surname><given-names>RP</given-names></name><name><surname>Nishida</surname><given-names>E</given-names></name><name><surname>Blackwell</surname><given-names>TK</given-names></name><name><surname>Matsumoto</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The <italic>C. elegans</italic> p38 MAPK pathway regulates nuclear localization of the transcription factor SKN-1 in oxidative stress response</article-title><source>Genes &amp; Development</source><volume>19</volume><fpage>2278</fpage><lpage>2283</lpage><pub-id pub-id-type="doi">10.1101/gad.1324805</pub-id><pub-id pub-id-type="pmid">16166371</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishijima</surname><given-names>N</given-names></name><name><surname>Kanki</surname><given-names>K</given-names></name><name><surname>Shimizu</surname><given-names>H</given-names></name><name><surname>Shiota</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Activation of AMP-activated protein kinase by retinoic acid sensitizes hepatocellular carcinoma cells to apoptosis induced by sorafenib</article-title><source>Cancer Science</source><volume>106</volume><fpage>567</fpage><lpage>575</lpage><pub-id pub-id-type="doi">10.1111/cas.12633</pub-id><pub-id pub-id-type="pmid">25683251</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janssens</surname><given-names>GE</given-names></name><name><surname>Lin</surname><given-names>XX</given-names></name><name><surname>Millan-Ariño</surname><given-names>L</given-names></name><name><surname>Kavšek</surname><given-names>A</given-names></name><name><surname>Sen</surname><given-names>I</given-names></name><name><surname>Seinstra</surname><given-names>RI</given-names></name><name><surname>Stroustrup</surname><given-names>N</given-names></name><name><surname>Nollen</surname><given-names>EAA</given-names></name><name><surname>Riedel</surname><given-names>CG</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Transcriptomics-based screening identifies pharmacological inhibition of Hsp90 as a means to defer aging</article-title><source>Cell Reports</source><volume>27</volume><fpage>467</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.03.044</pub-id><pub-id pub-id-type="pmid">30970250</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jayarathne</surname><given-names>S</given-names></name><name><surname>Ramalingam</surname><given-names>L</given-names></name><name><surname>Edwards</surname><given-names>H</given-names></name><name><surname>Vanapalli</surname><given-names>SA</given-names></name><name><surname>Moustaid-Moussa</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Tart cherry increases lifespan in <italic>Caenorhabditis elegans</italic> by altering metabolic signaling pathways</article-title><source>Nutrients</source><volume>12</volume><elocation-id>1482</elocation-id><pub-id pub-id-type="doi">10.3390/nu12051482</pub-id><pub-id pub-id-type="pmid">32443669</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jęśko</surname><given-names>H</given-names></name><name><surname>Stępień</surname><given-names>A</given-names></name><name><surname>Lukiw</surname><given-names>WJ</given-names></name><name><surname>Strosznajder</surname><given-names>RP</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The cross-talk between Sphingolipids and insulin-like growth factor signaling: Significance for aging and neurodegeneration</article-title><source>Molecular Neurobiology</source><volume>56</volume><fpage>3501</fpage><lpage>3521</lpage><pub-id pub-id-type="doi">10.1007/s12035-018-1286-3</pub-id><pub-id pub-id-type="pmid">30140974</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>S</given-names></name><name><surname>Jiang</surname><given-names>CP</given-names></name><name><surname>Cao</surname><given-names>P</given-names></name><name><surname>Liu</surname><given-names>YH</given-names></name><name><surname>Gao</surname><given-names>CH</given-names></name><name><surname>Yi</surname><given-names>XX</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Sonneradon A extends lifespan of <italic>Caenorhabditis elegans</italic> by modulating mitochondrial and IIS signaling pathways</article-title><source>Marine Drugs</source><volume>20</volume><elocation-id>59</elocation-id><pub-id pub-id-type="doi">10.3390/md20010059</pub-id><pub-id pub-id-type="pmid">35049915</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>X</given-names></name><name><surname>Moskophidis</surname><given-names>D</given-names></name><name><surname>Mivechi</surname><given-names>NF</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Heat shock transcription factor 1 is a key determinant of HCC development by regulating hepatic steatosis and metabolic syndrome</article-title><source>Cell Metabolism</source><volume>14</volume><fpage>91</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2011.03.025</pub-id><pub-id pub-id-type="pmid">21723507</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalén</surname><given-names>A</given-names></name><name><surname>Borchardt</surname><given-names>RA</given-names></name><name><surname>Bell</surname><given-names>RM</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Elevated ceramide levels in GH4C1 cells treated with retinoic acid</article-title><source>Biochimica et Biophysica Acta</source><volume>1125</volume><fpage>90</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1016/0005-2760(92)90160-w</pub-id><pub-id pub-id-type="pmid">1567913</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamath</surname><given-names>RS</given-names></name><name><surname>Ahringer</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Genome-wide RNAi screening in <italic>Caenorhabditis elegans</italic></article-title><source>Methods</source><volume>30</volume><fpage>313</fpage><lpage>321</lpage><pub-id pub-id-type="doi">10.1016/s1046-2023(03)00050-1</pub-id><pub-id pub-id-type="pmid">12828945</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kennedy</surname><given-names>BK</given-names></name><name><surname>Berger</surname><given-names>SL</given-names></name><name><surname>Brunet</surname><given-names>A</given-names></name><name><surname>Campisi</surname><given-names>J</given-names></name><name><surname>Cuervo</surname><given-names>AM</given-names></name><name><surname>Epel</surname><given-names>ES</given-names></name><name><surname>Franceschi</surname><given-names>C</given-names></name><name><surname>Lithgow</surname><given-names>GJ</given-names></name><name><surname>Morimoto</surname><given-names>RI</given-names></name><name><surname>Pessin</surname><given-names>JE</given-names></name><name><surname>Rando</surname><given-names>TA</given-names></name><name><surname>Richardson</surname><given-names>A</given-names></name><name><surname>Schadt</surname><given-names>EE</given-names></name><name><surname>Wyss-Coray</surname><given-names>T</given-names></name><name><surname>Sierra</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Geroscience: linking aging to chronic disease</article-title><source>Cell</source><volume>159</volume><fpage>709</fpage><lpage>713</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.10.039</pub-id><pub-id pub-id-type="pmid">25417146</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SC</given-names></name><name><surname>Kim</surname><given-names>YH</given-names></name><name><surname>Son</surname><given-names>SW</given-names></name><name><surname>Moon</surname><given-names>EY</given-names></name><name><surname>Pyo</surname><given-names>S</given-names></name><name><surname>Um</surname><given-names>SH</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Fisetin induces Sirt1 expression while inhibiting early adipogenesis in 3T3-L1 cells</article-title><source>Biochemical and Biophysical Research Communications</source><volume>467</volume><fpage>638</fpage><lpage>644</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2015.10.094</pub-id><pub-id pub-id-type="pmid">26499075</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Kim</surname><given-names>BK</given-names></name><name><surname>Park</surname><given-names>S</given-names></name><name><surname>Park</surname><given-names>SK</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Phosphatidylcholine extends lifespan via DAF-16 and reduces amyloid-beta-induced toxicity in <italic>Caenorhabditis elegans</italic></article-title><source>Oxidative Medicine and Cellular Longevity</source><volume>2019</volume><elocation-id>2860642</elocation-id><pub-id pub-id-type="doi">10.1155/2019/2860642</pub-id><pub-id pub-id-type="pmid">31379987</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kostrouch</surname><given-names>Z</given-names></name><name><surname>Kostrouchova</surname><given-names>M</given-names></name><name><surname>Rall</surname><given-names>JE</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Steroid/thyroid hormone receptor genes in <italic>Caenorhabditis elegans</italic></article-title><source>PNAS</source><volume>92</volume><fpage>156</fpage><lpage>159</lpage><pub-id pub-id-type="doi">10.1073/pnas.92.1.156</pub-id><pub-id pub-id-type="pmid">7816808</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Egan</surname><given-names>BM</given-names></name><name><surname>Kocsisova</surname><given-names>Z</given-names></name><name><surname>Schneider</surname><given-names>DL</given-names></name><name><surname>Murphy</surname><given-names>JT</given-names></name><name><surname>Diwan</surname><given-names>A</given-names></name><name><surname>Kornfeld</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Lifespan extension in <italic>C. elegans</italic> caused by bacterial colonization of the intestine and subsequent activation of an innate immune response</article-title><source>Developmental Cell</source><volume>49</volume><fpage>100</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2019.03.010</pub-id><pub-id pub-id-type="pmid">30965033</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuri-Harcuch</surname><given-names>W</given-names></name></person-group><year iso-8601-date="1982">1982</year><article-title>Differentiation of 3T3-F442A cells into adipocytes is inhibited by retinoic acid</article-title><source>Differentiation; Research in Biological Diversity</source><volume>23</volume><fpage>164</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1111/j.1432-0436.1982.tb01279.x</pub-id><pub-id pub-id-type="pmid">7166214</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lakowski</surname><given-names>B</given-names></name><name><surname>Hekimi</surname><given-names>S</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>The genetics of caloric restriction in <italic>Caenorhabditis elegans</italic></article-title><source>PNAS</source><volume>95</volume><fpage>13091</fpage><lpage>13096</lpage><pub-id pub-id-type="doi">10.1073/pnas.95.22.13091</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lazaro-Pena</surname><given-names>MI</given-names></name><name><surname>Ward</surname><given-names>ZC</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Strohm</surname><given-names>A</given-names></name><name><surname>Merrill</surname><given-names>AK</given-names></name><name><surname>Soto</surname><given-names>CA</given-names></name><name><surname>Samuelson</surname><given-names>AV</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>HSF-1: Guardian of the proteome through integration of longevity signals to the proteostatic network</article-title><source>Frontiers in Aging</source><volume>3</volume><elocation-id>861686</elocation-id><pub-id pub-id-type="doi">10.3389/fragi.2022.861686</pub-id><pub-id pub-id-type="pmid">35874276</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>YM</given-names></name><name><surname>Lee</surname><given-names>JO</given-names></name><name><surname>Jung</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Park</surname><given-names>SH</given-names></name><name><surname>Park</surname><given-names>JM</given-names></name><name><surname>Kim</surname><given-names>EK</given-names></name><name><surname>Suh</surname><given-names>PG</given-names></name><name><surname>Kim</surname><given-names>HS</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Retinoic acid leads to cytoskeletal rearrangement through AMPK-Rac1 and stimulates glucose uptake through AMPK-p38 MAPK in skeletal muscle cells</article-title><source>The Journal of Biological Chemistry</source><volume>283</volume><fpage>33969</fpage><lpage>33974</lpage><pub-id pub-id-type="doi">10.1074/jbc.M804469200</pub-id><pub-id pub-id-type="pmid">18927084</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>HP</given-names></name><name><surname>Casadesus</surname><given-names>G</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name><name><surname>Perry</surname><given-names>G</given-names></name><name><surname>Smith</surname><given-names>MA</given-names></name><name><surname>Gustaw-Rothenberg</surname><given-names>K</given-names></name><name><surname>Lerner</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>All-trans retinoic acid as a novel therapeutic strategy for Alzheimer’s disease</article-title><source>Expert Review of Neurotherapeutics</source><volume>9</volume><fpage>1615</fpage><lpage>1621</lpage><pub-id pub-id-type="doi">10.1586/ern.09.86</pub-id><pub-id pub-id-type="pmid">19903021</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>Y</given-names></name><name><surname>Lee</surname><given-names>JY</given-names></name><name><surname>Kim</surname><given-names>MH</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>PI3K/Akt pathway regulates retinoic acid-induced Hox gene expression in F9 cells</article-title><source>Development, Growth &amp; Differentiation</source><volume>56</volume><fpage>518</fpage><lpage>525</lpage><pub-id pub-id-type="doi">10.1111/dgd.12152</pub-id><pub-id pub-id-type="pmid">25212816</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>Y</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote</article-title><source>Nucleic Acids Research</source><volume>41</volume><elocation-id>e108</elocation-id><pub-id pub-id-type="doi">10.1093/nar/gkt214</pub-id><pub-id pub-id-type="pmid">23558742</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>Y</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>featureCounts: an efficient general purpose program for assigning sequence reads to genomic features</article-title><source>Bioinformatics</source><volume>30</volume><fpage>923</fpage><lpage>930</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btt656</pub-id><pub-id pub-id-type="pmid">24227677</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liberati</surname><given-names>NT</given-names></name><name><surname>Fitzgerald</surname><given-names>KA</given-names></name><name><surname>Kim</surname><given-names>DH</given-names></name><name><surname>Feinbaum</surname><given-names>R</given-names></name><name><surname>Golenbock</surname><given-names>DT</given-names></name><name><surname>Ausubel</surname><given-names>FM</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Requirement for a conserved Toll/interleukin-1 resistance domain protein in the <italic>Caenorhabditis elegans</italic> immune response</article-title><source>PNAS</source><volume>101</volume><fpage>6593</fpage><lpage>6598</lpage><pub-id pub-id-type="doi">10.1073/pnas.0308625101</pub-id><pub-id pub-id-type="pmid">15123841</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>K</given-names></name><name><surname>Dorman</surname><given-names>JB</given-names></name><name><surname>Rodan</surname><given-names>A</given-names></name><name><surname>Kenyon</surname><given-names>C</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>daf-16: An HNF-3/forkhead family member that can function to double the life-span of <italic>Caenorhabditis elegans</italic></article-title><source>Science</source><volume>278</volume><fpage>1319</fpage><lpage>1322</lpage><pub-id pub-id-type="doi">10.1126/science.278.5341.1319</pub-id><pub-id pub-id-type="pmid">9360933</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>WC</given-names></name><name><surname>Omari</surname><given-names>R</given-names></name><name><surname>Ray</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Williams</surname><given-names>I</given-names></name><name><surname>Jacobs</surname><given-names>C</given-names></name><name><surname>Hockaden</surname><given-names>N</given-names></name><name><surname>Bochman</surname><given-names>ML</given-names></name><name><surname>Carpenter</surname><given-names>RL</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>AKT1 mediates multiple phosphorylation events that functionally promote HSF1 activation</article-title><source>The FEBS Journal</source><volume>289</volume><fpage>3876</fpage><lpage>3893</lpage><pub-id pub-id-type="doi">10.1111/febs.16375</pub-id><pub-id pub-id-type="pmid">35080342</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lucanic</surname><given-names>M</given-names></name><name><surname>Plummer</surname><given-names>WT</given-names></name><name><surname>Chen</surname><given-names>E</given-names></name><name><surname>Harke</surname><given-names>J</given-names></name><name><surname>Foulger</surname><given-names>AC</given-names></name><name><surname>Onken</surname><given-names>B</given-names></name><name><surname>Coleman-Hulbert</surname><given-names>AL</given-names></name><name><surname>Dumas</surname><given-names>KJ</given-names></name><name><surname>Guo</surname><given-names>S</given-names></name><name><surname>Johnson</surname><given-names>E</given-names></name><name><surname>Bhaumik</surname><given-names>D</given-names></name><name><surname>Xue</surname><given-names>J</given-names></name><name><surname>Crist</surname><given-names>AB</given-names></name><name><surname>Presley</surname><given-names>MP</given-names></name><name><surname>Harinath</surname><given-names>G</given-names></name><name><surname>Sedore</surname><given-names>CA</given-names></name><name><surname>Chamoli</surname><given-names>M</given-names></name><name><surname>Kamat</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>MK</given-names></name><name><surname>Angeli</surname><given-names>S</given-names></name><name><surname>Chang</surname><given-names>C</given-names></name><name><surname>Willis</surname><given-names>JH</given-names></name><name><surname>Edgar</surname><given-names>D</given-names></name><name><surname>Royal</surname><given-names>MA</given-names></name><name><surname>Chao</surname><given-names>EA</given-names></name><name><surname>Patel</surname><given-names>S</given-names></name><name><surname>Garrett</surname><given-names>T</given-names></name><name><surname>Ibanez-Ventoso</surname><given-names>C</given-names></name><name><surname>Hope</surname><given-names>J</given-names></name><name><surname>Kish</surname><given-names>JL</given-names></name><name><surname>Guo</surname><given-names>M</given-names></name><name><surname>Lithgow</surname><given-names>GJ</given-names></name><name><surname>Driscoll</surname><given-names>M</given-names></name><name><surname>Phillips</surname><given-names>PC</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Impact of genetic background and experimental reproducibility on identifying chemical compounds with robust longevity effects</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>14256</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms14256</pub-id><pub-id pub-id-type="pmid">28220799</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maduro</surname><given-names>MF</given-names></name><name><surname>Meneghini</surname><given-names>MD</given-names></name><name><surname>Bowerman</surname><given-names>B</given-names></name><name><surname>Broitman-Maduro</surname><given-names>G</given-names></name><name><surname>Rothman</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Restriction of mesendoderm to a single blastomere by the combined action of SKN-1 and a GSK-3beta homolog is mediated by MED-1 and -2 in <italic>C. elegans</italic></article-title><source>Molecular Cell</source><volume>7</volume><fpage>475</fpage><lpage>485</lpage><pub-id pub-id-type="doi">10.1016/s1097-2765(01)00195-2</pub-id><pub-id pub-id-type="pmid">11463373</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mair</surname><given-names>W</given-names></name><name><surname>Morantte</surname><given-names>I</given-names></name><name><surname>Rodrigues</surname><given-names>APC</given-names></name><name><surname>Manning</surname><given-names>G</given-names></name><name><surname>Montminy</surname><given-names>M</given-names></name><name><surname>Shaw</surname><given-names>RJ</given-names></name><name><surname>Dillin</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Lifespan extension induced by AMPK and calcineurin is mediated by CRTC-1 and CREB</article-title><source>Nature</source><volume>470</volume><fpage>404</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.1038/nature09706</pub-id><pub-id pub-id-type="pmid">21331044</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mak</surname><given-names>HY</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Lipid droplets as fat storage organelles in <italic>Caenorhabditis elegans</italic>: Thematic review series: Lipid droplet synthesis and metabolism: from yeast to man</article-title><source>Journal of Lipid Research</source><volume>53</volume><fpage>28</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1194/jlr.R021006</pub-id><pub-id pub-id-type="pmid">22049244</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mark</surname><given-names>KA</given-names></name><name><surname>Dumas</surname><given-names>KJ</given-names></name><name><surname>Bhaumik</surname><given-names>D</given-names></name><name><surname>Schilling</surname><given-names>B</given-names></name><name><surname>Davis</surname><given-names>S</given-names></name><name><surname>Oron</surname><given-names>TR</given-names></name><name><surname>Sorensen</surname><given-names>DJ</given-names></name><name><surname>Lucanic</surname><given-names>M</given-names></name><name><surname>Brem</surname><given-names>RB</given-names></name><name><surname>Melov</surname><given-names>S</given-names></name><name><surname>Ramanathan</surname><given-names>A</given-names></name><name><surname>Gibson</surname><given-names>BW</given-names></name><name><surname>Lithgow</surname><given-names>GJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Vitamin D Promotes protein homeostasis and longevity via the stress response pathway genes skn-1, ire-1, and xbp-1</article-title><source>Cell Reports</source><volume>17</volume><fpage>1227</fpage><lpage>1237</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.09.086</pub-id><pub-id pub-id-type="pmid">27783938</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masiá</surname><given-names>S</given-names></name><name><surname>Alvarez</surname><given-names>S</given-names></name><name><surname>de Lera</surname><given-names>AR</given-names></name><name><surname>Barettino</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Rapid, nongenomic actions of retinoic acid on phosphatidylinositol-3-kinase signaling pathway mediated by the retinoic acid receptor</article-title><source>Molecular Endocrinology</source><volume>21</volume><fpage>2391</fpage><lpage>2402</lpage><pub-id pub-id-type="doi">10.1210/me.2007-0062</pub-id><pub-id pub-id-type="pmid">17595318</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKay</surname><given-names>JP</given-names></name><name><surname>Raizen</surname><given-names>DM</given-names></name><name><surname>Gottschalk</surname><given-names>A</given-names></name><name><surname>Schafer</surname><given-names>WR</given-names></name><name><surname>Avery</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>eat-2 and eat-18 are required for nicotinic neurotransmission in the <italic>Caenorhabditis elegans</italic> pharynx</article-title><source>Genetics</source><volume>166</volume><fpage>161</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1534/genetics.166.1.161</pub-id><pub-id pub-id-type="pmid">15020415</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>DH</given-names></name><name><surname>Stiles</surname><given-names>JW</given-names></name><name><surname>Santelli</surname><given-names>J</given-names></name><name><surname>Sanadi</surname><given-names>DR</given-names></name></person-group><year iso-8601-date="1979">1979</year><article-title>Synchronous growth and aging of <italic>Caenorhabditis elegans</italic> in the presence of fluorodeoxyuridine</article-title><source>Journal of Gerontology</source><volume>34</volume><fpage>28</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1093/geronj/34.1.28</pub-id><pub-id pub-id-type="pmid">153363</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizuno</surname><given-names>T</given-names></name><name><surname>Hisamoto</surname><given-names>N</given-names></name><name><surname>Terada</surname><given-names>T</given-names></name><name><surname>Kondo</surname><given-names>T</given-names></name><name><surname>Adachi</surname><given-names>M</given-names></name><name><surname>Nishida</surname><given-names>E</given-names></name><name><surname>Kim</surname><given-names>DH</given-names></name><name><surname>Ausubel</surname><given-names>FM</given-names></name><name><surname>Matsumoto</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>The <italic>Caenorhabditis elegans</italic> MAPK phosphatase VHP-1 mediates a novel JNK-like signaling pathway in stress response</article-title><source>The EMBO Journal</source><volume>23</volume><fpage>2226</fpage><lpage>2234</lpage><pub-id pub-id-type="doi">10.1038/sj.emboj.7600226</pub-id><pub-id pub-id-type="pmid">15116070</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mosbech</surname><given-names>MB</given-names></name><name><surname>Kruse</surname><given-names>R</given-names></name><name><surname>Harvald</surname><given-names>EB</given-names></name><name><surname>Olsen</surname><given-names>ASB</given-names></name><name><surname>Gallego</surname><given-names>SF</given-names></name><name><surname>Hannibal-Bach</surname><given-names>HK</given-names></name><name><surname>Ejsing</surname><given-names>CS</given-names></name><name><surname>Færgeman</surname><given-names>NJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Functional loss of two ceramide synthases elicits autophagy-dependent lifespan extension in <italic>C. elegans</italic></article-title><source>PLOS ONE</source><volume>8</volume><elocation-id>e70087</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0070087</pub-id><pub-id pub-id-type="pmid">23894595</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mukherjee</surname><given-names>S</given-names></name><name><surname>Date</surname><given-names>A</given-names></name><name><surname>Patravale</surname><given-names>V</given-names></name><name><surname>Korting</surname><given-names>HC</given-names></name><name><surname>Roeder</surname><given-names>A</given-names></name><name><surname>Weindl</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety</article-title><source>Clinical Interventions in Aging</source><volume>1</volume><fpage>327</fpage><lpage>348</lpage><pub-id pub-id-type="doi">10.2147/ciia.2006.1.4.327</pub-id><pub-id pub-id-type="pmid">18046911</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mullaney</surname><given-names>BC</given-names></name><name><surname>Ashrafi</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title><italic>C. elegans</italic> fat storage and metabolic regulation</article-title><source>Biochimica et Biophysica Acta</source><volume>1791</volume><fpage>474</fpage><lpage>478</lpage><pub-id pub-id-type="doi">10.1016/j.bbalip.2008.12.013</pub-id><pub-id pub-id-type="pmid">19168149</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>CT</given-names></name><name><surname>Hu</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Insulin/insulin-like growth factor signaling in <italic>C. elegans</italic></article-title><source>WormBook</source><volume>01</volume><fpage>1</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1895/wormbook.1.164.1</pub-id><pub-id pub-id-type="pmid">24395814</pub-id></element-citation></ref><ref id="bib109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Narasimhan</surname><given-names>SD</given-names></name><name><surname>Yen</surname><given-names>K</given-names></name><name><surname>Tissenbaum</surname><given-names>HA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Converging pathways in lifespan regulation</article-title><source>Current Biology</source><volume>19</volume><fpage>R657</fpage><lpage>R666</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2009.06.013</pub-id><pub-id pub-id-type="pmid">19674551</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newell Stamper</surname><given-names>BL</given-names></name><name><surname>Cypser</surname><given-names>JR</given-names></name><name><surname>Kechris</surname><given-names>K</given-names></name><name><surname>Kitzenberg</surname><given-names>DA</given-names></name><name><surname>Tedesco</surname><given-names>PM</given-names></name><name><surname>Johnson</surname><given-names>TE</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Movement decline across lifespan of <italic>Caenorhabditis elegans</italic> mutants in the insulin/insulin-like signaling pathway</article-title><source>Aging Cell</source><volume>17</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1111/acel.12704</pub-id><pub-id pub-id-type="pmid">29214707</pub-id></element-citation></ref><ref id="bib111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>TTM</given-names></name><name><surname>An</surname><given-names>YJ</given-names></name><name><surname>Cha</surname><given-names>JW</given-names></name><name><surname>Ko</surname><given-names>YJ</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name><name><surname>Chung</surname><given-names>CH</given-names></name><name><surname>Jeon</surname><given-names>SM</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Park</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Real-Time In-Organism NMR metabolomics reveals different roles of AMP-activated protein kinase catalytic subunits</article-title><source>Analytical Chemistry</source><volume>92</volume><fpage>7382</fpage><lpage>7387</lpage><pub-id pub-id-type="doi">10.1021/acs.analchem.9b05670</pub-id><pub-id pub-id-type="pmid">32392040</pub-id></element-citation></ref><ref id="bib112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niederreither</surname><given-names>K</given-names></name><name><surname>Dollé</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Retinoic acid in development: towards an integrated view</article-title><source>Nature Reviews. Genetics</source><volume>9</volume><fpage>541</fpage><lpage>553</lpage><pub-id pub-id-type="doi">10.1038/nrg2340</pub-id><pub-id pub-id-type="pmid">18542081</pub-id></element-citation></ref><ref id="bib113"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nikoletopoulou</surname><given-names>V</given-names></name><name><surname>Kyriakakis</surname><given-names>E</given-names></name><name><surname>Tavernarakis</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Cellular and molecular longevity pathways: the old and the new</article-title><source>Trends in Endocrinology and Metabolism</source><volume>25</volume><fpage>212</fpage><lpage>223</lpage><pub-id pub-id-type="doi">10.1016/j.tem.2013.12.003</pub-id><pub-id pub-id-type="pmid">24388148</pub-id></element-citation></ref><ref id="bib114"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Onken</surname><given-names>B</given-names></name><name><surname>Driscoll</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Metformin induces a dietary restriction-like state and the oxidative stress response to extend <italic>C. elegans</italic> healthspan via AMPK, LKB1, and SKN-1</article-title><source>PLOS ONE</source><volume>5</volume><elocation-id>e8758</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0008758</pub-id><pub-id pub-id-type="pmid">20090912</pub-id></element-citation></ref><ref id="bib115"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Onken</surname><given-names>B</given-names></name><name><surname>Sedore</surname><given-names>CA</given-names></name><name><surname>Coleman-Hulbert</surname><given-names>AL</given-names></name><name><surname>Hall</surname><given-names>D</given-names></name><name><surname>Johnson</surname><given-names>E</given-names></name><name><surname>Jones</surname><given-names>EG</given-names></name><name><surname>Banse</surname><given-names>SA</given-names></name><name><surname>Huynh</surname><given-names>P</given-names></name><name><surname>Guo</surname><given-names>S</given-names></name><name><surname>Xue</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>E</given-names></name><name><surname>Harinath</surname><given-names>G</given-names></name><name><surname>Foulger</surname><given-names>AC</given-names></name><name><surname>Chao</surname><given-names>EA</given-names></name><name><surname>Hope</surname><given-names>J</given-names></name><name><surname>Bhaumik</surname><given-names>D</given-names></name><name><surname>Plummer</surname><given-names>T</given-names></name><name><surname>Inman</surname><given-names>D</given-names></name><name><surname>Morshead</surname><given-names>M</given-names></name><name><surname>Guo</surname><given-names>M</given-names></name><name><surname>Lithgow</surname><given-names>GJ</given-names></name><name><surname>Phillips</surname><given-names>PC</given-names></name><name><surname>Driscoll</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Metformin treatment of diverse Caenorhabditis species reveals the importance of genetic background in longevity and healthspan extension outcomes</article-title><source>Aging Cell</source><volume>21</volume><elocation-id>e13488</elocation-id><pub-id pub-id-type="doi">10.1111/acel.13488</pub-id><pub-id pub-id-type="pmid">34837316</pub-id></element-citation></ref><ref id="bib116"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pairault</surname><given-names>J</given-names></name><name><surname>Quignard-Boulange</surname><given-names>A</given-names></name><name><surname>Dugail</surname><given-names>I</given-names></name><name><surname>Lasnier</surname><given-names>F</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>Differential effects of retinoic acid upon early and late events in adipose conversion of 3T3 preadipocytes</article-title><source>Experimental Cell Research</source><volume>177</volume><fpage>27</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1016/0014-4827(88)90022-5</pub-id><pub-id pub-id-type="pmid">2455651</pub-id></element-citation></ref><ref id="bib117"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paradis</surname><given-names>S</given-names></name><name><surname>Ruvkun</surname><given-names>G</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title><italic>Caenorhabditis elegans</italic> Akt/PKB transduces insulin receptor-like signals from AGE-1 PI3 kinase to the DAF-16 transcription factor</article-title><source>Genes &amp; Development</source><volume>12</volume><fpage>2488</fpage><lpage>2498</lpage><pub-id pub-id-type="doi">10.1101/gad.12.16.2488</pub-id><pub-id pub-id-type="pmid">9716402</pub-id></element-citation></ref><ref id="bib118"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>SK</given-names></name><name><surname>Link</surname><given-names>CD</given-names></name><name><surname>Johnson</surname><given-names>TE</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Life-span extension by dietary restriction is mediated by NLP-7 signaling and coelomocyte endocytosis in <italic>C. elegans</italic></article-title><source>FASEB Journal</source><volume>24</volume><fpage>383</fpage><lpage>392</lpage><pub-id pub-id-type="doi">10.1096/fj.09-142984</pub-id><pub-id pub-id-type="pmid">19783783</pub-id></element-citation></ref><ref id="bib119"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parkhitko</surname><given-names>AA</given-names></name><name><surname>Filine</surname><given-names>E</given-names></name><name><surname>Mohr</surname><given-names>SE</given-names></name><name><surname>Moskalev</surname><given-names>A</given-names></name><name><surname>Perrimon</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Targeting metabolic pathways for extension of lifespan and healthspan across multiple species</article-title><source>Ageing Research Reviews</source><volume>64</volume><elocation-id>101188</elocation-id><pub-id pub-id-type="doi">10.1016/j.arr.2020.101188</pub-id><pub-id pub-id-type="pmid">33031925</pub-id></element-citation></ref><ref id="bib120"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paysan-Lafosse</surname><given-names>T</given-names></name><name><surname>Blum</surname><given-names>M</given-names></name><name><surname>Chuguransky</surname><given-names>S</given-names></name><name><surname>Grego</surname><given-names>T</given-names></name><name><surname>Pinto</surname><given-names>BL</given-names></name><name><surname>Salazar</surname><given-names>GA</given-names></name><name><surname>Bileschi</surname><given-names>ML</given-names></name><name><surname>Bork</surname><given-names>P</given-names></name><name><surname>Bridge</surname><given-names>A</given-names></name><name><surname>Colwell</surname><given-names>L</given-names></name><name><surname>Gough</surname><given-names>J</given-names></name><name><surname>Haft</surname><given-names>DH</given-names></name><name><surname>Letunić</surname><given-names>I</given-names></name><name><surname>Marchler-Bauer</surname><given-names>A</given-names></name><name><surname>Mi</surname><given-names>H</given-names></name><name><surname>Natale</surname><given-names>DA</given-names></name><name><surname>Orengo</surname><given-names>CA</given-names></name><name><surname>Pandurangan</surname><given-names>AP</given-names></name><name><surname>Rivoire</surname><given-names>C</given-names></name><name><surname>Sigrist</surname><given-names>CJA</given-names></name><name><surname>Sillitoe</surname><given-names>I</given-names></name><name><surname>Thanki</surname><given-names>N</given-names></name><name><surname>Thomas</surname><given-names>PD</given-names></name><name><surname>Tosatto</surname><given-names>SCE</given-names></name><name><surname>Wu</surname><given-names>CH</given-names></name><name><surname>Bateman</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>InterPro in 2022</article-title><source>Nucleic Acids Research</source><volume>51</volume><fpage>D418</fpage><lpage>D427</lpage><pub-id pub-id-type="doi">10.1093/nar/gkac993</pub-id><pub-id pub-id-type="pmid">36350672</pub-id></element-citation></ref><ref id="bib121"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>Q</given-names></name><name><surname>Gao</surname><given-names>R</given-names></name><name><surname>Park</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>AAK-2 and SKN-1 are involved in chicoric-acid-induced lifespan extension in <italic>Caenorhabditis elegans</italic></article-title><source>Journal of Agricultural and Food Chemistry</source><volume>67</volume><fpage>9178</fpage><lpage>9186</lpage><pub-id pub-id-type="doi">10.1021/acs.jafc.9b00705</pub-id><pub-id pub-id-type="pmid">30835107</pub-id></element-citation></ref><ref id="bib122"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Penkov</surname><given-names>S</given-names></name><name><surname>Raghuraman</surname><given-names>BK</given-names></name><name><surname>Erkut</surname><given-names>C</given-names></name><name><surname>Oertel</surname><given-names>J</given-names></name><name><surname>Galli</surname><given-names>R</given-names></name><name><surname>Ackerman</surname><given-names>EJM</given-names></name><name><surname>Vorkel</surname><given-names>D</given-names></name><name><surname>Verbavatz</surname><given-names>JM</given-names></name><name><surname>Koch</surname><given-names>E</given-names></name><name><surname>Fahmy</surname><given-names>K</given-names></name><name><surname>Shevchenko</surname><given-names>A</given-names></name><name><surname>Kurzchalia</surname><given-names>TV</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A metabolic switch regulates the transition between growth and diapause in <italic>C. elegans</italic></article-title><source>BMC Biology</source><volume>18</volume><elocation-id>31</elocation-id><pub-id pub-id-type="doi">10.1186/s12915-020-0760-3</pub-id><pub-id pub-id-type="pmid">32188449</pub-id></element-citation></ref><ref id="bib123"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peterson</surname><given-names>ND</given-names></name><name><surname>Icso</surname><given-names>JD</given-names></name><name><surname>Salisbury</surname><given-names>JE</given-names></name><name><surname>Rodríguez</surname><given-names>T</given-names></name><name><surname>Thompson</surname><given-names>PR</given-names></name><name><surname>Pukkila-Worley</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Pathogen infection and cholesterol deficiency activate the <italic>C. elegans</italic> p38 immune pathway through a TIR-1/SARM1 phase transition</article-title><source>eLife</source><volume>11</volume><elocation-id>e74206</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.74206</pub-id><pub-id pub-id-type="pmid">35098926</pub-id></element-citation></ref><ref id="bib124"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petrascheck</surname><given-names>M</given-names></name><name><surname>Ye</surname><given-names>X</given-names></name><name><surname>Buck</surname><given-names>LB</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>An antidepressant that extends lifespan in adult <italic>Caenorhabditis elegans</italic></article-title><source>Nature</source><volume>450</volume><fpage>553</fpage><lpage>556</lpage><pub-id pub-id-type="doi">10.1038/nature05991</pub-id><pub-id pub-id-type="pmid">18033297</pub-id></element-citation></ref><ref id="bib125"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prichard</surname><given-names>BN</given-names></name><name><surname>Gillam</surname><given-names>PM</given-names></name></person-group><year iso-8601-date="1964">1964</year><article-title>Use of propranolol (inderal) in treatment of hypertension</article-title><source>British Medical Journal</source><volume>2</volume><fpage>725</fpage><lpage>727</lpage><pub-id pub-id-type="doi">10.1136/bmj.2.5411.725</pub-id><pub-id pub-id-type="pmid">14172036</pub-id></element-citation></ref><ref id="bib126"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pujol</surname><given-names>N</given-names></name><name><surname>Link</surname><given-names>EM</given-names></name><name><surname>Liu</surname><given-names>LX</given-names></name><name><surname>Kurz</surname><given-names>CL</given-names></name><name><surname>Alloing</surname><given-names>G</given-names></name><name><surname>Tan</surname><given-names>MW</given-names></name><name><surname>Ray</surname><given-names>KP</given-names></name><name><surname>Solari</surname><given-names>R</given-names></name><name><surname>Johnson</surname><given-names>CD</given-names></name><name><surname>Ewbank</surname><given-names>JJ</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>A reverse genetic analysis of components of the Toll signaling pathway in <italic>Caenorhabditis elegans</italic></article-title><source>Current Biology: CB</source><volume>11</volume><fpage>809</fpage><lpage>821</lpage><pub-id pub-id-type="doi">10.1016/S0960-9822(01)00241-X</pub-id><pub-id pub-id-type="pmid">11516642</pub-id></element-citation></ref><ref id="bib127"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiao</surname><given-names>J</given-names></name><name><surname>Paul</surname><given-names>P</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Qiao</surname><given-names>L</given-names></name><name><surname>Josifi</surname><given-names>E</given-names></name><name><surname>Tiao</surname><given-names>JR</given-names></name><name><surname>Chung</surname><given-names>DH</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>PI3K/AKT and ERK regulate retinoic acid-induced neuroblastoma cellular differentiation</article-title><source>Biochemical and Biophysical Research Communications</source><volume>424</volume><fpage>421</fpage><lpage>426</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2012.06.125</pub-id><pub-id pub-id-type="pmid">22766505</pub-id></element-citation></ref><ref id="bib128"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raizen</surname><given-names>DM</given-names></name><name><surname>Lee</surname><given-names>RY</given-names></name><name><surname>Avery</surname><given-names>L</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Interacting genes required for pharyngeal excitation by motor neuron MC in <italic>Caenorhabditis elegans</italic></article-title><source>Genetics</source><volume>141</volume><fpage>1365</fpage><lpage>1382</lpage><pub-id pub-id-type="doi">10.1093/genetics/141.4.1365</pub-id><pub-id pub-id-type="pmid">8601480</pub-id></element-citation></ref><ref id="bib129"><element-citation publication-type="software"><person-group person-group-type="author"><collab>R Development Core Team</collab></person-group><year iso-8601-date="2021">2021</year><data-title>R: a language and environment for statistical computing</data-title><publisher-loc>Vienna, Austria</publisher-loc><publisher-name>R Foundation for Statistical Computing</publisher-name><ext-link ext-link-type="uri" xlink:href="https://www.R-project.org/">https://www.R-project.org/</ext-link></element-citation></ref><ref id="bib130"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Restif</surname><given-names>C</given-names></name><name><surname>Ibáñez-Ventoso</surname><given-names>C</given-names></name><name><surname>Vora</surname><given-names>MM</given-names></name><name><surname>Guo</surname><given-names>S</given-names></name><name><surname>Metaxas</surname><given-names>D</given-names></name><name><surname>Driscoll</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>CeleST: computer vision software for quantitative analysis of <italic>C. elegans</italic> swim behavior reveals novel features of locomotion</article-title><source>PLOS Computational Biology</source><volume>10</volume><elocation-id>e1003702</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1003702</pub-id><pub-id pub-id-type="pmid">25033081</pub-id></element-citation></ref><ref id="bib131"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ribeiro</surname><given-names>C</given-names></name><name><surname>Farmer</surname><given-names>CK</given-names></name><name><surname>de Magalhães</surname><given-names>JP</given-names></name><name><surname>Freitas</surname><given-names>AA</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Predicting lifespan-extending chemical compounds for <italic>C. elegans</italic> with machine learning and biologically interpretable features</article-title><source>Aging</source><volume>15</volume><fpage>6073</fpage><lpage>6099</lpage><pub-id pub-id-type="doi">10.18632/aging.204866</pub-id><pub-id pub-id-type="pmid">37450404</pub-id></element-citation></ref><ref id="bib132"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>MD</given-names></name><name><surname>McCarthy</surname><given-names>DJ</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>edgeR: a Bioconductor package for differential expression analysis of digital gene expression data</article-title><source>Bioinformatics</source><volume>26</volume><fpage>139</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp616</pub-id><pub-id pub-id-type="pmid">19910308</pub-id></element-citation></ref><ref id="bib133"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>MD</given-names></name><name><surname>Oshlack</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A scaling normalization method for differential expression analysis of RNA-seq data</article-title><source>Genome Biology</source><volume>11</volume><elocation-id>R25</elocation-id><pub-id pub-id-type="doi">10.1186/gb-2010-11-3-r25</pub-id><pub-id pub-id-type="pmid">20196867</pub-id></element-citation></ref><ref id="bib134"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roe</surname><given-names>MM</given-names></name><name><surname>Hashimi</surname><given-names>M</given-names></name><name><surname>Swain</surname><given-names>S</given-names></name><name><surname>Woo</surname><given-names>KM</given-names></name><name><surname>Bimczok</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>p38 MAPK signaling mediates retinoic acid-induced CD103 expression in human dendritic cells</article-title><source>Immunology</source><volume>161</volume><fpage>230</fpage><lpage>244</lpage><pub-id pub-id-type="doi">10.1111/imm.13246</pub-id><pub-id pub-id-type="pmid">32737889</pub-id></element-citation></ref><ref id="bib135"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rowlands</surname><given-names>DJ</given-names></name><name><surname>Howitt</surname><given-names>G</given-names></name><name><surname>Markman</surname><given-names>P</given-names></name></person-group><year iso-8601-date="1965">1965</year><article-title>Propranolol (inderal) in disturbances of cardiac rhythm</article-title><source>British Medical Journal</source><volume>1</volume><fpage>891</fpage><lpage>894</lpage><pub-id pub-id-type="doi">10.1136/bmj.1.5439.891</pub-id><pub-id pub-id-type="pmid">14257400</pub-id></element-citation></ref><ref id="bib136"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>M</given-names></name><name><surname>Hiragun</surname><given-names>A</given-names></name><name><surname>Mitsui</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1980">1980</year><article-title>Preadipocytes possess cellular retinoid binding proteins and their differentiation is inhibited by retinoids</article-title><source>Biochemical and Biophysical Research Communications</source><volume>95</volume><fpage>1839</fpage><lpage>1845</lpage><pub-id pub-id-type="doi">10.1016/s0006-291x(80)80113-6</pub-id><pub-id pub-id-type="pmid">6998485</pub-id></element-citation></ref><ref id="bib137"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwarz</surname><given-names>EJ</given-names></name><name><surname>Reginato</surname><given-names>MJ</given-names></name><name><surname>Shao</surname><given-names>D</given-names></name><name><surname>Krakow</surname><given-names>SL</given-names></name><name><surname>Lazar</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Retinoic acid blocks adipogenesis by inhibiting C/EBPbeta-mediated transcription</article-title><source>Molecular and Cellular Biology</source><volume>17</volume><fpage>1552</fpage><lpage>1561</lpage><pub-id pub-id-type="doi">10.1128/MCB.17.3.1552</pub-id><pub-id pub-id-type="pmid">9032283</pub-id></element-citation></ref><ref id="bib138"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seo</surname><given-names>HW</given-names></name><name><surname>Cheon</surname><given-names>SM</given-names></name><name><surname>Lee</surname><given-names>MH</given-names></name><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Jeon</surname><given-names>H</given-names></name><name><surname>Cha</surname><given-names>DS</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Catalpol modulates lifespan via DAF-16/FOXO and SKN-1/Nrf2 activation in <italic>Caenorhabditis elegans</italic></article-title><source>Evidence-Based Complementary and Alternative Medicine</source><volume>2015</volume><elocation-id>524878</elocation-id><pub-id pub-id-type="doi">10.1155/2015/524878</pub-id><pub-id pub-id-type="pmid">25821490</pub-id></element-citation></ref><ref id="bib139"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shinozaki</surname><given-names>Y</given-names></name><name><surname>Sato</surname><given-names>Y</given-names></name><name><surname>Koizumi</surname><given-names>S</given-names></name><name><surname>Ohno</surname><given-names>Y</given-names></name><name><surname>Nagao</surname><given-names>T</given-names></name><name><surname>Inoue</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Retinoic acids acting through retinoid receptors protect hippocampal neurons from oxygen-glucose deprivation-mediated cell death by inhibition of c-jun-N-terminal kinase and p38 mitogen-activated protein kinase</article-title><source>Neuroscience</source><volume>147</volume><fpage>153</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2007.04.032</pub-id><pub-id pub-id-type="pmid">17521827</pub-id></element-citation></ref><ref id="bib140"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sirakawin</surname><given-names>C</given-names></name><name><surname>Lin</surname><given-names>D</given-names></name><name><surname>Zhou</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Kelleher</surname><given-names>R</given-names></name><name><surname>Huang</surname><given-names>S</given-names></name><name><surname>Long</surname><given-names>W</given-names></name><name><surname>Pires-daSilva</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Vinnikov</surname><given-names>IA</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>SKN-1/NRF2 upregulation by vitamin A is conserved from nematodes to mammals and is critical for lifespan extension in <italic>Caenorhabditis elegans</italic></article-title><source>Aging Cell</source><volume>23</volume><elocation-id>e14064</elocation-id><pub-id pub-id-type="doi">10.1111/acel.14064</pub-id><pub-id pub-id-type="pmid">38100161</pub-id></element-citation></ref><ref id="bib141"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soukas</surname><given-names>AA</given-names></name><name><surname>Kane</surname><given-names>EA</given-names></name><name><surname>Carr</surname><given-names>CE</given-names></name><name><surname>Melo</surname><given-names>JA</given-names></name><name><surname>Ruvkun</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Rictor/TORC2 regulates fat metabolism, feeding, growth, and life span in <italic>Caenorhabditis elegans</italic></article-title><source>Genes &amp; Development</source><volume>23</volume><fpage>496</fpage><lpage>511</lpage><pub-id pub-id-type="doi">10.1101/gad.1775409</pub-id><pub-id pub-id-type="pmid">19240135</pub-id></element-citation></ref><ref id="bib142"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spindler</surname><given-names>SR</given-names></name><name><surname>Li</surname><given-names>R</given-names></name><name><surname>Dhahbi</surname><given-names>JM</given-names></name><name><surname>Yamakawa</surname><given-names>A</given-names></name><name><surname>Sauer</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Novel protein kinase signaling systems regulating lifespan identified by small molecule library screening using <italic>Drosophila</italic></article-title><source>PLOS ONE</source><volume>7</volume><elocation-id>e29782</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0029782</pub-id><pub-id pub-id-type="pmid">22363408</pub-id></element-citation></ref><ref id="bib143"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srinivasan</surname><given-names>AV</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Propranolol: A 50-year historical perspective</article-title><source>Annals of Indian Academy of Neurology</source><volume>22</volume><fpage>21</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.4103/aian.AIAN_201_18</pub-id><pub-id pub-id-type="pmid">30692755</pub-id></element-citation></ref><ref id="bib144"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Statzer</surname><given-names>C</given-names></name><name><surname>Jongsma</surname><given-names>E</given-names></name><name><surname>Liu</surname><given-names>SX</given-names></name><name><surname>Dakhovnik</surname><given-names>A</given-names></name><name><surname>Wandrey</surname><given-names>F</given-names></name><name><surname>Mozharovskyi</surname><given-names>P</given-names></name><name><surname>Zülli</surname><given-names>F</given-names></name><name><surname>Ewald</surname><given-names>CY</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Youthful and age-related matreotypes predict drugs promoting longevity</article-title><source>Aging Cell</source><volume>20</volume><elocation-id>e13441</elocation-id><pub-id pub-id-type="doi">10.1111/acel.13441</pub-id><pub-id pub-id-type="pmid">34346557</pub-id></element-citation></ref><ref id="bib145"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steinkraus</surname><given-names>KA</given-names></name><name><surname>Smith</surname><given-names>ED</given-names></name><name><surname>Davis</surname><given-names>C</given-names></name><name><surname>Carr</surname><given-names>D</given-names></name><name><surname>Pendergrass</surname><given-names>WR</given-names></name><name><surname>Sutphin</surname><given-names>GL</given-names></name><name><surname>Kennedy</surname><given-names>BK</given-names></name><name><surname>Kaeberlein</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Dietary restriction suppresses proteotoxicity and enhances longevity by an hsf-1-dependent mechanism in <italic>Caenorhabditis elegans</italic></article-title><source>Aging Cell</source><volume>7</volume><fpage>394</fpage><lpage>404</lpage><pub-id pub-id-type="doi">10.1111/j.1474-9726.2008.00385.x</pub-id><pub-id pub-id-type="pmid">18331616</pub-id></element-citation></ref><ref id="bib146"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stroustrup</surname><given-names>N</given-names></name><name><surname>Ulmschneider</surname><given-names>BE</given-names></name><name><surname>Nash</surname><given-names>ZM</given-names></name><name><surname>López-Moyado</surname><given-names>IF</given-names></name><name><surname>Apfeld</surname><given-names>J</given-names></name><name><surname>Fontana</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The <italic>Caenorhabditis elegans</italic> lifespan machine</article-title><source>Nature Methods</source><volume>10</volume><fpage>665</fpage><lpage>670</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2475</pub-id><pub-id pub-id-type="pmid">23666410</pub-id></element-citation></ref><ref id="bib147"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Stroustrup</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Lifespan</data-title><version designator="ddb6578">ddb6578</version><source>GitHub</source><ext-link ext-link-type="uri" xlink:href="https://github.com/nstroustrup/lifespan">https://github.com/nstroustrup/lifespan</ext-link></element-citation></ref><ref id="bib148"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stuhr</surname><given-names>NL</given-names></name><name><surname>Curran</surname><given-names>SP</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Bacterial diets differentially alter lifespan and healthspan trajectories in <italic>C. elegans</italic></article-title><source>Communications Biology</source><volume>3</volume><elocation-id>653</elocation-id><pub-id pub-id-type="doi">10.1038/s42003-020-01379-1</pub-id><pub-id pub-id-type="pmid">33159120</pub-id></element-citation></ref><ref id="bib149"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Summers</surname><given-names>SA</given-names></name><name><surname>Chaurasia</surname><given-names>B</given-names></name><name><surname>Holland</surname><given-names>WL</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Metabolic messengers: ceramides</article-title><source>Nature Metabolism</source><volume>1</volume><fpage>1051</fpage><lpage>1058</lpage><pub-id pub-id-type="doi">10.1038/s42255-019-0134-8</pub-id><pub-id pub-id-type="pmid">32694860</pub-id></element-citation></ref><ref id="bib150"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Sphingosine kinases are involved in the regulation of all-trans retinoic acid sensitivity of K562 chronic myeloid leukemia cells</article-title><source>Oncology Letters</source><volume>22</volume><elocation-id>581</elocation-id><pub-id pub-id-type="doi">10.3892/ol.2021.12842</pub-id><pub-id pub-id-type="pmid">34122632</pub-id></element-citation></ref><ref id="bib151"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szutowicz</surname><given-names>A</given-names></name><name><surname>Bielarczyk</surname><given-names>H</given-names></name><name><surname>Jankowska-Kulawy</surname><given-names>A</given-names></name><name><surname>Ronowska</surname><given-names>A</given-names></name><name><surname>Pawełczyk</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Retinoic acid as a therapeutic option in Alzheimer’s disease: a focus on cholinergic restoration</article-title><source>Expert Review of Neurotherapeutics</source><volume>15</volume><fpage>239</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.1586/14737175.2015.1008456</pub-id><pub-id pub-id-type="pmid">25683350</pub-id></element-citation></ref><ref id="bib152"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szymański</surname><given-names>L</given-names></name><name><surname>Skopek</surname><given-names>R</given-names></name><name><surname>Palusińska</surname><given-names>M</given-names></name><name><surname>Schenk</surname><given-names>T</given-names></name><name><surname>Stengel</surname><given-names>S</given-names></name><name><surname>Lewicki</surname><given-names>S</given-names></name><name><surname>Kraj</surname><given-names>L</given-names></name><name><surname>Kamiński</surname><given-names>P</given-names></name><name><surname>Zelent</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Retinoic acid and its derivatives in skin</article-title><source>Cells</source><volume>9</volume><elocation-id>2660</elocation-id><pub-id pub-id-type="doi">10.3390/cells9122660</pub-id><pub-id pub-id-type="pmid">33322246</pub-id></element-citation></ref><ref id="bib153"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Talpaz</surname><given-names>M</given-names></name><name><surname>Shah</surname><given-names>NP</given-names></name><name><surname>Kantarjian</surname><given-names>H</given-names></name><name><surname>Donato</surname><given-names>N</given-names></name><name><surname>Nicoll</surname><given-names>J</given-names></name><name><surname>Paquette</surname><given-names>R</given-names></name><name><surname>Cortes</surname><given-names>J</given-names></name><name><surname>O’Brien</surname><given-names>S</given-names></name><name><surname>Nicaise</surname><given-names>C</given-names></name><name><surname>Bleickardt</surname><given-names>E</given-names></name><name><surname>Blackwood-Chirchir</surname><given-names>MA</given-names></name><name><surname>Iyer</surname><given-names>V</given-names></name><name><surname>Chen</surname><given-names>T-T</given-names></name><name><surname>Huang</surname><given-names>F</given-names></name><name><surname>Decillis</surname><given-names>AP</given-names></name><name><surname>Sawyers</surname><given-names>CL</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias</article-title><source>The New England Journal of Medicine</source><volume>354</volume><fpage>2531</fpage><lpage>2541</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa055229</pub-id><pub-id pub-id-type="pmid">16775234</pub-id></element-citation></ref><ref id="bib154"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>L</given-names></name><name><surname>Choe</surname><given-names>KP</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Characterization of skn-1/wdr-23 phenotypes in <italic>Caenorhabditis elegans</italic>; pleiotrophy, aging, glutathione, and interactions with other longevity pathways</article-title><source>Mechanisms of Ageing and Development</source><volume>149</volume><fpage>88</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1016/j.mad.2015.06.001</pub-id><pub-id pub-id-type="pmid">26056713</pub-id></element-citation></ref><ref id="bib155"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>Z</given-names></name><name><surname>Su</surname><given-names>KH</given-names></name><name><surname>Xu</surname><given-names>M</given-names></name><name><surname>Dai</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>HSF1 physically neutralizes amyloid oligomers to empower overgrowth and bestow neuroprotection</article-title><source>Science Advances</source><volume>6</volume><elocation-id>eabc6871</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.abc6871</pub-id><pub-id pub-id-type="pmid">33177089</pub-id></element-citation></ref><ref id="bib156"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teterina</surname><given-names>AA</given-names></name><name><surname>Coleman-Hulbert</surname><given-names>AL</given-names></name><name><surname>Banse</surname><given-names>SA</given-names></name><name><surname>Willis</surname><given-names>JH</given-names></name><name><surname>Perez</surname><given-names>VI</given-names></name><name><surname>Lithgow</surname><given-names>GJ</given-names></name><name><surname>Driscoll</surname><given-names>M</given-names></name><name><surname>Phillips</surname><given-names>PC</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Genetic diversity estimates for the <italic>Caenorhabditis</italic> intervention testing program screening panel</article-title><source>microPublication Biology</source><volume>2022</volume><elocation-id>e000518</elocation-id><pub-id pub-id-type="doi">10.17912/micropub.biology.000518</pub-id><pub-id pub-id-type="pmid">35098051</pub-id></element-citation></ref><ref id="bib157"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teuscher</surname><given-names>AC</given-names></name><name><surname>Jongsma</surname><given-names>E</given-names></name><name><surname>Davis</surname><given-names>MN</given-names></name><name><surname>Statzer</surname><given-names>C</given-names></name><name><surname>Gebauer</surname><given-names>JM</given-names></name><name><surname>Naba</surname><given-names>A</given-names></name><name><surname>Ewald</surname><given-names>CY</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The <italic>in-silico</italic> characterization of the <italic>Caenorhabditis elegans</italic> matrisome and proposal of a novel collagen classification</article-title><source>Matrix Biology Plus</source><volume>1</volume><elocation-id>100001</elocation-id><pub-id pub-id-type="doi">10.1016/j.mbplus.2018.11.001</pub-id><pub-id pub-id-type="pmid">33543001</pub-id></element-citation></ref><ref id="bib158"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Therneau</surname><given-names>TM</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>Coxme: mixed effects cox models</data-title><version designator="2.2.16">2.2.16</version><source>CRAN</source><ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/coxme/index.html">https://cran.r-project.org/web/packages/coxme/index.html</ext-link></element-citation></ref><ref id="bib159"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Todorova</surname><given-names>MN</given-names></name><name><surname>Savova</surname><given-names>MS</given-names></name><name><surname>Mihaylova</surname><given-names>LV</given-names></name><name><surname>Georgiev</surname><given-names>MI</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Icariin improves stress resistance and extends lifespan in <italic>Caenorhabditis elegans</italic> through hsf-1 and daf-2-driven hormesis</article-title><source>International Journal of Molecular Sciences</source><volume>25</volume><elocation-id>352</elocation-id><pub-id pub-id-type="doi">10.3390/ijms25010352</pub-id><pub-id pub-id-type="pmid">38203522</pub-id></element-citation></ref><ref id="bib160"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tullet</surname><given-names>JMA</given-names></name><name><surname>Hertweck</surname><given-names>M</given-names></name><name><surname>An</surname><given-names>JH</given-names></name><name><surname>Baker</surname><given-names>J</given-names></name><name><surname>Hwang</surname><given-names>JY</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Oliveira</surname><given-names>RP</given-names></name><name><surname>Baumeister</surname><given-names>R</given-names></name><name><surname>Blackwell</surname><given-names>TK</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Direct inhibition of the longevity-promoting factor SKN-1 by insulin-like signaling in <italic>C. elegans</italic></article-title><source>Cell</source><volume>132</volume><fpage>1025</fpage><lpage>1038</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2008.01.030</pub-id></element-citation></ref><ref id="bib161"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tullet</surname><given-names>JMA</given-names></name><name><surname>Green</surname><given-names>JW</given-names></name><name><surname>Au</surname><given-names>C</given-names></name><name><surname>Benedetto</surname><given-names>A</given-names></name><name><surname>Thompson</surname><given-names>MA</given-names></name><name><surname>Clark</surname><given-names>E</given-names></name><name><surname>Gilliat</surname><given-names>AF</given-names></name><name><surname>Young</surname><given-names>A</given-names></name><name><surname>Schmeisser</surname><given-names>K</given-names></name><name><surname>Gems</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The SKN-1/Nrf2 transcription factor can protect against oxidative stress and increase lifespan in <italic>C. elegans</italic> by distinct mechanisms</article-title><source>Aging Cell</source><volume>16</volume><fpage>1191</fpage><lpage>1194</lpage><pub-id pub-id-type="doi">10.1111/acel.12627</pub-id><pub-id pub-id-type="pmid">28612944</pub-id></element-citation></ref><ref id="bib162"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vanhaelen</surname><given-names>Q</given-names></name><name><surname>Lin</surname><given-names>YC</given-names></name><name><surname>Zhavoronkov</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The advent of generative chemistry</article-title><source>ACS Medicinal Chemistry Letters</source><volume>11</volume><fpage>1496</fpage><lpage>1505</lpage><pub-id pub-id-type="doi">10.1021/acsmedchemlett.0c00088</pub-id><pub-id pub-id-type="pmid">32832015</pub-id></element-citation></ref><ref id="bib163"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vilella</surname><given-names>AJ</given-names></name><name><surname>Severin</surname><given-names>J</given-names></name><name><surname>Ureta-Vidal</surname><given-names>A</given-names></name><name><surname>Heng</surname><given-names>L</given-names></name><name><surname>Durbin</surname><given-names>R</given-names></name><name><surname>Birney</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>EnsemblCompara genetrees: Complete, duplication-aware phylogenetic trees in vertebrates</article-title><source>Genome Research</source><volume>19</volume><fpage>327</fpage><lpage>335</lpage><pub-id pub-id-type="doi">10.1101/gr.073585.107</pub-id><pub-id pub-id-type="pmid">19029536</pub-id></element-citation></ref><ref id="bib164"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>MD</given-names></name><name><surname>Giese</surname><given-names>GE</given-names></name><name><surname>Holdorf</surname><given-names>AD</given-names></name><name><surname>Bhattacharya</surname><given-names>S</given-names></name><name><surname>Diot</surname><given-names>C</given-names></name><name><surname>García-González</surname><given-names>AP</given-names></name><name><surname>Horowitz</surname><given-names>BB</given-names></name><name><surname>Lee</surname><given-names>YU</given-names></name><name><surname>Leland</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Mirza</surname><given-names>Z</given-names></name><name><surname>Na</surname><given-names>H</given-names></name><name><surname>Nanda</surname><given-names>S</given-names></name><name><surname>Ponomarova</surname><given-names>O</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Yilmaz</surname><given-names>LS</given-names></name><name><surname>Walhout</surname><given-names>AJM</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>WormPaths: <italic>Caenorhabditis elegans</italic> metabolic pathway annotation and visualization</article-title><source>Genetics</source><volume>219</volume><elocation-id>iyab089</elocation-id><pub-id pub-id-type="doi">10.1093/genetics/iyab089</pub-id><pub-id pub-id-type="pmid">34117752</pub-id></element-citation></ref><ref id="bib165"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Lifespan extension in <italic>Caenorhabditis elegans</italic> by DMSO is dependent on sir-2.1 and daf-16</article-title><source>Biochemical and Biophysical Research Communications</source><volume>400</volume><fpage>613</fpage><lpage>618</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2010.08.113</pub-id></element-citation></ref><ref id="bib166"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Lu</surname><given-names>L</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The longevity effect of echinacoside in <italic>Caenorhabditis elegans</italic> mediated through daf-16</article-title><source>Bioscience, Biotechnology, and Biochemistry</source><volume>79</volume><fpage>1676</fpage><lpage>1683</lpage><pub-id pub-id-type="doi">10.1080/09168451.2015.1046364</pub-id><pub-id pub-id-type="pmid">26027643</pub-id></element-citation></ref><ref id="bib167"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>M</given-names></name><name><surname>Roy</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Increased levels of hydrogen peroxide induce a HIF-1-dependent modification of lipid metabolism in AMPK compromised <italic>C. elegans</italic> dauer larvae</article-title><source>Cell Metabolism</source><volume>16</volume><fpage>322</fpage><lpage>335</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2012.07.016</pub-id><pub-id pub-id-type="pmid">22921415</pub-id></element-citation></ref><ref id="bib168"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yilmaz</surname><given-names>LS</given-names></name><name><surname>Walhout</surname><given-names>AJM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>A <italic>Caenorhabditis elegans</italic> genome-scale metabolic network model</article-title><source>Cell Systems</source><volume>2</volume><fpage>297</fpage><lpage>311</lpage><pub-id pub-id-type="doi">10.1016/j.cels.2016.04.012</pub-id><pub-id pub-id-type="pmid">27211857</pub-id></element-citation></ref><ref id="bib169"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshimura</surname><given-names>J</given-names></name><name><surname>Ichikawa</surname><given-names>K</given-names></name><name><surname>Shoura</surname><given-names>MJ</given-names></name><name><surname>Artiles</surname><given-names>KL</given-names></name><name><surname>Gabdank</surname><given-names>I</given-names></name><name><surname>Wahba</surname><given-names>L</given-names></name><name><surname>Smith</surname><given-names>CL</given-names></name><name><surname>Edgley</surname><given-names>ML</given-names></name><name><surname>Rougvie</surname><given-names>AE</given-names></name><name><surname>Fire</surname><given-names>AZ</given-names></name><name><surname>Morishita</surname><given-names>S</given-names></name><name><surname>Schwarz</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Recompleting the <italic>Caenorhabditis elegans</italic> genome</article-title><source>Genome Research</source><volume>29</volume><fpage>1009</fpage><lpage>1022</lpage><pub-id pub-id-type="doi">10.1101/gr.244830.118</pub-id><pub-id pub-id-type="pmid">31123080</pub-id></element-citation></ref><ref id="bib170"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yousefzadeh</surname><given-names>MJ</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>McGowan</surname><given-names>SJ</given-names></name><name><surname>Angelini</surname><given-names>L</given-names></name><name><surname>Fuhrmann-Stroissnigg</surname><given-names>H</given-names></name><name><surname>Xu</surname><given-names>M</given-names></name><name><surname>Ling</surname><given-names>YY</given-names></name><name><surname>Melos</surname><given-names>KI</given-names></name><name><surname>Pirtskhalava</surname><given-names>T</given-names></name><name><surname>Inman</surname><given-names>CL</given-names></name><name><surname>McGuckian</surname><given-names>C</given-names></name><name><surname>Wade</surname><given-names>EA</given-names></name><name><surname>Kato</surname><given-names>JI</given-names></name><name><surname>Grassi</surname><given-names>D</given-names></name><name><surname>Wentworth</surname><given-names>M</given-names></name><name><surname>Burd</surname><given-names>CE</given-names></name><name><surname>Arriaga</surname><given-names>EA</given-names></name><name><surname>Ladiges</surname><given-names>WL</given-names></name><name><surname>Tchkonia</surname><given-names>T</given-names></name><name><surname>Kirkland</surname><given-names>JL</given-names></name><name><surname>Robbins</surname><given-names>PD</given-names></name><name><surname>Niedernhofer</surname><given-names>LJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Fisetin is a senotherapeutic that extends health and lifespan</article-title><source>EBioMedicine</source><volume>36</volume><fpage>18</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1016/j.ebiom.2018.09.015</pub-id><pub-id pub-id-type="pmid">30279143</pub-id></element-citation></ref><ref id="bib171"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>M</given-names></name><name><surname>Ge</surname><given-names>C</given-names></name><name><surname>Zeng</surname><given-names>W</given-names></name><name><surname>Mi</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Retinoic acid promotes proliferation of chicken primordial germ cells via activation of PI3K/Akt-mediated NF-κB signalling cascade</article-title><source>Cell Biology International</source><volume>36</volume><fpage>705</fpage><lpage>712</lpage><pub-id pub-id-type="doi">10.1042/CBI20110542</pub-id><pub-id pub-id-type="pmid">22548360</pub-id></element-citation></ref><ref id="bib172"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zacharias</surname><given-names>FJ</given-names></name><name><surname>Cowen</surname><given-names>KJ</given-names></name><name><surname>Prestt</surname><given-names>J</given-names></name><name><surname>Vickers</surname><given-names>J</given-names></name><name><surname>Wall</surname><given-names>BG</given-names></name></person-group><year iso-8601-date="1972">1972</year><article-title>Propranolol in hypertension: a study of long-term therapy, 1964-1970</article-title><source>American Heart Journal</source><volume>83</volume><fpage>755</fpage><lpage>761</lpage><pub-id pub-id-type="doi">10.1016/0002-8703(72)90206-2</pub-id><pub-id pub-id-type="pmid">5053145</pub-id></element-citation></ref><ref id="bib173"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>R</given-names></name><name><surname>Chen</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Transcriptional factors mediating retinoic acid signals in the control of energy metabolism</article-title><source>International Journal of Molecular Sciences</source><volume>16</volume><fpage>14210</fpage><lpage>14244</lpage><pub-id pub-id-type="doi">10.3390/ijms160614210</pub-id><pub-id pub-id-type="pmid">26110391</pub-id></element-citation></ref><ref id="bib174"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Deng</surname><given-names>B</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Cai</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>N</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Tan</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>G</given-names></name><name><surname>Jin</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>All-trans-retinoic acid suppresses neointimal hyperplasia and inhibits vascular smooth muscle cell proliferation and migration via activation of AMPK signaling pathway</article-title><source>Frontiers in Pharmacology</source><volume>10</volume><elocation-id>485</elocation-id><pub-id pub-id-type="doi">10.3389/fphar.2019.00485</pub-id><pub-id pub-id-type="pmid">31143119</pub-id></element-citation></ref><ref id="bib175"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Lu</surname><given-names>L</given-names></name><name><surname>Qi</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Emodin extends lifespan of <italic>Caenorhabditis elegans</italic> through insulin/IGF-1 signaling pathway depending on DAF-16 and SIR-2.1</article-title><source>Bioscience, Biotechnology, and Biochemistry</source><volume>81</volume><fpage>1908</fpage><lpage>1916</lpage><pub-id pub-id-type="doi">10.1080/09168451.2017.1365592</pub-id><pub-id pub-id-type="pmid">28831863</pub-id></element-citation></ref><ref id="bib176"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhavoronkov</surname><given-names>A</given-names></name><name><surname>Mamoshina</surname><given-names>P</given-names></name><name><surname>Vanhaelen</surname><given-names>Q</given-names></name><name><surname>Scheibye-Knudsen</surname><given-names>M</given-names></name><name><surname>Moskalev</surname><given-names>A</given-names></name><name><surname>Aliper</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Artificial intelligence for aging and longevity research: Recent advances and perspectives</article-title><source>Ageing Research Reviews</source><volume>49</volume><fpage>49</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1016/j.arr.2018.11.003</pub-id><pub-id pub-id-type="pmid">30472217</pub-id></element-citation></ref><ref id="bib177"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>Summers</surname><given-names>SA</given-names></name><name><surname>Birnbaum</surname><given-names>MJ</given-names></name><name><surname>Pittman</surname><given-names>RN</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Inhibition of Akt kinase by cell-permeable ceramide and its implications for ceramide-induced apoptosis</article-title><source>The Journal of Biological Chemistry</source><volume>273</volume><fpage>16568</fpage><lpage>16575</lpage><pub-id pub-id-type="doi">10.1074/jbc.273.26.16568</pub-id><pub-id pub-id-type="pmid">9632728</pub-id></element-citation></ref><ref id="bib178"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>KI</given-names></name><name><surname>Pincus</surname><given-names>Z</given-names></name><name><surname>Slack</surname><given-names>FJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Longevity and stress in <italic>Caenorhabditis elegans</italic></article-title><source>Aging</source><volume>3</volume><fpage>733</fpage><lpage>753</lpage><pub-id pub-id-type="doi">10.18632/aging.100367</pub-id><pub-id pub-id-type="pmid">21937765</pub-id></element-citation></ref><ref id="bib179"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zinda</surname><given-names>MJ</given-names></name><name><surname>Vlahos</surname><given-names>CJ</given-names></name><name><surname>Lai</surname><given-names>MT</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Ceramide induces the dephosphorylation and inhibition of constitutively activated Akt in PTEN negative U87mg cells</article-title><source>Biochemical and Biophysical Research Communications</source><volume>280</volume><fpage>1107</fpage><lpage>1115</lpage><pub-id pub-id-type="doi">10.1006/bbrc.2000.4248</pub-id><pub-id pub-id-type="pmid">11162641</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.104375.3.sa0</article-id><title-group><article-title>eLife Assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ghazi</surname><given-names>Arjumand</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>University of Pittsburgh School of Medicine</institution><country>United States</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Compelling</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Important</kwd></kwd-group></front-stub><body><p>This <bold>important</bold> study explores the power of computational methods to predict lifespan-extending small molecules, demonstrating that while these methods significantly increase hit rates, experimental validation remains essential. The study uses all-trans retinoic acid in <italic>Caenorhabditis elegans</italic> as a model, providing genetic and transcriptomic insights into its longevity effects. The data are <bold>compelling</bold> in describing a robust, computationally informed screening process for discovering compounds that extend lifespan in this species.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.104375.3.sa1</article-id><title-group><article-title>Reviewer #1 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>This study highlights the strengths of using predictive computational models to inform <italic>C. elegans</italic> screening studies of compounds' effects on aging and lifespan. The authors primarily focus on all-trans retinoic acid (atRA), one of the 5 compounds (out of 16 tested) that extended <italic>C. elegans</italic> lifespan in their experiments. They show that atRA has positive effects on <italic>C. elegans</italic> lifespan and age-related health, while it has more modest and inconsistent effects (i.e., some detrimental impacts) for <italic>C. briggsae</italic> and <italic>C. tropicalis</italic>. In genetic experiments designed to evaluate contributing mediators of lifespan extension with atRA exposure, it was found that 150 µM of atRA did not significantly extend lifespan in akt-1 or akt-2 loss-of-function mutants, nor in animals with loss of function of aak-2, or skn-1 (in which atRA had toxic effects); these genes appear to be required for atRA-mediated lifespan extension. hsf-1 and daf-16 loss-of-function mutants both had a modest but statistically significant lifespan extension with 150 µM of atRA, suggesting that these transcription factors may contribute towards mediating atRA lifespan extension, but that they are not individually required for some lifespan extension. RNAseq assessment of transcriptional changes in day 4 atRA-treated adult wild type worms revealed some interesting observations. Consistent with the study's genetic mutant lifespan observations, many of the atRA-regulated genes with the greatest fold-change differences are known regulated targets of daf-2 and/or skn-1 signaling pathways in <italic>C. elegans</italic>. hsf-1 loss-of-function mutants show a shifted atRA transcriptional response, revealing a dependence on hsf-1 for ~60% of the atRA-downregulated genes. On the other hand, RNAseq analysis in aak-2 loss-of-function mutants revealed that aak-2 is only required for less than a quarter of the atRA transcriptional response. All together, this study is a proof of the concept that computational models can help optimize <italic>C. elegans</italic> screening approaches that test compounds' effects on lifespan, and provides comprehensive transcriptomic and genetic insights into the lifespan-extending effects of all-trans retinoic acid (atRA).</p><p>Strengths:</p><p>A clearly described and well-justified account describes the approach used to prioritize and select compounds for screening, based on using the top candidates from a published list of computationally ranked compounds (Fuentealba et al., 2019) that were cross-referenced with other bioinformatics publications to predict anti-aging compounds, after de-selecting compounds previously evaluated in <italic>C. elegans</italic> as per the DrugAge database. 16 compounds were tested at 4-5 different concentrations to evaluate effects on <italic>C. elegans</italic> lifespan.</p><p>Robust experimental design was undertaken evaluating the lifespan effects of atRA, as it was tested on three strains each of <italic>C. elegans</italic>, <italic>C. briggsae</italic>, and <italic>C. tropicalis</italic>, with trial replication performed at three distinct laboratories. These observations extended beyond lifespan to include evaluations of health metrics related to swimming performance.</p><p>In-depth analyses of the RNAseq data of whole-worm transcriptional responses to atRA revealed interesting insights into regulator pathways and novel groups of genes that may be involved in mediating lifespan-extension effects (e.g., atRA-induced upregulation of sphingolipid metabolism genes, atRA-upregulation of genes in a poorly-characterized family of <italic>C. elegans</italic> paralogs predicted to have kinase-like activity, and disproportionate downregulation of collagen genes with atRA).</p><p>Weaknesses:</p><p>The authors' computational-based compound screening approach led to a ~30% prediction success rate for compounds that could extend the median lifespan of <italic>C. elegans</italic>. However, follow-up experiments on the top compounds highlighted the fact that some of these observed &quot;successes&quot; could be driven by indirect, confounding effects of these compounds on the bacterial food source, rather than direct beneficial effects on <italic>C. elegans</italic> physiology and lifespan. For instance, this appeared to be the case for the &quot;top&quot; hit of propranolol. Other compounds were not tested with metabolically inert or killed bacteria to preclude the possibility of bacteria-produced metabolites exerting observed effects; this might be a useful future direction to consider.</p><p>Transcriptomic analyses of atRA effects were extensive in this study, but discussions of potential non-transcriptional effects of key proposed regulators (such as AMPK) were limited. For instance, other outputs of aak-2/AMPK (non-transcriptional changes to metabolic balance, autophagy, etc.) might account for its requirement for mediating lifespan extension effects, since aak-2 was not required for a major proportion of atRA transcriptional responses.</p><p>Comments on revisions:</p><p>In their revisions, the authors resolved all of my initial recommendations, and I have no additional suggestions.</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.104375.3.sa2</article-id><title-group><article-title>Reviewer #2 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>In this manuscript, Banse et al. experimentally validate the power of computational approaches that predict anti-aging molecules using the multi-species approach of the Caenorhabditis Intervention Testing Program (CITP). Filtering candidate molecules based on transcriptional profiles, ML models, literature searches, and the DrugAge database, they selected 16 compounds for testing. Of those, eight did not affect <italic>C. elegans</italic>' lifespan, three shortened it, and five extended <italic>C. elegans</italic>' lifespan, resulting in a hit rate of over 30%. Of those five, they then focused on all-trans-retinoic acid (atRA), a compound that has previously resulted in contradictory effects. The lifespan-extending effect of atRA was consistent in all <italic>C. elegans</italic> strains tested, was absent in <italic>C. briggsae</italic>, and a small effect was observed in some <italic>C. tropicalis</italic> strains. Similar results were obtained for measures of healthspan. The authors then investigated the mechanism of action of atRA and showed that it was only partially dependent on daf-16 but required akt-1, akt-2, skn-1, hsf-1, and, to some degree, pmk-1. The authors further investigate the downstream effects of atRA exposure by conducting RNAseq experiments in both wild-type and mutant animals to show that some, but surprisingly few, of the gene expression changes that are observed in wild-type animals are lost in the hsf-1 and aak-2 mutants</p><p>Strengths:</p><p>Overall, this study is well-conceived and executed as it investigates the effect of atRA across different concentrations, strains, and species, including life and health span. Revealing the variability between sites, assays, and the method used is a powerful aspect of this study. It will do a lot to dispel the nonsensical illusion that we can determine a per cent increase in lifespan to the precision of two floating point numbers.</p><p>An interesting and potentially important implication arises from this study. The computational selection of compounds was agnostic regarding strain or species differences and was predominantly based on observations made in mammalian systems. The hit rate calculated is based on the results of <italic>C. elegans</italic> and not on the molecules' effectiveness in Briggsae or Tropicalis. If it were, the hit rate would be much lower. How is that? It would suggest that ML models and transcriptional data obtained from mammals have a higher predictive value for <italic>C. elegans</italic> than for the other two species. This selectivity for <italic>C. elegans</italic> over <italic>C. tropicalis</italic> and <italic>C. briggsae</italic> seems both puzzling and unexpected. The predictions for longevity were based on the transcriptional data in cell lines. Would it be feasible to compare the mammalian data to the transcriptional data in Fig. 5 and see how well they match? While this is clear beyond the focus of this study, an implied prediction is that running RNAseqs for all these strains exposed to atRA would reveal that the transcriptional changes observed in the strains where it extends lifespan the most should match the mammalian data best. Otherwise, how could the mammalian datasets be used to predict the effects for <italic>C. elegans</italic> over <italic>C. briggsae</italic> or <italic>C. tropicalis</italic> have more predictive for one species than the other? There are a lot of IFs in this prediction, but such an experiment would reconsider and validate the basis on which the original predictions were made.</p><p>Weaknesses:</p><p>Many of the most upregulated genes, such as cyps and pgps are xenobiotic response genes upregulated in many transcriptional datasets from <italic>C. elegans</italic> drug studies. Their expression might be necessary to deal with atRA breakdown metabolites to prevent toxicity rather than confer longevity. Because atRA is very light sensitive and has toxicity of breakdown, metabolites may explain some of the differences observed with the lifespan of machine effects compared to standard assay practices. However, the authors provide a potential explanation for that observation.</p><p>Comments on revisions:</p><p>The authors have adequately addressed my concerns and the paper is suitable for publication.</p></body></sub-article><sub-article article-type="referee-report" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.104375.3.sa3</article-id><title-group><article-title>Reviewer #3 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>In this study, Banse et al., demonstrate that combining computer prediction with genetic analysis in distinct <italic>Caenorhabditis</italic> species can streamline the discovery of aging interventions by taking advantage of the diverse pool of compounds that are currently available. They demonstrate that through careful prioritization of candidate compounds, they are able to accomplish a 30% positive hit rate for interventions that produce significant lifespan extensions. Within the positive hits, they focus on all-trans retinoic acid (atRA) and discover that it modulates lifespan through conserved longevity pathways such as AKT-1 and AKT-2 (and other conserved Akt-targets such as Nrf2/SKN-1 and HSF1/HSF-1) as well as through AAK-2, a conserved catalytic subunit of AMPK. To better understand the genetic mechanisms behind lifespan extension upon atRA treatment, the authors perform RNAseq experiments using a variety of genetic backgrounds for cross comparison and validation. Using this current state-of-the-art approach for studying gene expression, the authors determine that atRA treatment produces gene expression changes across a broad set of stress-response and longevity-related pathways. Overall, this study is important since it highlights the potential of combining traditional genetic analysis in the genetically tractable organism <italic>C. elegans</italic> with computational methods that will become even more powerful with the swift advancements being made in artificial intelligence. The study possesses both theoretical and practical implications not only in the field of aging, but also in related fields such as health and disease. Most of the claims in this study are supported by solid evidence, but the conclusions can be refined with a small set of additional experiments or re-analysis of data.</p><p>Strengths:</p><p>(1) The criteria for prioritizing compounds for screening are well-defined and is easy to replicate (Figure 1), even for scientists with limited experience in computational biology. The approach is also adaptable to other systems or model organisms.</p><p>(2) I commend the researchers for doing follow-up experiments with the compound propranolol to verify its effect of lifespan (Figure 2- figure supplement 2), given the observation that it affected the growth of OP50. To prevent false hits in the future, the reviewer recommends the use of inactivated OP50 for future experiments to remove this confounding variable.</p><p>(3) The sources of variation (Figure 3-figure supplement 2) are taken into account and demonstrates the need for advancing our understanding of the lifespan phenotype due to inter-individual variation.</p><p>(4) The addition of the <italic>C. elegans</italic> swim test in addition to the lifespan assays provides further evidence of atRA-induced improvement in longevity.</p><p>(5) The RNAseq approach was performed in a variety of genetic backgrounds, which allowed the authors to determine the relationship between AAK-2 and HSF-1 regulation of the retinoic acid pathway in <italic>C. elegans</italic>, specifically, that the former functions downstream of the latter.</p><p>Weaknesses:</p><p>(1) The authors demonstrate that atRA extends lifespan in a species-specific manner (Figure 3). Specifically, this extension only occurs in the species <italic>C. elegans</italic> yet, the title implies that atRA-induced lifespan extension occurs in different <italic>Caenorhabditis</italic> species when it is clearly not the case. While the authors state that failure to observe phenotypes in <italic>C. briggsae</italic> and <italic>C. tropicalis</italic> is a common feature of CITP tests, they do not speculate as to why this phenomenon occurs.</p><p>(2) There are discrepancies between the lifespan curves by hand (Figure 3-Figure supplement 1) and using the automated lifespan machine (Figure 3-supplement 3). Specifically, in the automated lifespan assays, there are drastic changes in the slope of the survival curve which do not occur in the manual assays and may be suggestive that confounding factors may still operate or produce additional variation in ALM experiments despite relatively well-controlled environmental conditions.</p></body></sub-article><sub-article article-type="author-comment" id="sa4"><front-stub><article-id pub-id-type="doi">10.7554/eLife.104375.3.sa4</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Banse</surname><given-names>Stephen A</given-names></name><role specific-use="author">Author</role><aff><institution>University of Oregon</institution><addr-line><named-content content-type="city">Eugene</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Sedore</surname><given-names>Christine A</given-names></name><role specific-use="author">Author</role><aff><institution>University of Oregon</institution><addr-line><named-content content-type="city">Eugene, OR</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Coleman-Hulbert</surname><given-names>Anna</given-names></name><role specific-use="author">Author</role><aff><institution>University of Oregon</institution><addr-line><named-content content-type="city">Eugene</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Johnson</surname><given-names>Erik</given-names></name><role specific-use="author">Author</role><aff><institution>University of Oregon</institution><addr-line><named-content content-type="city">Eugene</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Onken</surname><given-names>Brian</given-names></name><role specific-use="author">Author</role><aff><institution>Rutgers University</institution><addr-line><named-content content-type="city">Piscataway</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Hall</surname><given-names>David</given-names></name><role specific-use="author">Author</role><aff><institution>Buck Institute for Research on Aging</institution><addr-line><named-content content-type="city">Novato</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Segerdell</surname><given-names>Erik</given-names></name><role specific-use="author">Author</role><aff><institution>University of Oregon</institution><addr-line><named-content content-type="city">Eugene</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Jackson</surname><given-names>E Grace</given-names></name><role specific-use="author">Author</role><aff><institution>University of Oregon</institution><addr-line><named-content content-type="city">Eugene</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Song</surname><given-names>Yuhua</given-names></name><role specific-use="author">Author</role><aff><institution>Rutgers University</institution><addr-line><named-content content-type="city">Piscataway</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Osman</surname><given-names>Haley C</given-names></name><role specific-use="author">Author</role><aff><institution>Buck Institute for Research on Aging</institution><addr-line><named-content content-type="city">Novato</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Xue</surname><given-names>Jian</given-names></name><role specific-use="author">Author</role><aff><institution>Rutgers University</institution><addr-line><named-content content-type="city">Piscataway</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Basttistoni</surname><given-names>Elena</given-names></name><role specific-use="author">Author</role><aff><institution>Buck Institute for Research on Aging</institution><addr-line><named-content content-type="city">Novato</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Guo</surname><given-names>Suhzen</given-names></name><role specific-use="author">Author</role><aff><institution>Rutgers University</institution><addr-line><named-content content-type="city">Piscataway</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Foulger</surname><given-names>Anna</given-names></name><role specific-use="author">Author</role><aff><institution>Buck Institute for Research on Aging</institution><addr-line><named-content content-type="city">Novato</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Achanta</surname><given-names>Madhuri</given-names></name><role specific-use="author">Author</role><aff><institution>Rutgers University</institution><addr-line><named-content content-type="city">Piscataway</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Sheikh</surname><given-names>Mustafa</given-names></name><role specific-use="author">Author</role><aff><institution>Buck Institute for Research on Aging</institution><addr-line><named-content content-type="city">Novato</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Fitzgibbon</surname><given-names>Theresa</given-names></name><role specific-use="author">Author</role><aff><institution>Buck Institute for Research on Aging</institution><addr-line><named-content content-type="city">Novato</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Willis</surname><given-names>John H</given-names></name><role specific-use="author">Author</role><aff><institution>University of Oregon</institution><addr-line><named-content content-type="city">Eugene</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Woodruff</surname><given-names>Gavin C</given-names></name><role specific-use="author">Author</role><aff><institution>University of Oregon</institution><addr-line><named-content content-type="city">Eugene</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Driscoll</surname><given-names>Monica</given-names></name><role specific-use="author">Author</role><aff><institution>Rutgers, The State University of New Jersey</institution><addr-line><named-content content-type="city">Piscataway</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Lithgow</surname><given-names>Gordon</given-names></name><role specific-use="author">Author</role><aff><institution>Buck Institute for Research on Aging</institution><addr-line><named-content content-type="city">Novato</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Phillips</surname><given-names>Patrick C</given-names></name><role specific-use="author">Author</role><aff><institution>University of Oregon</institution><addr-line><named-content content-type="city">Eugene</named-content></addr-line><country>United States</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the original reviews.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #1 (Public review):</bold></p><p>Summary:</p><p>This study highlights the strengths of using predictive computational models to inform <italic>C. elegans</italic> screening studies of compounds' eCects on aging and lifespan. The authors primarily focus on all-trans retinoic acid (atRA), one of the 5 compounds (out of 16 tested) that extended <italic>C. elegans</italic> lifespan in their experiments. They show that atRA has positive eCects on <italic>C. elegans</italic> lifespan and age-related health, while it has more modest and inconsistent eCects (i.e., some detrimental impacts) for <italic>C. briggsae</italic> and <italic>C. tropicalis</italic>. In genetic experiments designed to evaluate contributing mediators of lifespan extension with atRA exposure, it was found that 150 µM of atRA did not significantly extend lifespan in akt1 or akt-2 loss-of-function mutants, nor in animals with loss of function of aak-2, or skn-1 (in which atRA had toxic eCects); these genes appear to be required for atRA-mediated lifespan extension. hsf-1 and daf-16 loss-of-function mutants both had a modest but statistically significant lifespan extension with 150 µM of atRA, suggesting that these transcription factors may contribute towards mediating atRA lifespan extension, but that they are not individually required for some lifespan extension. RNAseq assessment of transcriptional changes in day 4 atRA-treated adult wild-type worms revealed some interesting observations. Consistent with the study's genetic mutant lifespan observations, many of the atRA-regulated genes with the greatest fold-change diCerences are known regulated targets of daf-2 and/or skn-1 signaling pathways in <italic>C. elegans</italic>. hsf-1 loss-offunction mutants show a shifted atRA transcriptional response, revealing a dependence on hsf-1 for ~60% of the atRA-downregulated genes. On the other hand, RNAseq analysis in aak-2 loss-of-function mutants revealed that aak-2 is only required for less than a quarter of the atRA transcriptional response. All together, this study is proof of the concept that computational models can help optimize <italic>C. elegans</italic> screening approaches that test compounds' eCects on lifespan, and provide comprehensive transcriptomic and genetic insights into the lifespan-extending eCects of all-trans retinoic acid (atRA).</p><p>Strengths:</p><p>(1) A clearly described and well-justified account describes the approach used to prioritize and select compounds for screening, based on using the top candidates from a published list of computationally ranked compounds (Fuentealba et al., 2019) that were crossreferenced with other bioinformatics publications to predict anti-aging compounds, after de-selecting compounds previously evaluated in <italic>C. elegans</italic> as per the DrugAge database. 16 compounds were tested at 4-5 diCerent concentrations to evaluate eCects on <italic>C. elegans</italic> lifespan.</p><p>(2) Robust experimental design was undertaken evaluating the lifespan eCects of atRA, as</p><p>it was tested on three strains each of <italic>C. elegans</italic>, <italic>C. briggsae,</italic> and <italic>C. tropicalis</italic>, with trial replication performed at three distinct laboratories. These observations extended beyond lifespan to include evaluations of health metrics related to swimming performance.</p><p>(3) In-depth analyses of the RNAseq data of whole-worm transcriptional responses to atRA revealed interesting insights into regulator pathways and novel groups of genes that may be involved in mediating lifespan-extension eCects (e.g., atRA-induced upregulation of sphingolipid metabolism genes, atRA-upregulation of genes in a poorly-characterized family of <italic>C. elegans</italic> paralogs predicted to have kinase-like activity, and disproportionate downregulation of collagen genes with atRA).</p></disp-quote><p>We thank the reviewer for highlighting the strengths of our paper.</p><disp-quote content-type="editor-comment"><p>Weaknesses:</p><p>(1) The authors' computational-based compound screening approach led to a ~30% prediction success rate for compounds that could extend the median lifespan of <italic>C. elegans</italic>. However, follow-up experiments on the top compounds highlighted the fact that some of these observed &quot;successes&quot; could be driven by indirect, confounding eCects of these compounds on the bacterial food source, rather than direct beneficial eCects on <italic>C. elegans</italic> physiology and lifespan. For instance, this appeared to be the case for the &quot;top&quot; hit of propranolol; other compounds were not tested with metabolically inert or killed bacteria. In addition, there are no comparative metrics provided to compare this study's ~30% success rate to screening approaches that do not use computational predictions.</p></disp-quote><p>We do test whether compounds have a direct e:ect on bacterial growth. We have the text to clarify that fact. There may be potential lifespan e:ects from atRA due to changes in bacterial metabolites, however exploring that more fully is beyond the scope of the current work.</p><p>We very much appreciate the question regarding relative success. An appropriate benchmark for “hit rate” is perhaps best provided by Petrascheck, Ye &amp; Buck (2007), who conducted a large-scale screen of 88,000 compounds for e:ects on adult lifespan in <italic>C. elegans</italic>. They found an initial screening hit rate of 1.2% (1083/88000), which were then retested for a verified hit rate of 0.13% (115/88000), with a retest failure rate of 89% (968/1083). Similarly, Lucanic et al. (2016) screened 30,000 compounds, with an initial hit rate of approximately 1.7% (~500/30000), or these 180 were selected for retesting, resulting in a final verified hit rate of 0.19% (57/29680), which is comparable to the Petrascheck et al. result. The text in the discussion has been modified to include these studies.</p><disp-quote content-type="editor-comment"><p>(2)Transcriptomic analyses of atRA eCects were extensive in this study, but evaluations and discussions of non-transcriptional eCects of key proposed regulators (such as AMPK) were limited. For instance, non-transcriptional eCects of aak-2/AMPK might account for its requirement for mediating lifespan extension eCects, since aak-2 was not required for a major proportion of atRA transcriptional responses.</p></disp-quote><p>We naturally agree with the reviewer that non-transcriptional e:ects are possible and well worth pursuing in future work. However, these e:ects will still show within our study, as any upstream non-transcriptional e:ects are likely to reveal themselves in downstream transcriptional changes, as measured here.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Public review):</bold></p><p>Summary:</p><p>In this manuscript, Banse et al. experimentally validate the power of computational approaches that predict anti-aging molecules using the multi-species approach of the Caenorhabditis Intervention Testing Program (CITP). Filtering candidate molecules based on transcriptional profiles, ML models, literature searches, and the DrugAge database, they selected 16 compounds for testing. Of those, eight did not aCect <italic>C. elegan</italic>'s lifespan, three shortened it, and five extended <italic>C. elegan</italic>'s lifespan, resulting in a hit rate of over 30%. Of those five, they then focused on all-trans-retinoic acid (atRA), a compound that has previously resulted in contradictory eCects. The lifespan-extending eCect of atRA was consistent in all <italic>C. elegans</italic> strains tested, was absent in <italic>C. briggsae</italic>, and a small eCect was observed in some <italic>C. tropicalis</italic> strains. Similar results were obtained for measures of healthspan. The authors then investigated the mechanism of action of atRA and showed that it was only partially dependent on daf-16 but required akt-1, akt-2, skn-1, hsf-1, and, to some degree, pmk-1. The authors further investigate the downstream eCects of atRA exposure by conducting RNAseq experiments in both wild-type and mutant animals to show that some, but surprisingly few, of the gene expression changes that are observed in wild-type animals are lost in the hsf-1 and aak-2 mutants.</p><p>Strengths:</p><p>Overall, this study is well conceived and executed as it investigates the eCect of atRA across diCerent concentrations, strains, and species, including life and health span. Revealing the variability between sites, assays, and the method used is a powerful aspect of this study. It will do a lot to dispel the nonsensical illusion that we can determine a percent increase in lifespan to the precision of two floating point numbers.</p><p>An interesting and potentially important implication arises from this study. The computational selection of compounds was agnostic regarding strain or species diCerences and was predominantly based on observations made in mammalian systems. The hit rate calculated is based on the results of <italic>C. elegans</italic> and not on the molecules' eCectiveness in Briggsae or Tropicalis. If it were, the hit rate would be much lower. How is that? It would suggest that ML models and transcriptional data obtained from mammals have a higher predictive value for <italic>C. elegans</italic> than for the other two species. This selectivity for <italic>C. elegans</italic> over <italic>C. tropicalis</italic> and <italic>C. Briggsae</italic> seems both puzzling and unexpected. The predictions for longevity were based on the transcriptional data in cell lines.</p></disp-quote><p>This is a common observation in the CITP for which we do not currently have a satisfying explanation. For whatever reason, <italic>C. elegans</italic> is much more responsive to compounds than other species, much like it is more responsive to RNAi and other environmental interventions. It may be less active in detoxifying external agents than the other species, although this is just speculation at the moment. We continue to investigate this question, but that work is beyond the scope of the present paper.</p><disp-quote content-type="editor-comment"><p>Would it be feasible to compare the mammalian data to the transcriptional data in Figure 5 and see how well they match? While this is clear beyond the focus of this study, an implied prediction is that running RNAseqs for all these strains exposed to atRA would reveal that the transcriptional changes observed in the strains where it extends lifespan the most should match the mammalian data best. Otherwise, how could the mammalian datasets be used to predict the eCects of <italic>C. elegans</italic> over <italic>C. Briggsae</italic> or <italic>C. Tropicalis</italic> have more predictive for one species than the other? There are a lot of IFs in this prediction, but such an experiment would reconsider and validate the basis on which the original predictions were made.</p></disp-quote><p>These questions are worth pursuing in the future but are beyond the scope of the current work.</p><disp-quote content-type="editor-comment"><p>Weaknesses:</p><p>Many of the most upregulated genes, such as cyps and pgps are xenobiotic response genes upregulated in many transcriptional datasets from <italic>C. elegans</italic> drug studies. Their expression might be necessary to deal with atRA breakdown metabolites to prevent toxicity rather than confer longevity. Because atRA is very light sensitive and has toxicity of breakdown, metabolites may explain some of the diCerences observed with the lifespan of machine eCects compared to standard assay practices.</p></disp-quote><p>This is certainly a possibility, although we often observe longer lifespans on the ALM, perhaps because they themselves are stressful, thereby providing a more sensitive background environment for detecting positive stress response modulators.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #3 (Public review):</bold></p><p>Summary:</p><p>In this study, Banse et al., demonstrate that combining computer prediction with genetic analysis in distinct Caenorhabditis species can streamline the discovery of aging interventions by taking advantage of the diverse pool of compounds that are currently available. They demonstrate that through careful prioritization of candidate compounds, they are able to accomplish a 30% positive hit rate for interventions that produce significant lifespan extensions. Within the positive hits, they focus on all-trans retinoic acid (atRA) and discover that it modulates lifespan through conserved longevity pathways such as AKT-1 and AKT-2 (and other conserved Akt-targets such as Nrf2/SKN-1 and HSF1/HSF-1) as well as through AAK-2, a conserved catalytic subunit of AMPK. To better understand the genetic mechanisms behind lifespan extension upon atRA treatment, the authors perform RNAseq experiments using a variety of genetic backgrounds for cross-comparison and validation. Using this current state-of-the-art approach for studying gene expression, the authors determine that atRA treatment produces gene expression changes across a broad set of stress-response and longevity-related pathways. Overall, this study is important since it highlights the potential of combining traditional genetic analysis in the genetically tractable organism <italic>C. elegans</italic> with computational methods that will become even more powerful with the swift advancements being made in artificial intelligence. The study possesses both theoretical and practical implications not only in the field of aging but also in related fields such as health and disease. Most of the claims in this study are supported by solid evidence, but the conclusions can be refined with a small set of additional experiments or re-analysis of data.</p><p>Strengths:</p><p>(1) The criteria for prioritizing compounds for screening are well-defined and easy to replicate (Figure 1), even for scientists with limited experience in computational biology. The approach is also adaptable to other systems or model organisms.</p><p>(2) I commend the researchers for doing follow-up experiments with the compound propranolol to verify its eCect on lifespan (Figure 2 Supplement 2), given the observation that it aCected the growth of OP50. To prevent false hits in the future, the reviewer recommends the use of inactivated OP50 for future experiments to remove this confounding variable.</p><p>(3) The sources of variation (Figure 3, Figure Supplement 2) are taken into account and demonstrate the need for advancing our understanding of the lifespan phenotype due to inter-individual variation.</p><p>(4) The addition of the <italic>C. elegans</italic> swim test in addition to the lifespan assays provides further evidence of atRA-induced improvement in longevity.</p><p>(5) The RNAseq approach was performed in a variety of genetic backgrounds, which allowed the authors to determine the relationship between AAK-2 and HSF-1 regulation of the retinoic acid pathway in <italic>C. elegans</italic>, specifically, that the former functions downstream of the latter.</p></disp-quote><p>We thank the reviewer for highlighting these strengths.</p><disp-quote content-type="editor-comment"><p>Weaknesses:</p><p>(1) The filtering of compounds for testing using the DrugAge database requires that the database is consistently updated. In this particular case, even though atRA does not appear in the database, the authors themselves cite literature that has already demonstrated atRA-induced lifespan extension, which should have precluded this compound from the analysis in the first place.</p></disp-quote><p>As often happens in science, this work was initiated before Statzer et al. (2021) was published. As such, it is included in the test set.</p><disp-quote content-type="editor-comment"><p>(2) The threshold for determining positive hits is arbitrary, and in this case, a 30% positive hit rate was observed when the threshold is set to a lifespan extension of around 5% based on Figure 1B (the authors fail to explicitly state the cut-oC for what is considered a positive hit).</p></disp-quote><p>Any compound that statistically increases lifespan is considered a positive hit by the CITP. The CITP in general is powered to detect minimum e:ect sizes of 5%.</p><disp-quote content-type="editor-comment"><p>(3) The authors demonstrate that atRA extends lifespan in a species-specific manner (Figure 3). Specifically, this extension only occurs in the species <italic>C. elegans</italic> yet, the title implies that atRA-induced lifespan extension occurs in diCerent Caenorhabditis species when it is clearly not the case. While the authors state that failure to observe phenotypes in <italic>C. briggsae</italic> and <italic>C. tropicalis</italic> is a common feature of CITP tests, they do not speculate as to why this phenomenon occurs.</p></disp-quote><p>Please see the comment above.</p><disp-quote content-type="editor-comment"><p>(4) There are discrepancies between the lifespan curves by hand (Figure 3 Figure Supplement 1) and using the automated lifespan machine (Figure 3 Supplement 3). Specifically, in the automated lifespan assays, there are drastic changes in the slope of the survival curve which do not occur in the manual assays. This may be due to improper filtering of non-worm objects, improper annotation of death times, or improper distribution of plates in each scanner.</p></disp-quote><p>Our storyboarding SOP ensures that discrepancies in the shape of the curve are unlikely to be due to annotation errors. We check every page of the storyboard by hand, so all non-worm objects are excluded. Furthermore, the first and last ~10% of deaths are checked by hand (as we observed that these time points are the most likely to be wrongly called by the software), with a few deaths chosen at random from the middle to ensure that the software is calling death times accurately. If we find a high amount of inaccurately called deaths, the entire plate is annotated by hand. For this specific experiment, 18% of the total deaths were hand annotated. Plates are randomly distributed across each scanner in an e:ort to prevent bias. As noted above, it does appear that the ALM environment and the “by hand” environment are somewhat di:erent.</p><disp-quote content-type="editor-comment"><p>(5) The authors miss an opportunity to determine whether the lifespan extension phenotype attributed to the retinoic acid pathway is mostly transcriptional in nature or whether some of it is post-transcriptional. The authors even state &quot;that while aak-2 is absolutely required for the longevity eCects of atRA, aak-2 is required only for a small proportion (~1/4) of the transcriptional response&quot;, suggesting that some of the eCects are post-transcriptional. Further information could have been obtained had the authors also performed RNAseq analysis on the tol-1 mutant which exhibited an enhanced response to atRA compared to wild-type animals, and comparing the magnitude of gene expression changes between the tol-1 mutant and all other genetic backgrounds for which RNAseq was performed.</p><p><bold>Reviewer #1 (Recommendations for the authors):</bold></p><p>(1) Will the raw RNA-seq data be publicly deposited? Please clarify. This would strengthen the value of the study.</p></disp-quote><p>All data is available. We have clarified this in the text.</p><disp-quote content-type="editor-comment"><p>(2) Since all-trans retinoic acid is a metabolite of vitamin A, it seems important to include a discussion of and reference to the recent study SKN-1/NRF2 upregulation by vitamin A is conserved from nematodes to mammals and is critical for lifespan extension in <italic>Caenorhabditis elegans</italic> (Sirakawin et al Cell Reports 2024). Sirakawin et al include data that corroborates and expands on the findings of the current study, including the observation that vitamin A reduces whole-body lipid deposition (agrees with some of the transcriptional findings in the current study); that vitamin A protects against oxidative stress; that vitamin A elevates expression of gst-5, skn-1, and pmk-1; and that loss-offunction mutation of skn-1 has similar eCects to the current study, in terms of suppressing lifespan-extending eCects of vitamin A. In addition, adding some discussion of oxidative stress would strengthen this work, in light of widespread perceptions of the antioxidant properties of vitamin A (and its metabolites).</p></disp-quote><p>Thank you for this suggestion. We have added this citation to the discussion.</p><disp-quote content-type="editor-comment"><p>(3) Minor typo: Lines 341-342 - After a sentence that contains the phrase &quot;collagen and neuropeptide related genes&quot;, the next sentence uses the term &quot;the latter&quot; in reference to the collagen genes (should be &quot;the former&quot;).</p></disp-quote><p>Edited in text.</p><disp-quote content-type="editor-comment"><p>(4) Minor correction: In Figure 6, the information in the figure legend is swapped for figure panels (A and B).</p></disp-quote><p>Edited in figure caption.</p><disp-quote content-type="editor-comment"><p>(5) To me, the subtitle heading &quot;Loss of AMPK leads to a unique transcriptional profile in response to atRA treatment&quot; (Line 403) is misleading, considering the contents of the text in that section, and the data presented in Figure 6.</p></disp-quote><p>We have altered this heading to reflect this comment.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Recommendations for the authors):</bold></p><p>Using diCerent colors for the diCerent testing sites would make Figure 3 more readable.</p></disp-quote><p>Edited so that each lab is represented by a di:erent shade of green.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #3 (Recommendations for the authors):</bold></p><p>It would be interesting to investigate the eCect of even higher concentrations of atRA as it has been reported that atRA accumulation is associated with deleterious phenotypes in mice (Snyder et al., 2020, FASEB J).</p></disp-quote><p>We tested the highest concentration (150 uM) based on the solubility of the compound using our standardized plate treatment protocol, so we are unable to test higher concentrations.</p><disp-quote content-type="editor-comment"><p>A good first guess for a downstream retinoid receptor is nhr-23 which is the homolog of the vertebrate ROR genes. Stehlin-Gaon et al. (2003, Nat Struct Mol Biol) have shown that atRA is a ligand for the orphan nuclear receptor RORβ. It might be interesting to study the eCects of atRA on an nhr-23::AID (auxin inducible degron) background. This would allow you to circumvent the developmental phenotypes as a result of nhr-23 knockdown. Patrick/Stephen</p></disp-quote><p>A few notes on the text/figures:</p><disp-quote content-type="editor-comment"><p>Line 342: I believe the authors meant &quot;former&quot; instead of &quot;latter&quot;.</p></disp-quote><p>Corrected in text.</p><disp-quote content-type="editor-comment"><p>Line 346: Can you also highlight col-144 in Fig. 5 S1?</p></disp-quote><p>This is not really feasible, as it is in the cluster near the where the axes meet (red arrow).</p><disp-quote content-type="editor-comment"><p>Line 400: CUB pathogen - based on Figure 6 Supp 1, this occurs in aak-2 and not in hsf-1.</p></disp-quote><p>Great catch by the reviewer. We have updated the figure with the correct information.</p><disp-quote content-type="editor-comment"><p>Line 414: hedgehog-like signaling - occurs in hsf-1 instead of aak-2. Similar inconsistencies occur in lines 415 (sterol), 417 (C-type lectin), and 418 (unassigned pathogens)</p></disp-quote><p>We have updated the text to eliminate potential conflicts/confusion in the presentation here.</p><disp-quote content-type="editor-comment"><p>Line 434: I believe the authors meant Figure &quot;6&quot; instead of &quot;7&quot;</p></disp-quote><p>Edited in text.</p><disp-quote content-type="editor-comment"><p>Line 475: Is it &quot;fifteen&quot; or &quot;sixteen&quot; compounds initially targeted?</p></disp-quote><p>Edited in text.</p><disp-quote content-type="editor-comment"><p>Can you please include the population sizes for the lifespan assays if not yet included in the detailed protocol to be published in FigShare (to which I currently do not have access to)?</p></disp-quote><p>Added “50 animals per petri plate” to Lifespan Assay methods section; additionally, all sample sizes are included as a summary tab in each dataset on figshare.com (10.6084/m9.figshare.c.6320690).</p></body></sub-article></article>